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ABSTRACT 
SYNTHETIC STRATIGIES TOWARD THE TOTAL SYNTHESIS OF TETRAPETALONE A 
In 2003 Hirota and coworkers reported the isolation of tetrapetalone A (1) from the 
culture filtrate of Streptomyces sp. USF-4727, a Streptomyces strain isolated from a soil sample 
taken from Yada, Shizuoka City, Japan. The molecular structure of 1 was initially reported and 
then revised in a series of two papers which both appeared in 2003. In addition to the interesting 
molecular architecture, 1 demonstrated inhibition of soybean lipoxygenase (SBL) (IC50 of 190 
M) comparable to well-known human lipoxygenase and cyclooxygenase inhibitors. While no 
total synthesis has been reported to date, the groups of Porco, Hong and Sarpong have disclosed 
synthetic approaches toward the tetrapetalone core. 
Efforts in the Wood group to synthesize 1 are based on highly convergent synthetic 
strategies, the first of which was directed at constructing an advanced indanone coupling partner 
via a Stetter reaction. To this end, a route employing a diastereoselective Claisen rearrangement 
afforded a highly substituted Stetter reaction precursor but we were unable to realize the latter 
chemistry. We developed a synthetic route employing a Dieckmann condensation to furnish a 
highly functionalized tetramic acid. Coupling the tetramic acid with ortho substituted aryl 
halides under aryl amidation conditions proved futile. In an effort to promote an intramolecular 
aryl amidation we pursued an alternative coupling strategy, which relied on an extremely 
challenging ring closing metathesis. The desired ring closing metathesis product was not 
realized. Relay ring closing metathesis investigations provide confidence that the desired olefins 
will engage in metathesis chemistry. Current synthetic efforts are focused on a diastereoselective 
intramolecular Tsuji-Trost allylation to furnish a highly functionalized indanone, which has 
proven to be a competent coupling partner with allylamine under Pd(0)-catalyzed aryl amination 
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conditions. Elaboration of this advanced indanone intermediate is expected to eventually provide 
a total synthesis of 1.   
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Chapter 1  
Tetrapetalones: Introduction and Background  
1.1 Isolation of the Tetrapetalones and Ansaetherone 
In 2003, as part of an ongoing effort to discover novel lipoxygenase inhibitors, Hirota and 
coworkers screened several Streptomyces strains using a soybean lipoxygenase inhibitory assay 
and identified tetrapetalone A (1) (Figure 1.1) from the culture filtrate of Streptomyces sp. 
USF-4727, a Streptomyces strain isolated from a soil sample taken from Yada, Shizuoka City, 
Japan. 
1,2
 In a subsequent report, Hirota and coworkers reported the isolation of three additional 
congeners that also possess lipoxygenase inhibitory properties from the culture filtrate of the 
same Streptomyces.  Structurally these latter compounds were determined to be oxidized variants 
of 1 and were aptly named tetrapetalone B (2), tetrapetalone C (3), and tetrapetalone D (4).
3
  
In 2008, the Hirota group reported efforts wherein a 1,1-diphenyl-2-picrylhydrazyl 
(DPPH) radical scavenging assay was employed to screen the culture broth of Streptomyces sp. 
USF-4727.  These studies resulted in the isolation of ansaetherone (5), a radical scavenger that is 





Figure 1.1 Tetrapetalone Series and Ansaetherone 
1.2 Tetrapetalone A Structure Elucidation 
The molecular structure of tetrapetalone A (1) was initially reported and then revised in a 
series of two papers which both appeared in 2003.
1,5
 In the initial report the structure of 
tetrapetalone A (1) was assigned as illustrated as I in Figure 1.2 on the basis of spectroscopic 












C HMBC and 2D-INADEQUATE data.
1,5
 
Subsequent efforts to confirm the position and substitution pattern of the nitrogen atom 




N HMBC study of the long-range coupling patterns. The latter revealed the 
presence of an amide nitrogen (due to its chemical shift), which possessed long-range couplings 
to both 13-H and 17-H. This result was clearly not consistent with the originally assigned 
























































































































depicted as 1, wherein the positions of the amide nitrogen and C(14) oxygen are interchanged 
(c.f., I and II in Figure 1.2). 
 
Figure 1.2 Structural Revision of Tetrapetalone A 
The stereochemistry of tetrapetalone A (1) was assigned on a piece-by-piece basis. The 
relative stereochemistry of the 2-methyltetrahydropyran unit was initially assigned based on a 
comparison of 
1
H NMR derived chemical shift and coupling constant data to that for 
-D-rhodinose (7) and further supported by 
1
NOESY correlations observed for 1’-H and 5’-H. 
The absolute stereochemistry of this ring was determined by a modified Mosher analysis which 
revealed the absolute stereochemistry at C-4’ to be R.  
The relative stereochemistry of the tetracyclic core was assigned based upon 
spectroscopic studies of the O-methylated derivative 6 (Figure 1.3). Specifically, the syn 
relationship of the C(7)-H, C(9)-H and ethyl group residing at C(4) as well as the 1,3-syn 
relationship of the C(9)-H and C(15)-OH were all assigned based on NOE correlations derived 
from a NOESY spectrum.
5
 The absolute stereochemistry was assigned as illustrated based upon a 







































Figure 1.3 Stereochemical Assignment of Tetrapetalone A  
1.3 Biological Activity 
Tetrapetalone A (1) demonstrated inhibition of soybean lipoxygenase (SBL) comparable 
to the well-known human lipoxygenase and cyclooxygenase inhibitors nordihydroguaiareic acid 
(NDGA) (8) and kojic acid (9) (Table 1.1 and Figure 1.4). Interestingly, tetrapetalones B–D (2-4) 
also demonstrated SBL inhibition;
3
 however, methylation of tetrapetalone A resulted in a 
compound (i.e., 10) that demonstrated very little SBL inhibitory activity.
2
 Given that NDGA (8) 
inhibits both human lipoxygenase and cyclooxygenase, there is a possibility that the 
tetrapetalones (1-4) may also display inhibitory activity against these latter enzymes. 
  






























































































Table 1.1 Inhibitory Activities against Soybean Lipoxygenase 
 
Human lipoxygenase (HLO) and cyclooxygenase (COX) mediate the metabolism of 
arachidonic acid (11), a key precursor to a large family of hormones that are generally classified 
as eicosanoids and include the prostaglandins, thromboxanes, prostacyclins and leukotrienes 
(Figure 1.5).
6
 The resulting leukotrienes, lipoxins, and prostaglandins are important signaling 
molecules that are short-lived and display their effects on cells in proximity to their point of 
biosynthetic origin. Nevertheless these compounds have been identified as important to the 
modulation of many biological processes involved in human diseases, including: inflammation, 
bronchospasm, regulation of blood pressure, congestion, ion transport across membranes, and 
synaptic transmission.
2,3
 Thus, searching for potent inhibitors of these oxygenases continues to 
be a significant topic in medicinal chemistry. 
Cyclooxygenase (COX) has become a major target for the development of 
anti-inflammatory drugs.
6
 Aspirin (12), a common anti-inflammatory, anti-pyretic, 
anti-thrombotic analgesic, has been used for centuries and only in recent years has been shown to 
irreversibly inhibit cyclooxygenase by acylating a serine residue within the active site. The 































The leukotriene pathway has also become an important target for drug discovery.
6
 
Overproduction of leukotrienes causes asthmatic attacks, and thus inhibiting the production of 
these signaling molecules is one target of antiasthmatic drugs such as Prednisone (13). 
 
Figure 1.5 General Archidonic Acid Pathway and Known Inhibitors 
In contrast to HLO, the role of SBL is to catalyze the oxidation of certain unsaturated 
fatty acids possessing a cis,cis-1,4-pentadiene moiety.
7
 However, there is homology in the amino 
acid sequence of the active sites in SBL and human 5-lipoxygenase (5-LO). Although the ideal 
substrate for SBL is linoleic acid, arachidonic acid (11) can also serve as a substrate and 
undergoes a reaction analogous to 15-lipoxygenase activity.
2
 In addition the well-known human 
lipoxygenase/cyclooxygenase inhibitor NDGA (8), a natural product, also has been shown to be 
a potent inhibitor of SBL. Clearly, given that human and soybean lipoxygenases act on several 
common substrates, the search for possible inhibitors of these enzymes can be guided by studies 































1.4 Biosynthesis  
1.4.1 AHBA-Derived Natural Products 
3-Amino-5-hydroxybenzoic acid (AHBA) derived natural products are a sizeable group 
of secondary metabolites produced by microorganisms.
8
 They fall, so far, into three structural 
classes; the great majority represents the family of ansamycins, in which AHBA has served as a 
starter for a polyketide assembly ultimately resulting in a macrocyclic lactam (Figure 1.6). The 
ansamycin class can be further segregated based on the incorporation of the AHBA unit into 
naphthalenic (14–19) and benzenic (20–25) ansamycins. The tetrapetalones (1–4) and 
ansaetherone (5) fall into the benzenic ansamycin structural class.  A second class is the 
mitomycins (26), in which AHBA has been combined with an aminosugar moiety to give unique 
tricyclic structures. A third class can be classified as degraded ansamycins (27). In most of the 
compounds derived from AHBA this starter unit eventually serves as a precursor to a structural 
“meta-C7N” unit comprised of a six-membered carbocycle, aromatic (naphthalenic/benzenic) or 
quinoid, functionalized with a carbon and a nitrogen in a meta arrangement (Highlighted in Bold, 
Figure 1.6).  
 8 
 












































































































































































































































Prior to its incorporation into the polyketide biosynthetic machinery, AHBA is 
biosynthesized by a unique amino-shikimate biosynthetic pathway, illustrated in Scheme 1.1.
8,9
 
In three reactions paralleling the normal shikimate pathway, the imine of erythrose 4-phospate 34 
is converted into 5-deoxy-5-amino-dehydroshikimic acid 37, which is then aromatized to AHBA 
by the pyriodoxal phosphate-enzyme, AHBA synthase. The origin of the imine 34 was traced to 
the biosynthesis of kanosamine (31), which then undergoes phosphorylation, isomerization and 
cleavage by transketolase. 
Rifamycins were the first group of ansamycins isolated from a microorganism,
8
 and 
accordingly genes responsible for AHBA biosynthesis were first identified as part of the 
rifamycin biosynthetic gene cluster. Most of the products encoded by these genes are consistent 
with the proposed AHBA biosynthetic pathway, such as aminoDAHP synthase (RifH), 
aminoDHQ synthase (RifG), aminoDHQ dehydratase (RifJ), AHBA synthatase (RifK) and those 
putatively responsible for the early steps in the biosynthesis of imine 34, including 
oxidoreductase (RifL) and kinase (RifN) (Scheme 1.1). AHBA synthase catalyzes both the 
reductive amination of 29 to 30 at the early stage of the pathway and the final dehydration of 37 
to AHBA (38). 
 10 
 
Scheme 1.1 Proposed AHBA Biosynthetic Pathway 
1.4.2 Tetrapetalone Biosynthesis 
Biosynthesis of the tetrapetalones (1–4) has, so far, only been studied by feeding 
experiments with isotope-labeled precursors.
8,10
 The feeding experiments indicated that the 
ansamacrocyclic aglycon of the tetrapetalones is assembled on a polyketide synthase (PKS) 
using AHBA (38) as the starter unit, followed by incorporation of three propionate (39) and one 
butyrate (40) extender units (Scheme 1.2). The deoxysugar moiety is derived from glucose (41). 
The acetoxy groups of tetrapetalones B (2) and D (4) are derived from acetate. 
Due to the similar structural features of ansaetherone (5), it is proposed to be an 
intermediate compound in the tetrapetalone biosynthesis (Scheme 1.2).
4
































































































biosynthetic pathway, suggests that the tetracyclic aglycon of the tetrapetalones is formed after 
conjunction with the sugar moiety. First, AHBA is synthesized (Scheme 1.1) and employed as a 
starter unit for constructing an ansa bridge containing intermediate. Second, a sugar moiety 
derived from a glucose unit (41) is attached to the ansa bridge-containing fragment to provide 
precursor 42. Precursor 42 is subjected to structural modifications to afford ansaetherone (5), 
from which tetrapetalone A (1) is derived. Oxidation of 1 at C-17 to introduce a hydroxyl group 
and subsequent acetoxylation affords tetrapetalone B (2). Tetrapetalone A (1) and B (2) are 
oxidized to tetrapetalones C (3) and D (4), respectively. This oxidation was supported by 
experimental evidence; exposure of tetrapetalones A (1) and B (2) to aqueous hydrogen peroxide 
yielded the oxidized tetrapetalones C (3) and D (4), respectively. 
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Scheme 1.2 Proposed Biosynthesis of Tetrapetalones 
1.5 Previous Synthetic Approaches Towards the Tetrapetalones 
















































































































Porco and colleagues at Boston University became interested in the tetrapetalones due to 
the unique structural features of the tetracyclic core and their similarity to the ansamycin 
antibiotics.
11
 Based on the proposed biosynthesis of the tetrapetalones which involves 
macrocyclic lactam formation followed by oxidation of the aromatic core, Porco and coworkers 
envisioned a corresponding synthetic strategy wherein the tetracyclic core of the tetrapetalones 
(1–4) would derive from an oxidative transannular [4+3] cyclization process. In the event, 
oxidation of hydroquinone 45 was expected to provide the arene-derived oxonium ion 44 that 
would engage the diene fragment and promote subsequent reaction with the amide nitrogen to 
furnish the tetracyclic skeleton of the tetrapetalones (43). Hydroquinone 45 seen as arising from 
a ring closing metathesis (RCM) reaction of acyclic substrate 46, which would, in turn, derive 
from condensation of aniline 47 and carboxylic acid 48.  
 14 
 
Scheme 1.3 Porco’s Retrosynthetic Analysis of Tetrapetalone A Aglycon 
Porco initiated his synthesis with an asymmetric crotylation of aldehyde 49 using the 
chiral cis-crotylboronate derived from L-diisopropyltartrate (50) to afford chiral alcohol 51 as a 
single diastereomer in quantitative yield (Scheme 1.4). Silylation followed by reduction of the 
nitro group afforded the desired aniline 47 in 62% yield over two steps. Synthesis of the requisite 
diene acid 48 commenced with an Evans syn-aldol condensation of dienal 52 with chiral 
oxazolidinone 53 to afford chiral alcohol 54 as a single diastereomer. Methoxy methyl protection 
of the alcohol and hydrolysis of the chiral auxilary afforded carboxylic acid 48 in 85% yield over 



























































Scheme 1.4 Synthesis of Aniline and Carboxylic Acid Coupling Partners  
 
Coupling of fragments 47 and 48 was achieved via the intermediacy of an acid chloride 
and provided triene 46 without epimerization (Scheme 1.5). However, treatment of acyclic triene 
46 with the Grubbs second-generation catalyst (56) did not produce the desired macrocyclic 
diene 55. 
1
H NMR spectroscopic analysis of the crude reaction mixture revealed that the 
ruthenium catalyst had reacted with the monosubstituted olefin, with no evidence of metathesis 
of the 1,1-disubstituted olefin. Porco and coworkers propose that this particular reaction, which 
attempts to incorporate a rather unreactive 1,1-disubstituted olefin into a ring closing metathesis 
event that would furnish a strained “meta bridging” macrocycle 55, was beyond the scope of the 






















(85% yield, three steps)
2. LiOH, H2O2

























     Et3N, –78 ® 0 °C
2. NaBH4, S8
    THF, 65 °C











Scheme 1.5 Ring Closing Metathesis Approach to Macrolactam  
The failure of the RCM to 45 led Porco and coworkers to next target what they believed 
would be a less strained and synthetically more accessible “ortho-bridge” macrolactone 
intermediate (i.e., 57).  Subsequent intramolecular acyl transfer was envisioned as giving rise to 
the ring-expanded macrolactam 45 (Scheme 1.6). Lactone 57 would be prepared via selective 
reduction of the nitro group of 58, which would be obtained from a ring closing metathesis 
reaction applied to the coupling product derived from nitrophenol 59 and acid chloride 60. 
i. (COCl)2, cat. DMF












































Scheme 1.6 Macrolactam Revised Retrosynthetic Analysis 
The revised synthesis began with nitration of phenol 61 followed by silylation to afford 
bis-silylether 62 in 70% yield, over two steps (Scheme 1.7). Asymmetric crotylation of aldehyde 
62 using cis-crotylboronate 50 provided chiral alcohol 63 as a single diastereomer in quantitative 
yield. Deprotonation of the secondary alcohol of 63 generated the sodium phenoxide species 64 
in situ through intramolecular transfer of a silyl group. Subsequent addition of acid chloride 60 
(Et3N and DMAP) resulted in acylation of 64 to afford ester 65. Exposure of 65 to Grubbs 
second-generation catalyst resulted in RCM macrocyclization to afford the cyclic diene, which 
upon exposure to tetrabutylammonium fluoride (TBAF) underwent selective desilylation to 
furnish nitrophenol 58. Chemoselective reduction of the nitro group in 58 was achieved when 
Pd/CaCO3 was employed as the catalyst in a cosolvent of triethylamine. Filtration of the reaction 
mixture through silica gel followed by elution with ethyl acetate induced the desired acyl 















































Scheme 1.7 Synthesis of Macrolactam 
With macrolactam 45 in hand, Porco and coworkers next investigated their key step, 
biomimetic transannular oxidative [4+3] cyclization. It was hypothesized that exposure of 
hydroquinone 45 to the hypervalent iodine reagent, (diacetoxyiodo)benzene, would result in an 
arene-derived oxonium ion that could be trapped by the diene fragment, which subsequently 
could react with the amide nitrogen atom to form the tetracyclic skeleton (Scheme 1.3). Upon 
first inspection of the oxidized product it was believed that this was indeed the case and Porco 
published what he believed was an approach to the core ring system;
11
 however, a year later, 
after further spectral analysis, it was realized that the oxidized product was not the tetracyclic 







1. Cu(NO3)× 3 H2O
    Ac2O, 0 ® 25 °C
2. TBSCl, Et3N, DMF























































1. Grubbs II (52)
    benzene, 80 °C
2. TBAF, HOAc
    THF, 0 °C


















Scheme 1.8 Attempted Biomimetic Oxidative Transannular [4+3] Cyclization 
1.5.2 Hong’s Approach to the Tetrapetalones 
Hong and colleagues at the Shanghai Institute of Organic Chemistry became interested in 
the tetrapetalones and also sought to take advantage of a biomimetic approach.
13
 Recognizing 
that the formation of the fully substituted carbon center (C4) bearing an amide group may have 
hampered the previous biomimetic endeavor by the Porco group, Hong and coworkers planned to 
explore an alternate biomimetic approach wherein the cyclohexadienone moiety of 1 was 
envisaged as arising from a late stage oxidation of an intermediate tetracyclic phenol 68 (Scheme 
1.9). This strategy, which calls for formation of the C(7)–C(15) bond prior to introduction of the 
C(15)-hydroxy group is strategically similar to the biosynthesis of ansamycins. This strategy 
relies on the proposed ability of singlet oxygen to effect oxidation to the requisite C(15)-alcohol 







































Scheme 1.9 Construction of the 1-Benzazepine via N-Acyliminium Ion Cyclization 
With an overarching synthetic design in mind, the Hong group began to consider 
approaches to the requisite 1-benzazepines (C-ring) and proposed generating a reactive 
N-acyliminium ion (69) that would engage a pendant olefin in a cyclization reaction to furnish 
carbocation 70 which, upon nucleophilic quenching, would afford the requisite ring system (e.g., 
71) (Scheme 1.9). Based on seminal contributions from Speckamp and Hiemstra, N-acyliminium 
ion cyclization chemistry has evolved into a powerful reaction that has played a key role in many 
natural product syntheses;
14
 thus, Hong and coworkers had considerable precedents on which to 
base their proposed construction of the tetracyclic core of the tetrapetalones.  
The Hong group initiated their synthetic efforts with a three step sequence that began 
with exposure of cinnamic alcohol derivative 72 to a Johnson-Claisen rearrangement and was 
followed by diisobutylaluminum hydride (DIBAL) reduction of the resultant ester, benzyl 
protection of the resultant primary alcohol afforded 1,1-disubstituted olefin 73 in 54% overall 
yield (Scheme 1.10). Reduction of the nitro group followed by condensation with succinic 
anhydride furnished imide 74 which, upon careful treatment with DIBAL, underwent 
monoreduction to the desired -hydroxylactam 75. Having set the stage for the key 
N-acyliminium cyclization, the -hydroxylactam 75 was exposed to a combination of iron 
 21 
trichloride (catalytic) and trimethylchlorosilane (excess) and found to afford a mixture of 
diastereomeric products (76 and 77).  
 
Scheme 1.10 Speckamp Cyclization 
In efforts to further advance the benzazepine intermediates to compounds possessing the 
tetrapetalone B-ring (Scheme 1.11), Hong and coworkers moved forward with the desired 
diastereomer 77. To this end, tetrahydrofuran 77 was oxidized to the corresponding lactone (78) 
which, upon treatment with phosphoric acid, underwent Friedel–Crafts acylation and subsequent 
dehydration to furnish 79 in 30% yield over two steps. 
 
Scheme 1.11 Friedel–Crafts Acylation   
Although the Hong group clearly demonstrated that N-acyliminium ion cyclization was 
an effective way to arrive at the 1-benzazepine ring system (Scheme 1.10) and were able to 
demonstrate that a Friedel–Crafts acylation/dehydration sequence could be employed to 
construct the B-ring (Scheme 1.11), a considerable amount of the work remains to either advance 
this relatively under functionalized system or advance more functionalized starting materials. To 
NO2
1. HC(OEt)3







































72 73 74(54% yield, three steps)
3. NaH, BnCl






















date there have been no further publications from the Hong laboratory concerning advancement 
of this synthetic route. 
1.5.3 Sarpong’s Approach to the Tetrapetalones  
Sarpong and colleagues at the University of California, Berkeley envisioned an approach 
that in its later stages was somewhat akin to the Hong strategy in that it called for advancing 
tetracycle 80 via oxidative dearomatization to install the para-quinol moiety and the late stage 
introduction of the -rhodinose (Scheme 1.12). In contrast to Hong, Sarpong envisioned the 
tetramic acid moiety as arising from a reductive alkylation reaction of a corresponding acylated 
pyrrole (81). Plans for the early stages of the synthesis were clearly influenced by Sarpong’s 
interest in pentannulation chemistry using the Nazarov cyclization, which led him to propose this 





Scheme 1.12 Sarpong’s Retrosynthetic Analysis of Tetrapetalone A 
The Sarpong synthesis commenced with the preparation of dienone 82 via 
halogen-lithium exchange of dibromide 83 followed by coupling with Weinreb amide 84 
(Scheme 1.13). Exposure of dienone 82 to aluminum trichloride effected Nazarov cyclization to 










































to the dominating para directing influence of the methoxy substituent. The indanone was a 9:1 
mixture of cis/trans isomers, respectively; thus, it was necessary to effect epimerization to 
achieve the requisite trans relationship between the methyl and isopropenyl substituents. To this 
end, base mediated epimerization produced the desired indanone 85 as a 4:1 trans/cis mixture, 
73% yield, over two steps. Reduction of the ketone in 85 proceeded as anticipated with hydride 
delivery occurring from the -face of the indanone and silylation of the resultant hydroxyl group 
delivered the TBS protected secondary alcohol. At this point a variety of palladium and 
copper-mediated C–N bond-forming reactions failed to accomplish the desired C–N bond 
formation. Thus, a more traditional approach for introducing nitrogen was employed that 
involved halogen-lithium exchange followed by addition of tosyl azide. The resultant azide (86) 
was reduced with lithium aluminum hydride to afford the aniline, which upon exposure to 
modified Paal–Knorr conditions, yielded pyrrole 87 in 97% yield. 
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Scheme 1.13 Indanone Synthesis via Nazarov Cyclization 
With pyrrole 87 in hand the next challenge of the synthesis was installation of the 
functionalized azepine ring (Scheme 1.14). To set the stage for this task, terminal olefin 87 was 
subjected to hydroboration followed by an oxidative workup to afford the primary alcohol 88 
(87% yield). Treatment of the primary alcohol 88 with excess Dess–Martin periodinane resulted 
in formation of tetracycle 81 in excellent yield.  Presumably, this transformation proceeds via the 
intermediate aldehyde 89 followed by activation of the carbonyl group (by the hypervalent 
iodine species or residual acetic acid), which leads to attack by the proximal pyrrole. The 
resulting pseudobenzylic secondary hydroxyl group 90 can then undergo further oxidation to 
produce tetracyclic ketone 81. This mechanistic scenario is supported by the observation of 
mixtures of 89, 90 and 81 when less than two equivalents of the Dess–Martin periodinane was 
employed. Exposure of the tetracycle 81 to sodium in liquid ammonia/THF in the presence of 
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    dioxane, 80 °C
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3. tBuLi, THF, –78 °C       
    then Ts-N3, –78 °C ® rt
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2. 2,5-Dimethoxytetrahydrofuran
    HOAc, ClCH2CH2Cl/H2O, 80 °C
87
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pyrrolidine 91 in 59% yield. Notably, the arene moiety remained intact, and the ethyl group was 
introduced on the -face of the tetracycle with excellent diastereocontrol. 
 
Scheme 1.14 An Oxidative Cyclization and Reductive Alkylation of Pyrrole 
Focus was then directed to construction of the tetramic acid moiety (Scheme 1.15). 
Oxidation of pyrrolidine 91 to the corresponding ,-unsaturated lactam 92 was accomplished 
with catalytic manganese(III) acetate along with tert-butyl hydroperoxide (TBHP) as 
stoichiometric oxidant (56% yield). Treatment of tetracycle 92 with lithium diisopropylamide 
(LDA) and iodomethane resulted in methylation of the ene-lactam moiety to provide 91 without 
competing alpha-methylation of the ketone. Presumably, deprotonation alpha to the ketone group 
is not favorable due to poor orbital overlap of the C–H bond and the * of the C=O bond. 
Conjugate addition of boron pinacolato ester to ene-lactam 93 followed by immediate oxidation 

























































oxidation at this stage was employed to install the tetramic acid moiety of tetracycle 95 in 65% 
yield. 
 
Scheme 1.15 Construction of Tetramic Acid Moiety 
Sarpong and coworkers reported the synthesis of a tetracycle (95) bearing a tetramic acid 
en route to tetrapetalone A (Scheme 1.15). This late-stage intermediate contains all the carbons 
of the aglycon of natural product 1. Key developments include the use of oxidative conditions for 
the construction of the tetracyclic core of the tetrapetalones and a reductive alkylation reaction 
for installation of the angular ethyl group (Scheme 1.14). It appears that the limitation of this 
approach may be the ketone functionality that is left upon formation of the azepine ring. To date, 
no work has been published from the Sarpong lab that pertains to the elimination of this ketone. 
It should also be noted that the relative stereochemistry of the substituents on the B-ring afforded 
by reduction of the indanone provides the -hydroxyl group, to obtain the natural product this 
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Chapter 2  
Synthetic Studies Toward a para-Quinol Coupling Partner  
2.1 Retrosynthetic Analysis 
As outlined in Scheme 2.1 our first-generation retrosynthetic analysis of tetrapetalone A 
(1) envisaged completion of the natural product via glycosylation of aglycon 96 followed by 
subsequent deprotection of the tetramic acid moiety and C(15)-hydroxyl group. Aglycon 96 was 
envisioned as deriving from a ring closing metathesis (RCM) applied to diene 97 and selective 
deprotection of the C(9)-hydroxyl group. Diene 97 would be assembled in a convergent manner 
by the coupling of para-quinol 98 and protected tetramic acid 99. Thus, in accord with this plan 
our primary objective became the synthesis of coupling partners 98 and 99.  To this end, we 
began our efforts by developing a synthesis of para-quinol 98.  
 
Scheme 2.1 First-Generation Retrosynthetic Analysis of Tetrapetalone A 
2.2 Retrosynthetic Analysis of a para-Quinol Coupling Partner 
Synthesis of para-quinol 98 would be completed with a hydroxyl group directed 
reduction of cyclic -hydroxy ketone 100 (Scheme 2.2). Intrigued by the application of 
umpolung reactivity to form C–C bonds, we hypothesized that construction of the last C–C bond 
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to afford-hydroxy ketone 100 could be achieved via a Stetter reaction and concomitant 
elimination from spiro lactol 101. Spiro lactol 101 would derive from phenolic oxidation of 
aldehyde 102, the reduction product of carboxylic acid derivative 103. Requisite ,-unsaturated 
carboxylic acid derivative 103 would be prepared via a Claisen rearrangement of allylic alcohol 
104 which, in turn would arise from aldehyde 105 via a Horner-Wadsworth-Emmons (HWE) 
olefination reduction sequence. 
 
Scheme 2.2 Retrosynthetic Analysis of para-Quinol Coupling Partner 
2.3 Dichlorophenol Substrate  
2.3.1 Allylic Ester Synthesis 
In assessing the viability of the above approach we discovered that a suitable precursor to 
105 was known and thus began our synthetic efforts toward 98 with preparation of aldehyde 108 
(Scheme2.3).
17
 Silylation of commercially available 2,6-dichorophenol (106) furnished 
TIPS-ether 107 which, upon ortho-lithiation and trapping of the derived anion with 
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N,N-dimethylformamide followed by acidic hydrolysis, provided aldehyde 108 in excellent yield 
(81%, two steps). Methylation of the phenol afforded aldehyde 109 and set the stage for a HWE 
olefination that produced (E)--unsaturated ester 110. Lithium aluminum hydride mediated 
reduction of ester 110 provided an allylic alcohol (111) that, upon acylation, afforded allylic 
ester 112. 
 
Scheme 2.3 Allylic Ester Synthesis 
2.3.2 Ireland-Claisen Rearrangement 
In terms of the pending Ireland-Claisen rearrangement that would give rise to the 
requisite ,-unsaturated carboxylic acid, we took solace in the fact that it has been well 
documented to provide extremely high diastereoselectivity, an outcome often dependent on the 
enolization conditions invoked.
18,19
 For example, Daub and coworkers have demonstrated that 
(E)-allylic esters (e.g., 113) participate efficiently in the Ireland-Claisen rearrangement and that 
enolization of these substrates with lithium diisopropylamide in tetrahydrofuran followed by 
silylation with tert-butyldimethylsilyl chloride in hexamethylphosphoramide affords an 
 32 
intermediate mixture of silyl ketene acetals wherein the (E)-isomer predominates (Scheme 2.4).
20
 
In this particular example Daub showed that exposure of 113 to these enolization conditions 
followed by warming to reflux, induces the desired sigmatropic rearrangement. Methylation of 
the derived carboxylic acids in situ afforded -unsaturated ester 114 anti and 115 syn in 
moderate yield as a 3:1 anti:syn mixture. 
 
Scheme 2.4 Daub’s Ireland-Claisen Rearrangement of an (E)-Allylic Ester 
The relative stereochemistry of the methyl and isopropenyl groups in para-quinol 98 
(Scheme 2.2) would be accessible directly from the anti product of an Ireland-Claisen 
rearrangement, the major isomer observed in Daub’s study. Disappointingly, exposure of 
(E)-allylic ester 112 to various Ireland-Claisen rearrangement conditions failed to produce the 
desired carboxylic acid 118 and resulted only in the formation of -ketoester 116 and TBS-ether 

























Scheme 2.5 Attempted Ireland-Claisen Rearrangement 
2.3.3 Johnson-Claisen Rearrangement 
In addition to their work with the Ireland-Claisen reaction, Daub and coworkers have 
carried out extensive studies concerning acyclic stereoselection of the Johnson-Claisen 
rearrangement.
20
 These latter efforts revealed that Johnson-Claisen rearrangements of 
trisubstituted allylic alcohols also exhibit significant levels of diastereoselection. In contrast to 
the Ireland conditions, the reaction of (E)-allylic alcohols under Johnson-Claisen rearrangement 
conditions result in intermediates wherein 1,3-diaxial interactions in the chair-like transition state 
render the reaction syn selective. Daub and coworkers showed that exposure of (E)-allylic 
alcohol 119 to triethyl orthopropionate and catalytic propionic acid affords the unsaturated 
esters 120 syn and 121 anti in high yield and good diastereoselectivity (Scheme 2.6).  
 
Scheme 2.6 Daub’s Johnson-Claisen Rearrangement 
We were excited to find that indeed exposure of (E)-allylic alcohol 111 to triethyl 
orthopropionate and catalytic propionic acid provided access to the unsaturated ester 122 syn 
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as a single diastereomer, albeit in moderate yield under both thermal and microwave reaction 
conditions (Scheme 2.7).  
 
Scheme 2.7 Johnson-Claisen rearrangement 
As anticipated by the Daub studies ester 122 syn was the expected major diastereomer for 
the above Johnson-Claisen rearrangement (Scheme 2.7). Analysis of the nonbonding interactions 
in the corresponding chair-like transition states that would result from the corresponding E and Z 
ketene acetals (Scheme 2.8) indicates chair-like transition state 125, which leads to the anti 
isomer 123, suffers from 1,3-diaxial interactions. In contrast, syn isomer 122 would derive form 




Scheme 2.8 Stereochemical Model for Johnson-Claisen rearrangement 
Relative stereochemistry of unsaturated ester 122 was inferred from 
1
H NMR 
spectroscopy via chemical shift trend comparisons with the Johnson-Claisen products reported 
by Daub and coworkers
20
 (Table 2.1). Anisotropy introduced by the aromatic ring led to specific 
upfield shifts of the alpha methyl group in the syn isomer, and correspondingly upfield shifts of 
the ethyl ester group in the anti isomer. Chemical shift trends of unsaturated ester 122 
correlate with that of the syn isomer 120.  
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2.4 Retrosynthetic Analysis of an Indanone Coupling Partner 
Although at the point we had developed Claisen rearrangement conditions suitable for 
use on the hindered dichlorophenol, the predominant syn isomer (123) derived from 
rearrangement of 111 possesses the undesired relative stereochemistry. To rectify this problem 
our first instinct was to prepare the corresponding Z isomer of allylic alcohol 111. Altering the 
double bond geometry should, in theory, change the course of the reaction such that 
Johnson-Claisen rearrangement would furnish the desired anti isomer.  
In addition to correcting the stereochemical outcome of the Claisen rearrangement we 
also began to consider the subsequent Stetter reaction. To this end, we decided that it maybe 
advantageous to explore the reactivity of substrates possessing one ortho functional group; for 
example, spiro lactol 128 (Schemes 2.9). Products (i.e. 127) derived from these substrates would 
be prone to aromatization; we were intrigued by the issue of chemo/regio-selectivity imposed on 
the Stetter reaction by the different electronic and steric environments within these substrates.  
 
Scheme 2.9 Retrosynthetic Analysis of an Indanone Coupling Partner 
2.5 Dimethoxybenzaldehyde Substrate 
2.5.1 Allylic Alcohol Synthesis 
With the notion of exploring Stetter chemistry on a substrate akin to 128, we initiated our 
efforts with the HWE olefination of aldehyde 129 (Scheme 2.10).  Reduction of the derived 




Scheme 2.10 Allylic Alcohol Synthesis 
2.5.2 Johnson-Claisen Rearrangement 
Given that in our previous efforts Johnson-Claisen rearrangements had proven most 
successful, our initial studies in this series involved exposure of (E)-allylic alcohol 131 to triethyl 
orthopropionate and catalytic propionic acid under Dean-Stark conditions. As illustrated in 
Scheme 2.11, this reaction furnished the desired -unsaturated esters 132 syn and 133 anti in 
56% yield as a separable mixture (2:1, respectively). As before, the assignment of the 
stereochemistry illustrated for -unsaturated esters 132 syn and 133 anti, as based upon the 
comparison of 
1




Scheme 2.11 Johnson-Claisen Rearrangement 
2.5.3 Ireland-Claisen Rearrangement 
Although in our previous studies we had been unsuccessful in efforts to employ the 
Ireland-Claisen rearrangement we decided to reinvestigate these conditions on the less sterically 
encumbered substrate 134 (Scheme 2.12) Acylation of allylic alcohol 131 afforded requisite 
allylic ester 134 in 72% yield. Interestingly, enolization of (E)-allylic ester 134 with lithium 













































in hexamethylphosphoramide and concomitant sigmatropic rearrangement conducted at 
tetrahydrofuran reflux afforded -unsaturated carboxylic acids 135 anti and 136 syn in 58% 
yield as a 3:1 anti:syn mixture of separable diastereomers. Production of the desired 
-unsaturated ester (135 anti), as the major diastereomer is in accord with the transition state 
models mentioned above and, provided subsequent studies of the Stetter reaction proved fruitful, 
would obviate the need for adjusting the olefin geometry of the allylic alcohol. 
 
Scheme 2.12 Ireland-Claisen Rearrangement 
2.5.4 Lithium Enolate Claisen Rearrangement 
Although we were satisfied to move forward with the moderate yield of the 
Ireland-Claisen rearrangement (Scheme 2.12), we were inspired by the work of Collum and 
Godenschwager
21
 to explore a lithium enolate variant of the Claisen rearrangement. In 2008, 
Collum and Godenschwager disclosed the lithium enolate Claisen rearrangement of trans allylic 
ester 137 (Scheme 2.13). They reported that enolization of 137 using lithium 
hexamethyldisilazide (LiHMDS) and triethylamine in toluene at –78 ºC affords an estimated 
20:1 preference for enolate 138. Claisen rearrangement of 138 at –20 ºC affords a 35:1 ratio of 
139 anti and 140 syn in 79% isolated yield. The standard protocol, enolization and rearrangement 
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in neat tetrahydrofuran (THF) proceeded in 11% yield. The low yields using LiHMDS/THF are 
postulated to stem from either a poor enolization or a poor rearrangement from the (Z)-isomer as 
noted by Ireland in a similar silyl Claisen rearrangement.
21,22
 Encouraged by this report we opted 
to investigate the LiHMDS/triethylamine mediated enolization on our trisubstituted allylic ester 
system. 
 
Scheme 2.13 Collum’s LiHMDS Mediated Claisen Rearrangement 
Gratifyingly, exposure of (E)-allylic ester 134 to enolization with LiHMDS and 
triethylamine in toluene followed by warming to room temperature affords -unsaturated 
carboxylic acid 135 anti in excellent yield and diastereoselectivity (Scheme 2.14).  
 
Scheme 2.14 Lithium Enolate Variant of Claisen Rearrangement 
2.5.5 Selective Methyl Ether Cleavage 
To advance substrate 135 to a spiro lactol (i.e. 128, Scheme 2.9) we would need to effect 
a selective demethylation. Exposure of carboxylic acid 135 to boron tribromide afforded a 




























attempt to selectively cleave the para methyl ether under Lewis acid conditions prompted us to 
investigate nucleophilic cleavage reaction conditions. 
 
Scheme 2.15 Attempted Lewis acid Mediated Methyl Ether Cleavage 
Treatment of carboxylic acid 135 with sodium ethanethiolate in N,N-dimethyformamide 
at reflux did indeed provide a selective methyl ether cleavage, unfortunately, the undesired ortho 
methyl ether was cleaved and subsequent lactonization under the reaction conditions afforded 
lactone 143 (Scheme 2.16). Our failure to identify selective demethylation conditions motivated 
us to design a synthetic strategy employing an orthogonal protection strategy. 
 
Scheme 2.16 Attempted Nucleophilic Methyl Ether Cleavage 
2.6 Dihydroxybenzaldehyde Substrate 
2.6.1 Orthogonal Protection  
The orthogonal protection strategy began with selective alkylation of the para-hydroxyl 
group of 2,4-dihydroxybenzaldehyde (144) to afford SEM-ether 145 which was subsequently 
methylated to yield orthogonally protected aldehyde 146 in excellent yield over two steps 
























ester 147, lithium aluminum hydride reduction and acylation of the derived alcohol (148) with 
propionyl chloride, furnished Claisen rearrangement precursor 149. Enolization of allylic ester 
149 with LiHMDS and triethylamine in toluene followed by warming to room temperature 
resulted in [3,3] sigmatropic rearrangement to provide the desired anti -unsaturated carboxylic 
acid (150) as the major diastereomer in excellent yield. Cleavage of the SEM-ether was achieved 
upon exposure to tetrabutylammonium fluoride at tetrahydrofuran reflux unveiling phenol 142 in 
moderate yield. 
 
Scheme 2.17 Phenolic Oxidation Precursor via an Orthogonal Protection Strategy 
2.6.2 Spiro Lactol Formation via Phenolic Oxidation 
To construct the spiro lactol (i.e. 128, Scheme 2.9) we turned to a 1987 report by Tamura 
and coworkers wherein a continuation of their study on hypervalent iodine compounds was 
described as having led them to an efficient oxidant, [bis(trifluoroacetoxy)iodo]benzene, which 
reacts with various types of para-alkoxyphenols to give the para-benzoquinone monoacetals in 
excellent yield under mild reaction conditions (Scheme 2.18a).
23
 Oxidation was extended to 
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intramolecular ipso-trapping by some nucleophiles such as carboxy, amido and hydroxy groups, 
leading to the corresponding spiro compounds (Scheme 2.18b).  
 
Scheme 2.18 Hypervalent Iodine Mediated Oxidation of para-Alkoxyphenols 
With carboxylic acid 142 on hand, we were excited to investigate the phenolic oxidation 
of such a highly functionalized substrate. Exposure of carboxylic acid 142 to 
[bis(trifluoroacetoxy)iodo]benzene in acetonitrile at room temperature successfully provided 
access to spiro lactone 157 in high yield and excellent diastereoselectivity (Scheme 2.19). 
Assignment of the illustrated relative stereochemistry of spiro lactone 157 was based on NOE 
studies. Attempts to afford a Stetter reaction precursor, spiro lactol (i.e. 128, Scheme 2.9), via a 
chemoselective reduction proved to be futile and resulted in both reduction of the lactone and the 
vinylogous ester of 157. Unable to selectively reduce the lactone, we considered an alternative 
strategy wherein reduction of the acid would occur prior to aryl oxidation. The success of our 
initial phenolic oxidation studies left us hopeful that the derived aldehyde would similarly 






















Scheme 2.19 Lactonization via Phenolic Oxidation 
Upon scaling up the synthetic route, we found it was advantageous to prepare methyl 
ester 158, via diazomethane methylation, directly following lithium enolate Claisen 
rearrangement (Scheme 2.20). This two-step sequence could be performed using only an aqueous 
work up of the intermediate carboxylic acid prior to methylation. Reduction of methyl ester 158 
was accomplished with lithium aluminum hydride; subsequent tetrabutylammonium fluoride 
mediated cleavage of SEM-ether 159 provided alcohol 160 and Swern oxidation yielded the 
desired phenolic aldehyde 161 in modest yield (41%), over three steps. Exposure of phenolic 
aldehyde 161 to [bis(trifluoroacetoxy)iodo]benzene in a solvent mixture of acetonitrile and water 
at room temperature successfully provided access to the desired Stetter reaction precursor, spiro 
lactol 162 in moderate yield. 
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Scheme 2.20 Synthesis of a Spiro Lactol via Phenolic Oxidation 
2.6.3 Intramolecular Stetter Reaction with Spiro Lactol Substrates 
Umpolung
24,25
 reactivity, introduced by E. J. Corey and D. Seebach, is a method in which 
the normal electron donor and acceptor reactivity of a functional group is inverted to provide 
complementary reactivity in organic synthesis. The Stetter reaction
26
 is an umpolung process in 
which an acylanion equivalent, generated from an aldehyde in the presence of a nucleophilic 
catalyst, is added to a Michael acceptor to form a C–C bond.  
Although, the classic Stetter reaction utilizes sodium cyanide as a catalyst, extensive 
research has found that carbene catalysts, derived from thiazolium and triazolium salts, can 
greatly enhance reactivity and also lead to diastereo- and enantiomerically enriched products. 
Rovis and coworkers have developed a family of triazolium catalysts that promote 
intramolecular Stetter reactions in excellent enantioselectivities and diastereoselectivities.
27-31
 In 
2006, Liu and Rovis disclosed that exposure of alicyclic aldehyde 163 to optimized, in situ 
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carbene catalyst formation reaction conditions afforded only undesired indanone 165 (Scheme 
2.21a).
32,33
 It was suggested that indanone 165 is derived from the elimination of the expected 
product under the reaction conditions. It was found that elimination could be avoided if the 
reaction of alicyclic aldehyde 163 is conducted using the preformed free carbene to provide the 
desired hydrindane 167 (Scheme 2.21b).  
 
Scheme 2.21 Intramolecular Stetter Reaction of an Alicyclic Substrate 
Cullen and Rovis extended the method to spiro lactol 168. Treatment of 168 with catalyst 
169 and potassium bis(trimethylsilyl)amide (KHMDS) in toluene provided the desired Stetter 
product 170 in low yield, but afforded aromatized product 165 in high yield (Scheme 2.22a). 
Attributing dehydration to the base in the reaction, it was found that exposure of spiro lactol 169 
to catalytic free carbene 171 resulted in a reversal of product ratio, favoring the desired 
























PhCH3, 23 °C, 16 h
163 165
163 167(60% yield, 90% ee, >95:5 dr)
a) In situ carbene catalyst formation







Scheme 2.22 Intramolecular Stetter Reaction Applied to a Spiro Lactol Substrate 
Unfortunately, we found that spiro lactol 162 does not participate in the Stetter reaction 
(Scheme 2.23). Surveying reaction conditions proved to be futile and starting material was 
always recovered from the reaction. Comparison of spiro lactol 162 with the aforementioned 
Stetter reaction examples led us to propose that spiro lactol 162 does not participate in the Stetter 





































a) In situ carbene catalyst formation





Scheme 2.23 Attempted Stetter Reaction 
2.7 Aryl Bromide Substrate Deficient of -Methyl Group 
2.7.1 Allylic Alcohol Synthesis 
Suspecting that the Stetter reaction did not work because of the -methyl group we opted 
to investigate the reactivity of spiro lactol deficient of alpha substituents, while simultaneously 
exploring the potentially more reactive substrate, which possesses a bromide. To this end 
p-anisaldehyde (172) was halogenated using the Comins’s -amino alkoxide directed ortho 
metalation procedure to afford known aryl bromide 173 in 65% yield (Scheme 2.24).
34-37
 
Horner-Wadsworth-Emmons olefination of aldehyde 173 gave (E)--unsaturated ester 173, 
reduction with lithium aluminum hydride provided access to allylic alcohol 175 in 75% yield, 






























temperature: rt, 60 °C






Scheme 2.24 Allylic Alcohol Synthesis 
2.7.2 Synthesis of Spiro lactol 
Given our speculation that the methyl group was prohibiting the Stetter reaction we 
decided to prepare a desmethyl substrate. In a manner analogous to 162, construction of spiro 
lactol 180 began with a Johnson-Claisen rearrangement of allylic alcohol 175 to access methyl 
ester 176 (Scheme 2.25). Simultaneous nucleophilic cleavage of the methyl ester and methyl 
ether of 176 was achieved upon exposure to sodium ethanethiolate in N,N-dimethylformamide at 
reflux. The derived carboxylic acid (177) was produced in high yield and when exposed to 
hypervalent iodine mediated phenolic oxidation underwent conversion to spiro lactone 178. 
Immediate diisobutylaluminum hydride (DIBAL) reduction of 178 produced bisallylic alcohol 
179 in moderate yield. Dess-Martin periodinane oxidation was employed to achieve a 
chemoselective oxidation affording the desired dienone 180 in excellent yield. 
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Scheme 2.25 Synthesis of Desmethyl Spiro Lactol 
2.7.3 oxy-Cope Rearrangement a Substrate Complication 
We found that spiro lactol 180 underwent facile oxy-Cope rearrangement to aldehyde 183 
at ambient temperature (Scheme 2.26). Aldehyde 183 was also isolated from Stetter reaction 
attempts with substrate 180. Spiro lactol 180 thus proved to be incompatible with the Stetter 
reaction.  
 
Scheme 2.26 Proposed oxy-Cope Rearrangement 
2.8 Second-Generation Retrosynthetic Analysis  
Unable to realize the desired Stetter reaction to afford an indanone coupling partner (i.e. 
126, Scheme 2.9) we redesigned our retrosynthetic analysis of Tetrapetalone A (1). Guided by 
the reactivity issues of our previous Stetter reaction substrates we proposed a retrosynthetic 
synthetic analysis that would employ a Friedel-Crafts alkylation to afford the B-ring of the 




























generation retrosynthetic analysis is envisioned to conclude with a glycosylation, deprotection 
sequence from aglycon 184. Introduction of the C(15)-hydroxyl group of aglycon 184 would be 
achieved upon phenolic oxidation of tetracycle 185. Friedel-Crafts alkylation of benzazepine 186 
affords the B ring of desired tetracycle 185. Following amidation of aryl bromide 188 with 
protected tetramic acid 99, ring-closing metathesis of diene 187 would provide benzazepine 186. 
 
Scheme 2.27 Second-Generation Retrosynthetic Analysis of Tetrapetalone A 
2.9 Synthesis of Aryl Bromide Coupling Partner 
To this end we synthesized the desired aryl bromide 188, in a manner analogous to 158. 
To set the stage for an enolate Claisen rearrangement allylic alcohol 175 was acylated with 
propionyl chloride to furnish allylic ester 189 (Scheme 2.28). We were delighted to find that 
LiHMDS/triethylamine mediated enolization of allylic ester 189 followed by warming to room 
temperature resulted in [3,3] sigmatropic rearrangement to the desired -unsaturated carboxylic 
acid 190 in modest yield (56%) and good diastereoselectivity. Exposure of carboxylic acid 190 








































































Scheme 2.28 Synthesis of Aryl Bromide Coupling Partner 
2.10 Conclusion 
In the course of executing a synthetic effort toward an indanone-coupling partner, with 
the goal of employing an intramolecular Stetter reaction, we sought to investigate the 
regio/chemo-selectivity that would be imparted by highly functionalized dienone substrates. In 
the course of exploring these ideas we discovered the inherent limitations of the Stetter reaction 
and based on this were led to believe that it would likely be unsuitable for this application. Thus, 
we redevised our synthetic strategy to a route that would employ an aryl bromide and tetramic 
acid coupling partners (Scheme 2.27), upon aryl amidation we conceived the application of ring 
closing metathesis technology followed by Friedel-Crafts alkylation would afford an advanced 
tetracycle containing all requisite carbons of tetrapetalone A (1). To this end, we successfully 
developed a synthetic route to the desired aryl bromide-coupling partner and turned our focus to 
the synthesis of a tetramic acid coupling partner. 
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2.11 Experimental Section 
2.11.1 Materials and Methods 
Unless stated otherwise, reactions were performed in flame-dried glassware under a 
nitrogen atmosphere. Triethylamine, diisopropylamine, and methanol were dried over anhydrous 
calcium hydride and freshly distilled. 1,4-Dioxane was distilled from sodium, calcium chloride 
and molecular sieve (0.4 nm). Benzene, tetrahydrofuran, dichloromethane, toluene, and diethyl 
ether were dried using a solvent purification system manufactured by Glass Contour Solvent 
Systems, SG Water U.S.A., LLC using technology based upon that originally described by 
Grubbs et al.
38
 Anhydrous N,N-dimethyformamide, acetonitrile, dimethylsulfoxide, 1,2-
dichloroethane was purchased from the Colorado State University Stockroom and supplied by 
Sigma-Aldrich or Fischer Scientific and stored under nitrogen atmosphere. Commercially 
available reagents were obtained from Sigma-Aldrich, Strem, TCI, Combi-Blocks, Acros or 
Alfa-Aesar and were used as received. All known compounds were identified by comparison of 
NMR spectra to reported in the literature. 
Unless otherwise stated, all reactions were monitored by thin layer chromatography 
(TLC) was using Silicycle glass-backed extra hard layer, 60 Å plates (indicator F-254, 250 m). 
Developed TLC plates were visualized using a 254 nm UV lamp and/or with the appropriate 
stain followed by heating. Typical stains utilized were potassium permanganate, ethanolic 
anisaldehyde and ceric ammonium molybdate. In general, the flash chromatography guidelines 
reported by Still et al
39
 were followed. Silicycle SiliaFlash
®  
P60 (230-400 mesh) silica gel was 
employed as the stationary phase. When reactions were absorbed onto silica gel, the amount of 
silica gel used was approximately equal to two times the weight of the reagents. 
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Infrared spectra were obtained using a Nicolet Avatar 320 FTIR or Bruker Tensor27 
FTIR. Samples were analyzed as thin films on NaCl plates (samples was dissolved in CH2Cl2 or 





H) and carbon (
13
C) NMR spectra were recorded on a Varian Inova 
500, Varian Inova 400, Varian Inova 400 auto sampler, or Varian Inova 300 MHz spectrometer. 
Spectra were obtained at 22 °C in CDCl3 unless otherwise noted. Chemical shifts () are reported 
in parts per million (ppm) and are referenced to the internal solvent peak. Coupling constants (J) 
are reported in Hertz (Hz) and are rounded to the nearest 0.1 Hz. Multiplicities are defined as: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, dd = doublet of doublets, dt = doublet 
of triplets, ddd = doublet of doublet of doublets, dddd = doublet of doublet of doublet of 
doublets, br = broad, app = apparent, par = partial. High-resolution mass spectra were obtained 
from the University of Colorado Central Instrument Facility, performed on an Agilent 6210 TOF 
LCMS by Donald L. Dick.  
2.11.2 Preparative Procedures 
Preparation of TIPS-ether 107: 
 
TIPS-ether 107. To a stirred solution of 3,5-dichlorophenol (10.0 g, 61.3 mmol) and 1,8-
diazabicyclo[5.4.0]undec-7-ene (18.3 mL, 122.6 mmol) in CH2Cl2 (200 mL) was added 
triisopropylsilyl chloride (19.5 mL, 92.0 mmol) at 0 °C and reaction was warmed to room 
temperature. Reaction progress was monitored by TLC. TLC plates were developed with 5% 
EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain. After hydrolysis with H2O 










concentrated under reduced pressure. The crude oil was purified by silica gel chromatography 
(elution with hexanes) to give 107 (19.0 g, 97% yield) as colorless oil. 
TIPS-ether 107 is a known compound, the 
1
H NMR spectra was obtained and structure 





H-NMR (300 MHz; CDCl3): δ 6.95 (t, J = 1.8 Hz, 1H), 6.77 (d, J = 1.8 
Hz, 2H), 1.31-1.19 (m, J = 6.0 Hz, 3H), 1.10 (d, J = 6.8 Hz, 18H). 
Preparation of aldehyde 108: 
 
Aldehyde 108. A solution of n-butyllithium (1.6 M, 21.2 mL, 33.9 mmol) was added to a 
stirred solution of TIPS-ether 107 (9.0 g, 28.2 mmol) in THF (150 mL) at –78 °C. The reaction 
solution was stirred for 45 minutes at –78 °C. Anhydrous N,N-dimethyformamide (3.3 mL, 42.3 
mmol) was added at –78 °C and warmed to room temperature. After addition of 2 M HCl (75 
mL, 150 mmol), reaction mixture was stirred vigorously for 1 hour at room temperature. TLC 
was used to monitor reaction progress at all steps. TLC plates were developed with 5% 
EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain.  Phases were separated 
(aided by the addition of NaCl), the organic layer was dried over anhydrous Na2SO4 and 
concentrated under reduced pressure. Crude solid was triturated with hexanes to afford aldehyde 
108 (4.5 g, 83% yield) as a white solid. 
Aldehyde 108 is a known compound, the 
1
H NMR spectra was obtained and structure 






i. n-BuLi, THF, –78 °C
ii. DMF,  –78 °C ® rt








H-NMR (300 MHz; DMSO-d6): δ 11.47 (s, 1H), 10.24 (s, 1H), 6.94 (s, 
2H). 
Preparation of methyl ether 109: 
 
Methyl ether 109. To a stirred solution of phenol 108 (4.0 g, 20.9 mmol) in 
N,N-dimethyformamide (70 mL) was added K2CO3 and iodomethane (2.6 mL, 41.9 mmol) at 
room temperature. The reaction solution was stirred over night at room temperature. TLC was 
used to monitor reaction progress. TLC plates were developed with 10% EtOAc/Hex solution 
and visualized by UV lamp and KMnO4 stain.  Reaction solution was diluted with Et2O (100 
mL) and H2O (100 mL). Solution was stirred vigorously for 1 hour at room temperature. Phases 
were separated and organic phase was washed three times with H2O (100 mL) to remove residual 
N,N-dimethyformamide. Organic phase was washed with brine (100 mL), dried over anhydrous 
MgSO4 and concentrated under reduced pressure. Methyl ether 109 (4.2 g, 98% yield) was 
isolated as a white solid and required no further purification. 
Methyl ether 109. 
1
H-NMR (300 MHz; CDCl3): δ 10.42 (s, 1H), 6.91 (s, 2H), 3.88 (s, 
4H). 


























-Unsaturated ester 110. To a stirred heterogeneous solution of sodium hydride (1.3 
g, 31.7 mmol) in THF (25 mL) was added triethyl-2-phosphonopropionate (8 mL, 36.5 mmol) at 
0 ºC. Aldehyde 109 was added as a solution in THF (25 mL) to the reaction solution via cannula 
at 0 ºC. Reaction solution was then warmed to room temperature. Reaction progress was 
monitored by TLC. TLC plates were developed with 10% EtOAc/Hex solution and visualized by 
UV lamp and KMnO4 stain. Reaction was quenched with saturated NH4Cl solution. Phases were 
separated, organic phase was washed with H2O (50 mL) and brine (50 mL). Dried over 
anhydrous MgSO4 and concentrated under reduced pressure. Crude oil was purified with silica 
gel chromatography (gradient elution 510% EtOAc/Hex) to yield -unsaturated ester 110 
(5.6 g, 80% yield) as colorless oil. 
-Unsaturated ester 110. 
1
H-NMR (300 MHz; CDCl3): δ  7.41 (q, J = 1.3 Hz, 1H), 
6.90 (s, 2H), 4.28 (q, J = 7.1 Hz, 3H), 3.80 (s, 4H), 1.77 (d, J = 1.4 Hz, 3H), 1.35 (t, J = 7.1 Hz, 
4H). 
Preparation of allylic alcohol 111: 
 
Allylic alcohol 111. To a stirred heterogeneous solution of lithium aluminum hydride 
(2.0 g, 50.5 mmol) in THF (80 mL) was added -unsaturated ester 110 (7.3 g, 25.3 mmol) as a 
solution in THF (50 mL) via cannula at 0 °C. Reaction progress was monitored by TLC. TLC 
plates were developed with 30% EtOAc/Hex solution and visualized by UV lamp and KMnO4 














at 0 °C. After stirring at 0 °C for 10 minutes reaction was warmed to room temperature and 
stirred 15 minutes. A scoop of anhydrous MgSO4 was added and stirred for 15 minutes. Solution 
was filtered through a sand/celite pad. Organic phase was washed with saturated NH4Cl solution 
(100 mL), H2O (100 mL) and brine (100 mL). Organic phase was dried over anhydrous MgSO4 
and concentrated under reduced pressure. Crude material was purified with silica gel 
chromatography (eluted with 30% EtOAc/Hex) to afford allylic alcohol 111 (4.7 g, 76% yield) as 
viscous colorless oil.  
Allylic alcohol 111. 
1
H-NMR (300 MHz; CDCl3): δ 6.89 (s, 2H), 6.24 (q, J = 1.3 Hz, 
1H), 4.24 (d, J = 1.1 Hz, 2H), 1.66 (s, 1H), 1.57 (d, J = 1.3 Hz, 3H).  
Preparation of allylic ester 112:  
 
Allylic ester 112. To a stirred solution of allylic alcohol 111 (95.9 mg, 0.39 mmol) and 
4-(dimethylamino)pyridine (catalytic amount) in dichloromethane (2 mL) was added pyridine 
(41 L, 0.78 mmol) followed by addition of propionyl chloride (53 L, 0.59 mmol) at 0 ºC. 
Stirred reaction solution for 30 minutes at 0 ºC and warmed to room temperature. Reaction was 
stirred over night at room temperature. Reaction progress was monitored by TLC. TLC plates 
were developed with 30% EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain. 
Reaction solution was diluted with dichloromethane (5 mL). Organic phase was washed with 
saturated CuSO4 solution (2 mL), H2O (2 mL) and brine (2 mL). Organic phase was dried over 
anhydrous MgSO4 and concentrated under reduced pressure. Crude oil was purified with silica 
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gel chromatography (eluted with 30% EtOAc/Hex) to afford allylic ester 112 (76 mg, 64% yield) 
as colorless oil. 
Allylic ester 112. 
1
H-NMR (300 MHz; CDCl3): δ 6.89 (s, 2H), 6.23 (s, 1H), 4.68 (s, 2H), 
3.79 (s, 3H), 2.42 (q, J = 7.6 Hz, 2H), 1.57 (s, 3H), 1.19 (t, J = 7.6 Hz, 3H). 
Attempted Ireland-Claisen rearrangement of allylic ester 112: 
 
Following the protocol of Daub and et al.
20
 To a solution of diisopropylamine (0.21 ml, 
1.5 mmol) in THF (2 mL) was added n-butyllithium (1.6 M, 0.70 mL, 1.1 mmol) at 0 ºC. 
Reaction solution was stirred 2 minutes at 0 ºC and cooled to –78 ºC. Allylic ester 112 (303 mg, 
1 mmol) was added to the reaction solution drop wise over approximately 3 minutes as a solution 
in THF (1 mL) at  –78 ºC; followed by stirring for 2 minutes. tert-Butyldimethylsilyl chloride 
(170 mg, 1.1 mmol) was added as a solution in hexamethylphosphoramide (0.50 mL, 3.0 mmol) 
at –78 ºC, stirred 2 minutes and warmed to room temperature. Reaction solution was refluxed for 
2 hours, oil bath set to 80 ºC. Reaction progress was monitored by TLC. TLC plates were 
developed with 10% EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain. 
Reaction was cooled to room temperature and quenched with 10% HCl solution (1 mL); stirred 
for 1 hour. 15% NaOH solution was added and aqueous phase was extracted three times with 
diethyl ether (3 mL). Concentrated HCl was added to the aqueous phase, until pH = 3 paper at 0 
ºC. Acidic aqueous phase was extracted three times with diethyl ether (3 mL). Organic phase was 
washed with H2O (5 mL), brine (5 mL), dried over anhydrous MgSO4 and concentrated under 
 59 
reduced pressure. By 
1
H-NMR no desired carboxylic acid was isolated. Basic extract was thus 
moved forward with. Organic phase was washed with H2O (5 mL), brine (5 mL), dried over 
anhydrous MgSO4 and concentrated under reduced pressure. Crude material was purified with 
silica gel chromatography (gradient elution 510% EtOAc/Hex) to afford TBS-ether 117, 
allylic ester 112 (75 mg, 25% yield recovered starting material) and -ketoester 116. 
TBS-ether 117. 
1
H-NMR (300 MHz; CDCl3): δ 6.89 (s, 2H), 6.25 (s, 1H), 4.22 (s, 2H), 
3.79 (s, 3H), 1.50 (s, 3H), 0.95 (s, 9H), 0.13 (s, 6H). 
-ketoester 116. 
1
H-NMR (300 MHz; CDCl3): δ 6.86 (s, 2H), 6.22 (s, 1H), 4.76 (d, J = 
12.9 Hz, 1H), 4.66 (d, J = 12.9 Hz, 1H), 3.79 (s, 3H), 3.64 (q, J = 7.2 Hz, 1H), 2.65 (dq, J =7.5 
Hz, 1H), 2.57 (dq, J =7.5 Hz, 1H), 1.54 (s, 3H), 1.38 (d, J = 7.2 Hz, 3H), 1.06 (t, J =7.2 Hz, 3H), 
note data was not available to calculate all J values for dq’s at 2.65 and 2.57; 
13
C APT NMR 
(100 MHz, CDCl3): δ 206.5, 170.5, 159.2, 136.7, 135.4, 126.8, 122.9, 114.1, 69.3, 55.9, 52.8, 
35.1, 16.0, 13.1, 7.9. 
Preparation of -Unsaturated ester 123: 
 
-Unsaturated ester 123. (Method A) To a round bottom flask fitted with a magnetic 
stir bar was added allylic alcohol 111 (589.6 mg, 2.40 mmol), triethyl orthopropionate (5 mL, 
24.0 mmol) and propionic acid (18 L, 0.2 mmol). System was fitted with a short path 
distillation condenser and collecting round bottom flask. Reaction was heated to 152 °C for 4 
hours. Reaction was cooled to room temperature and diluted with Et2O (20 mL). Organic phase 
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was washed with 10% HCl (20 mL), NaHCO3 (20 mL), H2O (20 mL) and brine (20 mL). 
Organic phase was dried over anhydrous MgSO4 and concentrated under reduced pressure. 
Crude material was purified with silica gel chromatography (gradient elution 1030% 
EtOAc/Hex) to afford -unsaturated ester 122 syn (357 mg, 45% yield) as yellow oil. 
-Unsaturated ester 122. (Method B) To a microwave reactor tube fitted with a 
magnetic stir bar was added allylic alcohol 111 (503.0 mg, 2.40 mmol), triethyl orthopropionate 
(4.1 mL, 20.4 mmol) and propionic acid (15 L, 0.2 mmol). Reaction was heated in microwave 
reactor at 250 °C for 1.5 hours, power setting 250. Reaction was cooled to room temperature and 
diluted with Et2O (20 mL). Organic phase was washed with 10% HCl (20 mL), NaHCO3 (20 
mL), H2O (20 mL) and brine (20 mL). Organic phase was dried over anhydrous MgSO4 and 
concentrated under reduced pressure. Crude material was purified with silica gel chromatography 
(gradient elution 1030% EtOAc/Hex) to afford -unsaturated ester 123 syn (324 mg, 48% 
yield) as yellow oil. 
-Unsaturated ester 123. 
1
H NMR (400 MHz; CDCl3): δ 6.91 (d, J = 2.7 Hz, 1H), 6.79 
(d, J = 2.7 Hz, 1H), 4.95 (s, 1H), 4.92 (s, 1H), 4.58 (d, J = 11.3 Hz, 1H), 4.17 (app dq, J = 7.1, 
3.0 Hz, 3H), 3.76 (s, 4H), 3.62 (dq, J = 11.3, 7.1 Hz, 1H), 1.55 (d, J = 0.6 Hz, 4H), 1.26 (t, J = 
7.1 Hz, 4H), 0.92 (d, J = 7.2 Hz, 4H); 
13
C NMR (101 MHz; CDCl3): δ 176.7, 158.4, 143.1, 
138.3, 136.2, 127.4, 116.1, 114.3, 111.8, 60.6, 55.7, 49.4, 39.6, 23.0, 16.7, 14.3; HRMS (EI) m/z 
331.08622 [calc’d for C6H21O3Cl2 (M+) 331.0855]. 
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Preparation of -unsaturated ester 130: 
 
-Unsaturated ester 130. To a stirred heterogeneous solution of sodium hydride (53 g, 
137.24 mmol) in THF (1 L) was added triethyl 2-phosphonopropionate (35.5 g, 158.35 mmol) at 
0 °C. 2,4-Dimethoxybenzaldehyde (126) (18 g, 105.57 mmol) was added to reaction solution at 0 
°C, followed by immediate warming to room temperature. Reaction was stirred at room 
temperature over night. Reaction progress was monitored by TLC. TLC plates were developed 
with 30% EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain. Reaction was 
quenched with saturated NH4Cl solution (500 mL) at 0 °C. Quenched solution was warmed to 
room temperature and diluted with H2O to dissolve salts. Organic phase was washed with H2O 
(500 mL), brine (500 mL), dried over anhydrous MgSO4 and concentrated under reduced 
pressure to afford -unsaturated ester 130 (>25 g, 10:1 dr) as yellow oil. The crude material 
was carried on without further purification. 
-Unsaturated ester 130. 
1
H-NMR (300 MHz; CDCl3): δ 7.80 (br s, 1H), 7.26 (d, J = 
8.4 Hz, 2H), 6.51 (dd, J = 8.4, 2.4 Hz, 1H), 6.47 (d, J = 2.4 Hz, 1H), 4.26 (q, J = 7.1 Hz, 2H), 
3.84 (s, 6H), 2.06 (d, J = 1.5 Hz, 3H), 1.34 (t, J = 7.1 Hz, 3H). 


























Allylic alcohol 131. To a heterogeneous stirred solution of lithium aluminum hydride 
(5.3 g, 138 mmol) in THF (500 mL) was added crude -unsaturated ester 130 (>25 g, 106 
mmol) as a solution in THF (50 mL), addition completed via addition funnel, at 0 °C. Reaction 
progress was monitored by TLC. TLC plates were developed with 20% EtOAc/Hex solution and 
visualized by UV lamp and KMnO4 stain. Quenched reaction with extremely slow drop wise 
addition of H2O (7 mL), 15% NaOH solution (7 mL) and H2O (21 mL) stirred for 30 minutes at 
0 °C. Warmed to room temperature. Added 3 scoops of anhydrous MgSO4 and stirred for 1 hour. 
Filtered through sand/celite pad. Concentrated to reduce volume. Organic phase was washed 
with H2O (200 ml), brine (200 mL), dried over anhydrous MgSO4 and concentrated under 
reduced pressure to afford allylic alcohol 131 (23.3 g) as oil. Crude material was carried on 
without further purification. 
Allylic alcohol 131. 
1
H-NMR (300 MHz; CDCl3): δ 7.16 (d, J = 7.9 Hz, 1H), 6.52 (br s, 
1H), 6.49 (dd, J = 2.5 Hz, 1H), 6.46 (d, J = 2.0 Hz, 2H), 4.20 (2, 2H), 3.82 (s, 3H), 3.81 (s, 3H), 
1.85 (d, J = 1.4 Hz, 3H), 1.61 (s, 1H), note unable to calculate complete J values for aromatic 
region in full due to overlapping chemical shifts. 
Preparation of -unsaturated esters 132 syn and 133 anti: 
 
-Unsaturated esters 132 syn and 133 anti. Following the procedure of Daub et al.
20
 
To round bottom flask was added allylic alcohol 131 (378 mg, 1.82 mmol), triethyl 
























path distillation apparatus and collection round bottom flask, heated oil bath to 150 ºC. Reaction 
progress was monitored by TLC. TLC plates were developed with 20% EtOAc/Hex solution and 
visualized by UV lamp and KMnO4 stain. Cooled reaction room temperature and diluted with 
diethyl ether (10 mL) quenched with 10% HCl (10 mL) and stirred vigorously for 1 hour. 
Organic phase was washed with saturated NaHCO3 (10 mL), H2O (15 mL), brine (15 mL), dried 
over anhydrous MgSO4 and concentrated under reduced pressure. Crude material was purified 
with silica gel chromatography (gradient elution 1234510% EtOAc/Hex) to afford 
-unsaturated esters 132 syn and 133 anti (combined yield 56%, 2:1 dr) both are colorless oils. 
-Unsaturated ester 132 syn. FTIR (thin film/NaCl): 2977, 2836, 1732, 1646, 1611, 
1586, 1505, 1456, 1418, 1373, 1322, 1294, 1261, 1208, 1157, 1123, 1106, 1037, 938, 892, 834; 
1
H-NMR (400 MHz; CDCl3): δ 7.03 (d, J = 9.1 Hz, 1H), 6.46 (dd, J = 9.0, 2.9 Hz, 1H), 6.44 (d, J 
= 3.5 Hz, 1H), 4.92 (s, 1H), 4.78 (t, J = 1.4 Hz, 1H), 4.14 (q, J = 6.9 Hz, 2H), 3.96 (d, J = 11.5 
Hz, 1H), 3.80 (s, 3H), 3.79 (s, 3H), 2.97 (dq, J = 11.7, 6.9 Hz, 1H), 1.60 (s, 3H), 1.25 (t, J = 7.1 
Hz, 3H), 0.94 (d, J = 7.0 Hz, 3H); 
13
C-NMR (101 MHz; CDCl3): δ 176.8, 159.4, 159.1, 147.6, 
128.8, 121.6, 109.9, 104.6, 98.6, 60.2, 55.58, 55.42, 46.7, 43.4, 22.4, 16.4, 14.4; HRMS (EI) m/z 
292.16764 [calc’d for C17H24O4 (M+) 292.16746]. 
-Unsaturated ester 133 anti. FTIR (thin film/NaCl): 3076, 2976, 2836, 1733, 1643, 
1610, 1586, 1505, 1463, 1418, 1374, 1262, 1208, 1037, 939, 892,834; 
1
H-NMR (400 MHz; 
CDCl3): δ 7.10 (d, J = 9.0 Hz, 1H), 6.41 (dd, J = 9.0, 4.8 Hz, 1H), 6.40 (app s, 1H), 4.96 (s, 1H), 
4.81 (t, J = 1.7 Hz, 1H), 3.94 (d, J = 11.7 Hz, 1H), 3.88 (app dd, J = 7.1, 4.3 Hz, 2H), 3.79 (s, 
3H), 3.76 (s, 3H), 3.08 (dq, J = 11.7, 6.8 Hz, 1H), 1.59 (d, J = 0.7 Hz, 3H), 1.22 (d, J = 6.8 Hz, 
3H), 0.96 (t, J = 7.1 Hz, 3H); 
13
C-NMR (101 MHz; CDCl3): δ 176.1, 159.3, 158.4, 144.8, 128.4, 
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122.8, 112.7, 103.9, 98.9, 60.0, 55.7, 55.4, 47.8, 41.6, 20.0, 16.8, 14.1; HRMS (EI) m/z 
292.16779 [calc’d for C17H24O4 (M+) 292.16746].  
Preparation of allylic ester 134: 
 
Allylic ester 134. To a solution of allylic alcohol 131 (23.3 g, 110 mmol), 
4-(dimethylamino)pyridine (1.4 g, 11 mmol) in dichloromethane (500 mL) was added pyridine 
(12 mL, 220 mmol) followed by addition of propionyl chloride (25 mL, 275 mmol) at 0 °C. 
Reaction was warmed to room temperature. Reaction progress was monitored by TLC. TLC 
plates were developed with 20% EtOAc/Hex solution and visualized by UV lamp and KMnO4 
stain. Reaction was quenched with 1M HCl (300 mL). Organic phase was washed with saturated 
NaHCO3 (300 mL), H2O (250 mL), brine (250 mL), dried over anhydrous MgSO4 and 
concentrated under reduced pressure. Crude material was purified with silica gel chromatography 
(gradient elution 10152025% EtOAc/Hex) to afford allylic ester 134 (15.8 g, 57% yield, 
over three steps). 
Allylic ester 134. FTIR (thin film/NaCl): 2941, 2837, 1737, 1609, 1579, 1503,1463, 
1417, 1341, 1286, 1209, 1124, 1081, 1034, 937, 834; 
1
H-NMR (400 MHz; CDCl3): δ 7.15 (d, J = 
8.2 Hz, 1H), 6.54 (s, 1H), 6.46 (dd, J = 10.2, 2.1 Hz, 1H), 6.45 (d, J = 2.2 Hz, 1H), 4.66 (d, J = 
0.9 Hz, 2H), 3.80 (s, 3H), 3.79 (s, 3H), 2.39 (q, J = 7.6 Hz, 2H), 1.84 (d, J = 1.4 Hz, 3H), 1.17 (t, 
J = 7.6 Hz, 3H); 
13
C-NMR (101 MHz; CDCl3): δ 174.4, 160.1, 158.3, 132.0, 131.5, 130.6, 125.8, 
123.5, 118.7, 103.8, 98.3, 70.3, 64.4, 55.43, 55.35, 27.7, 21.8, 15.7, 9.2; HRMS (EI) m/z 
264.13501 [calc’d for C15H20O4 (M+) 264.13616]. 
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Preparation of -unsaturated carboxylic acids 135 anti and 136 syn: 
 
-Unsaturated carboxylic acids 135 anti and 136 syn. Following the protocol of Daub 
and et al.
20
 To a solution of diisopropylamine (0.10 ml, 0.68 mmol) in THF (2 mL) was added n-
butyllithium (1.32 M, 0.33 mL, 0.44 mmol) at 0 ºC. Reaction solution was stirred 2 minutes at 0 
ºC and cooled to –78 ºC. Allylic ester 134 (72 mg, 0.27 mmol) was added to the reaction solution 
drop wise over approximately 3 minutes as a solution in THF (1 mL) at  –78 ºC; followed by 
stirring for 2 minutes. tert-Butyldimethylsilyl chloride (45 mg, 0.3 mmol) was added as a 
solution in hexamethylphosphoramide (0.14 mL, 0.81 mmol) at –78 ºC, stirred 2 minutes and 
warmed to room temperature. Reaction solution was refluxed for 2 hours; oil bath heat set to 80 
ºC. Reaction progress was monitored by TLC. TLC plates were developed with 30% EtOAc/Hex 
solution and visualized by UV lamp and KMnO4 stain. Reaction was cooled to room temperature 
and quenched with 10% HCl solution (1 mL); stirred for 1 hour. 15% NaOH solution was added 
and aqueous phase was extracted three times with diethyl ether (3 mL). Concentrated HCl was 
added to the aqueous phase, until pH = 3 at 0 ºC. Acidic aqueous phase was extracted three times 
with diethyl ether (3 mL). Organic phase was washed with H2O (5 mL), brine (5 mL), dried over 
anhydrous MgSO4 and concentrated under reduced pressure. Crude material was purified with 
silica gel chromatography (gradient elution 203050% EtOAc/Hex) to afford -unsaturated 
carboxylic acids 135 anti and 136 syn (combined 42 mg, 58% yield, 3:1 dr) both colorless oils.  
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-Unsaturated carboxylic acids 135 anti and 136 syn. Following the procedure of 
Collum et al.
21
 To a solution of LiHMDS (1M in toluene, 11.4 mL, 11.34 mmol), triethylamine 
(16mL, 113.4 mmol) in toluene (40 mL) was added allylic ester 134 (1 g, 3.78 mmol) as a 
solution in toluene (10 mL) at –78 ºC. Stirred reaction for 1 hour at –78 ºC than warmed to room 
temperature. TLC was used to monitor reaction progress. TLC plates were developed with 30% 
EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain. Reaction was basified with 
15% NaOH (25 mL). Extracted basified reaction solution with diethyl ether (50 mL). 
Concentrated HCl was added to the aqueous phase, until pH = 3 at 0 ºC. Extracted acidified 
aqueous phase three times with diethyl ether (25 mL). Combined organic phase was washed with 
H2O (50 mL), brine (50 mL), dried over anhydrous MgSO4 and concentrated under reduced 
pressure to yield -unsaturated carboxylic acids 135 anti and 136 syn (0.80g, 80% yield, 19:1 
dr) as white solid. No further purification required. 
-Unsaturated carboxylic acids 135 anti. FTIR (thin film/NaCl) 3077 (br, s), 2969 (s), 





H-NMR (400 MHz; CDCl3): δ 7.09 (d, J = 8.2 Hz, 1H), 6.42 (dd, J = 8.0, 2.5 
Hz, 1H), 6.39 (t, J = 3.0 Hz, 1H), 4.93 (s, 1H), 4.82 (t, J = 1.7 Hz, 1H), 3.91 (d, J = 11.5 Hz, 1H), 
3.77 (s, 3H), 3.73 (s, 3H), 3.05 (dq, J = 11.6, 6.8 Hz, 1H), 1.56 (s, 3H), 1.22 (d, J = 6.8 Hz, 4H); 
13
C-NMR (101 MHz; CDCl3): δ 181.5, 159.4, 158.4, 144.4, 128.1, 122.3, 113.0, 104.0, 99.1, 
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55.7, 55.4, 47.5, 41.2, 20.0, 16.9; HRMS (EI) m/z 264.13637 [calc’d for C15H20O4 (M+) 
264.13616]. 
-Unsaturated carboxylic acids 136 syn. 
1
H-NMR (300 MHz; CDCl3): δ 7.02 (d, J = 
9.1 Hz, 1H), 6.47 (dd, J = 9.0, 2.5 Hz, 1H), 6.45 (d, J = 2.4 Hz, 2H), 4.97 (s, 1H), 4.82 (s, 1H), 
3.95 (d, J = 11.2 Hz, 1H), 3.80 (s, 6H), 3.00 (app dd, J = 11.1, 6.8 Hz, 1H), 1.60 (s, 3H), 0.98 (d, 
J = 6.9 Hz, 3H). 
Attempted cleavage of methyl ether 135: 
 
Lactone 141. To a stirred solution of -unsaturated carboxylic acid 135 (50 mg, 0.20 
mmol) in dichloromethane (2 mL) was added boron tribromide (100 L, 0.22 mmol) at –78 ºC. 
Reaction solution was slowly warmed to room temperature. TLC was used to monitor reaction 
progress. TLC plates were developed with 50% EtOAc/Hex solution and visualized by UV lamp 
and KMnO4 stain. Reaction was quenched with H2O (5 mL). Organic phase was washed with 
brine (5 mL), dried over anhydrous MgSO4 and concentrated under reduced pressure. Crude 
material was purified with silica gel chromatography (gradient elution 10203050% 
EtOAc/Hex) to afford lactone 141 (15 mg, 30% yield) as the major product, white solid. 
Lactone 141. 
1
H-NMR (300 MHz; CDCl3): δ 6.86 (d, J = 9.1 Hz, 1H), 6.44 (app s, 1H), 
6.41 (dd, J = 9.0, 2.5 Hz), 3.80 (s, 3H), 3.73 (s, 3H), 3.45 (br app s, 1H), 3.23-3.13 (m, 1H), 1.52 

















Attempted cleavage of methyl ether 135: 
 
Lactone 143. To a stirred solution of -unsaturated carboxylic acid 135 (471 mg, 1.78 
mmol) in N,N-dimethylformamide (18 mL) was added sodium ethanethiolate (314 mg, 3.74 
mmol). Reaction was heated to reflux (153 ºC) over night. Reaction progress was monitored by 
TLC. TLC plates were developed with 30% EtOAc/Hex solution and visualized by UV lamp and 
KMnO4 stain. Reaction was quenched with 10% HCl (10 mL). Diluted with diethyl ether (20 
mL). Organic phase was washed three times with H2O (40 mL), brine (40 mL), dried over 
anhydrous MgSO4 and concentrated under reduced pressure. Crude material was purified with 
silica gel chromatography (gradient elution 10203050% EtOAc/Hex) to afford lactone 
143 (112 mg, 25% yield) as a white solid. 
Lactone 143. FTIR (thin film/NaCl) 3077 (m), 2975 (s), 2838 (m), 2594 (w), 2416 (w), 
2235 (w), 1766 (s), 1623 (s), 1377 (m), 1318 (m), 1260 (m), 1080 (m), 1033 (m), 839 (m); 
1
H-NMR (400 MHz; CDCl3): δ 6.99 (d, J = 8.4 Hz, 1H), 6.66 (dd, J = 8.5, 2.6 Hz, 1H), 6.60 (d, J 
= 2.6 Hz, 1H), 5.08 (quintet, J = 1.5 Hz, 1H), 4.91 (t, J = 0.8 Hz, 1H), 3.78 (s, 3H), 3.38 (d, J = 
9.9 Hz, 1H), 2.75 (dq, J = 9.9, 6.9 Hz, 1H), 1.65 (t, J = 0.6 Hz, 3H), 1.25 (d, J = 6.9 Hz, 3H); 
13
C-NMR (101 MHz; CDCl3): δ 171.4, 159.9, 152.2, 142.2, 128.7, 116.8, 115.6, 110.6, 102.3, 
55.6, 49.1, 37.4, 17.9, 14.2; HRMS (EI) m/z 232.10984 [calc’d for C14H16O3 (M+) 232.10994]. 
 69 
Preparation of SEM-ether 145: 
 
SEM-ether 145. To a stirred heterogeneous solution of 2,4-dihydroxybenzaldehyde 
(144) (5 g, 36.20 mmol) in dichloromethane (250 mL) was added N,N-diisopropylethylamine (8 
mL, 43.44 mmol) and 2-(trimethylsilyl)ethoxymethyl chloride (6.4 mL, 36.20 mmol) at 0 ºC. 
Reaction was warmed to room temperature. TLC was used to monitor reaction progress. TLC 
plates were developed with 30% EtOAc/Hex solution and visualized by UV lamp and KMnO4 
stain. Quenched reaction with saturated NH4Cl solution (100 mL) at 0 ºC and warmed to room 
temperature. Organic phase was washed with H2O (100 mL), brine (100 mL), dried over 
anhydrous Na2SO4, with stirring. Concentrated under reduced pressure to afford SEM-ether 145 
(9.4 g, 97% yield) as oil. No further purification was necessary. 
SEM-ether 145. FTIR (thin film/NaCl): 3099, 2954, 2897, 1654, 1577, 1502, 1431, 
1361, 1333, 1289, 1249, 1215, 1164, 1119, 1087, 993, 955, 917, 836, 806, 758, 713, 695, 653, 
613; 
1
H-NMR (400 MHz; CDCl3): δ 11.38 (s, 1H), 9.74 (d, J = 0.5 Hz, 1H), 7.45 (d, J = 8.6 Hz, 
1H), 6.65 (dd, J = 8.6, 2.3 Hz, 1H), 6.61 (d, J = 2.3 Hz, 1H), 5.26 (s, 2H), 3.77-3.73 (m, 2H), 
0.98-0.93 (m, 2H), 0.00 (s, 9H); 
13
C-NMR (101 MHz; CDCl3): δ 194.7, 164.7, 164.3, 135.5, 













Preparation of methyl ether 146: 
 
Methyl ether 146. To a stirred solution of SEM-ether 145 (9.4 g, 35.02 mmol) in 
tetrahydrofuran (200 mL) was added tetrabutylammonium hydrogen sulfate (6 g, 17.51 mmol), 
NaOH solution (2M, 88 mL, 175.10 mmol) and iodomethane (16 mL, 245.14 mmol). Reaction 
was stirred at room temperature overnight. TLC was used to monitor reaction progress. TLC 
plates were developed with 30% EtOAc/Hex solution and visualized by UV lamp and KMnO4 
stain. Phases were separated. Organic phase was washed with H2O (200 mL), brine (200 mL), 
dried over anhydrous Na2SO4 and concentrated under reduced pressure. Crude material was 
purified with silica gel chromatography (gradient elution 51020% EtOAc/Hex) to afford 
methyl ether 146 (9.4 g, 95% yield) as yellow oil. 
Methyl ether 146. FTIR (thin film/NaCl): 3299, 2953, 1679, 1603, 1502, 1466, 1425, 
1397, 1315, 1261, 1203, 1165, 1088, 1029, 998, 935, 836, 694; 
1
H-NMR (400 MHz; CDCl3): δ 
10.30 (d, J = 0.6 Hz, 1H), 7.78 (d, J = 8.7 Hz, 1H), 6.68 (dd, J = 8.7, 1.5 Hz, 1H), 6.60 (d, J = 
2.1 Hz, 1H), 5.27 (s, 2H), 3.89 (s, 3H), 3.77 (dd, J = 9.4, 7.3 Hz, 2H), 0.94 (dd, J = 9.4, 7.3 Hz, 
2H), -0.00 (s, 9H); 
13
C-NMR (101 MHz; CDCl3): δ 188.6, 164.2, 163.7, 130.7, 119.6, 108.3, 













Preparation of -unsaturated ester 147: 
 
-Unsaturated ester 147. To a stirred heterogeneous solution of sodium hydride (1.8 
g, 45.11 mmol) in THF (100 mL) was added triethyl 2-phosphonopropionate (11.4 mL, 52.05 
mmol) at 0 °C. Aldehyde 146 (9.8 g, 34.70 mmol) as a solution in THF (30 mL) was added at 0 
°C, drop wise via addition funnel, followed by immediate warming to room temperature. TLC 
was used to monitor reaction progress. TLC plates were developed with 20% EtOAc/Hex 
solution and visualized by UV lamp and anisaldehyde stain. Reaction was quenched with 
saturated NH4Cl solution (100 mL) at 0 °C. Quenched solution was warmed to room temperature 
and diluted with H2O to dissolve salts. Organic phase was washed with H2O (100 mL), brine 
(100 mL), dried over anhydrous MgSO4 and concentrated under reduced pressure. Crude 
material was purified with silica gel chromatography (gradient elution 57102050% 
EtOAc/Hex) to afford -unsaturated ester 147 (11.3 g, 10:1 dr) as yellow oil.  
-Unsaturated ester 147. FTIR (thin film/NaCl): 2954, 1702, 1607, 1577, 1501, 1464, 
1419, 1366, 1247, 1201, 1087, 1000, 935, 836, 753, 736, 694; 
1
H-NMR (400 MHz; CDCl3): δ 
7.79 (s, 1H), 7.24 (d, J = 8.5 Hz, 1H), 6.66 (dd, J = 8.5, 2.3 Hz, 1H), 6.60 (d, J = 2.3 Hz, 1H), 
5.24 (s, 2H), 4.25 (q, J = 7.1 Hz, 2H), 3.83 (s, 3H), 3.77 (dd, J = 9.5, 7.2 Hz, 2H), 2.05 (d, J = 
1.5 Hz, 3H), 1.34 (t, J = 7.1 Hz, 3H), 0.97 (dd, J = 9.5, 7.2 Hz, 2H), 0.00 (s, 8H); 
13
C-NMR (101 















55.7, 18.2, 14.53, 14.43, -1.3; HRMS (EI) m/z 366.18651 [calc’d for C19H30O5Si (M+) 
366.18651]. 
Preparation of allylic alcohol 148: 
 
Allylic alcohol 148. To a heterogeneous stirred solution of lithium aluminum hydride 
(304 mg, 8.02 mmol) in THF (40 mL) was added -unsaturated ester 147 (1.96 g, 5.35 mmol) 
as a solution in THF (10 mL) at 0 °C. TLC was used to monitor reaction progress. TLC plates 
were developed with 30% EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain. 
Quenched reaction with extremely slow drop wise addition of H2O (1 mL), 15% NaOH solution 
(1 mL) and H2O (3 mL) stirred for 30 minutes at 0 °C. Warmed to room temperature. Added 1 
scoop of anhydrous MgSO4 and stirred for 1 hour. Filtered through sand/celite pad. Concentrated 
to reduce volume. Organic phase was washed with H2O (50 ml), brine (50 mL), dried over 
anhydrous MgSO4 and concentrated under reduced pressure. Crude material was purified with 
silica gel chromatography (gradient elution 1020304050% EtOAc/Hex) to afford 
allylic alcohol 148 (1.67 g, 97% yield) as colorless oil. 
Allylic alcohol 148. FTIR (thin film/NaCl): 3415, 2953, 1607, 1501, 1464, 1417, 1250, 
1198, 1006, 934, 836, 694; 
1
H-NMR (400 MHz; CDCl3): δ 7.14 (d, J = 8.3 Hz, 1H), 6.63 (dd, J 
= 8.3, 2.3 Hz, 1H), 6.59 (d, J = 2.3 Hz, 1H), 6.52 (s, 1H), 5.23 (s, 2H), 4.19 (s, 2H), 3.80 (s, 3H), 
3.77 (t, J = 8.4 Hz, 2H), 1.85 (s, 3H), 1.65 (s, 1H), 0.97 (t, J = 8.4 Hz, 2H), 0.01 (s, 9H); 
13
C-NMR (101 MHz; CDCl3): δ 158.2, 157.8, 136.9, 130.7, 120.5, 120.0, 106.9, 99.9, 93.2, 
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69.4, 66.4, 55.6, 18.2, 15.5, -1.2; HRMS (EI) m/z 322.15996 [calc’d for C17H26O4Si (M+) 
322.16004]. 
Preparation of allylic ester 149: 
 
Allylic ester 149. To a solution of allylic alcohol 148 (1.67 g, 5.15 mmol), 
4-(dimethylamino)pyridine (64 mg, 0.52 mmol) in dichloromethane (50 mL) was added pyridine 
(400 L, 7.73 mmol) followed by addition of propionyl chloride (930 L, 10.3 mmol) at 0 °C. 
Reaction was warmed to room temperature. TLC was utilized to monitor reaction progress. TLC 
plates were developed with 50% EtOAc/Hex solution and visualized by UV lamp and KMnO4 
stain. Reaction was quenched with 1M HCl (10 mL). Organic phase was washed with saturated 
NaHCO3 (50 mL), H2O (50 mL), brine (50 mL), dried over anhydrous MgSO4 and concentrated 
under reduced pressure. Crude material was purified with silica gel chromatography (gradient 
elution 5710% EtOAc/Hex) to afford allylic ester 149 (1.57 g, 80% yield) as colorless oil. 
Allylic ester 149. FTIR (thin film/NaCl): 3451, 2952, 1737, 1608, 1579, 1502, 1463, 
1418, 1279, 1199, 1085, 1010, 935, 836; 
1
H-NMR (400 MHz; CDCl3): δ 7.14 (d, J = 8.4 Hz, 
1H), 6.63 (dd, J = 8.4, 2.3 Hz, 1H), 6.58 (d, J = 2.3 Hz, 1H), 6.54 (s, 1H), 5.22 (s, 2H), 4.66 (s, 
2H), 3.80 (s, 3H), 3.78 (dd, J = 9.5, 7.4 Hz, 2H), 2.40 (q, J = 7.6 Hz, 2H), 1.84 (d, J = 1.3 Hz, 
3H), 1.18 (t, J = 7.6 Hz, 3H), 0.95 (dd, J = 9.5, 7.4 Hz, 2H), 0.00 (s, 9H); 
13
C-NMR (101 MHz; 
CDCl3): δ 174.5, 158.3, 158.0, 131.9, 130.7, 123.6, 119.6, 106.9, 99.9, 93.1, 70.4, 66.5, 55.6, 
27.8, 18.2, 15.8, 9.4, -1.2; HRMS (EI) m/z 380.20201 [calc’d for C20H32O5Si (M+) 380.2019]. 
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Preparation of -unsaturated carboxylic acid 150: 
 
-Unsaturated carboxylic acid 150. Following the procedure of Collum et al.
21
 A 
solution of lithium bis(trimethylsilyl)amide (1M in toluene, 16 mL, 15.77 mmol) and 
triethylamine (22 mL, 157.80 mmol) in toluene (40 mL) was stirred for 10 minutes at room 
temperature; followed by cooling to –78 ºC. A precooled solution of allylic ester 149 (2 g, 5.26 
mmol) in toluene (25 mL) was added over 1 hour to the reaction solution at –78 ºC. Upon 
complete addition reaction solution was stirred for 10 minutes at –78 ºC prior to warming to 
room temperature. TLC was utilized to monitor reaction progress. TLC plates were developed 
with 20% EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain. Quenched reaction 
with 1M HCl (80 mL) at 0 ºC. Organic phase was washed with H2O (100 mL), brine (100 mL), 
dried over anhydrous MgSO4 and concentrated under reduced pressure. Crude material was 
purified with silica gel chromatography (gradient elution 5710% EtOAc/Hex; doped eluent 
with 1% AcOH) to afford -unsaturated carboxylic acid 150 (1.7g; 85% yield, 20:1 dr) as oil. 
-Unsaturated carboxylic acid 150. FTIR (thin film/NaCl) 2952 (br s), 1708 (s), 1609 
(m), 1503 (m), 1250 (m), 1198 (m), 1163 (m), 1140 (m), 1086 (m), 1013 (s), 937 (m), 859 (m), 
836 (s); 
1
H-NMR (400 MHz; CDCl3): δ 7.07 (d, J = 8.4 Hz, 1H), 6.55 (dd, J = 8.4, 2.3 Hz, 1H), 
6.52 (d, J = 2.3 Hz, 1H), 5.19 (d, J = 6.9 Hz, 1H), 5.17 (d, J = 7.0 Hz, 1H), 4.94 (s, 1H), 4.82 (s, 
1H), 3.93 (d, J = 11.5 Hz, 1H), 3.77-3.73 (t, J = 8.4 Hz, 2H), 3.74 (s, 3H), 3.06 (dq, J = 12.1, 6.3 



















(101 MHz; CDCl3): δ 181.0, 158.3, 157.3, 144.4, 128.1, 123.3, 113.2, 107.1, 100.6, 93.2, 66.4, 
55.7, 47.5, 41.0, 19.9, 18.2, 16.9, -1.2; HRMS (EI) m/z 381.2092 [calc’d for C20H32O5Si (M+H)+ 
380.2019]. 
Preparation of phenol 142: 
 
Phenol 142. To a stirred solution of -unsaturated carboxylic acid 150 (1.7 g, 4.47 
mmol) in tetrahydrofuran (7 mL) was added tetrabutylammonium fluoride (1M in THF, 23 mL, 
22.33 mmol). Reaction was refluxed (65 ºC). Aliquots of the reaction were taken and analyzed 
by 
1
H NMR to monitor progress. Quenched with 1M HCl (20 mL). Organic phase was washed 
with H2O (15 mL), brine (15 mL), dried over anhydrous MgSO4 and concentrated under reduced 
pressure. Crude material was triturated with chloroform to afford phenol 142 (549 mg, 50% 
yield) as a white powder. 
Phenol 142. FTIR (thin film/NaCl): 3327, 2969, 1708, 1613, 1506, 1457, 1290, 1198; 
1
H-NMR (400 MHz; DMSO-d6): δ 11.75 (s, 2H), 9.21 (s, 2H), 6.97 (d, J = 8.3 Hz, 1H), 6.31 (d, 
J = 2.3 Hz, 1H), 6.26 (dd, J = 8.3, 2.3 Hz, 1H), 4.86 (s, 1H), 4.72 (s, 1H), 3.77 (d, J = 11.6 Hz, 
1H), 3.67 (s, 3H), 2.94 (dq, J = 12.2, 6.4 Hz, 1H), 1.49 (s, 3H), 1.07 (d, J = 6.8 Hz, 3H); 
13
C- NMR (101 MHz; DMSO-d6): δ 176.6, 157.9, 156.8, 144.6, 127.7, 120.1, 112.5, 106.3, 99.1, 















Preparation of spiro lactone 157: 
 
Spiro lactone 157. To a stirred solution of [bis(trifluoroacetoxy)iodo]benzene (120 mg, 
0.28 mmol) in acetonitrile (8.2 mL) was added phenol 142 (58 mg, 0.23 mmol) as a solution in 
acetonitrile (1 mL) at room temperature. TLC was utilized to monitor reaction progress. TLC 
plates were developed with 20% EtOAc/Hex solution and visualized by UV lamp and KMnO4 
stain. Reaction solution was concentrated under reduced pressure and purified with silica gel 
chromatography (gradient elution 203050% EtOAc/Hex ) to afford spiro lactone 157 (52.9 
mg, 93% yield, 14:1 dr) as white solid. 
Spiro lactone 157. FTIR (thin film/NaCl) 2939 (w), 1787 (s), 1667 (s), 1606 (m), 1455 
(w), 1373 (w), 1314 (w), 1228 (m), 1180 (w), 1070 (w), 975 (w), 858 (w), 646 (w); 
1
H-NMR 
(300 MHz; CDCl3): δ 6.50 (d, J = 10.1 Hz, 1H), 6.21 (dd, J = 10.1, 1.7 Hz, 1H), 5.67 (d, J = 1.7 
Hz, 1H), 5.04 (s, 1H), 4.80 (s, 1H), 3.84 (s, 3H), 3.28 (d, J = 12.9 Hz, 1H), 2.95 (dq, J = 13.1, 6.6 
Hz, 1H), 1.61 (s, 3H), 1.32 (d, J = 6.9 Hz, 3H); 
13
C-NMR (101 MHz; CDCl3): δ 186.0, 169.7, 
169.3, 139.2, 137.4, 129.8, 115.2, 104.2, 56.5, 55.9, 37.0, 22.2, 13.9. 





























    PhCH3, –78 °C ® rt
2. CH2N2, Et2O, 0 °C
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Methyl ester 158. Following the procedure of Collum et al.
21
 A solution of lithium 
bis(trimethylsilyl)amide (1M in toluene, 40 mL, 39.41 mmol) and triethylamine (55 mL, 394.20 
mmol) in toluene (95 mL) was stirred for 15 minutes at room temperature; followed by cooling 
to –78 ºC. A precooled solution of allylic ester 149 (5 g, 5.26 mmol) in toluene (75 mL) was 
added over 1 hour to the reaction solution at –78 ºC. Upon complete addition reaction solution 
was stirred for 15 minutes at –78 ºC prior to warming to room temperature. Reaction was 
warmed to 30 ºC and stirred for 12 hours. TLC was utilized to monitor reaction progress. TLC 
plates were developed with 25% EtOAc/Hex solution and visualized by UV lamp and 
anisaldehyde stain. Quenched reaction with 1M HCl (125 mL) at 0 ºC. Organic phase was 
washed with 1M HCl (250 mL), H2O (500 mL), brine (100 mL), dried over anhydrous MgSO4 
and concentrated under reduced pressure to afford crude -unsaturated carboxylic acid (4.6 g; 
crude yield 92%). Crude material was taken on directly to methylation.  
Diazomethane was prepared from Diazald, using Aldrich Diazald apparatus.
40
 
For an alcohol-containing ethereal solution: 
 Condenser was filled with dry ice, isopropanol was added slowly until cold-finger was 
approximately one-third full. Ethanol (95%, 10 mL) was added to a solution of potassium 
hydroxide (5 g) in water (8 mL) in the reaction vessel. Receiving flask (100 mL) was attached to 
condenser and cooled in a dry ice/isopropanol bath.  
A separatory funnel was place over the reaction vessel and charged with a solution of 
Diazald (5.0 g, 23 mmol) in ether (45 mL). The reaction vessel was warmed to 65 ºC with a H2O 
bath. Diazald solution was added over a period of 20 minutes. The rate of distillation should 
approximate the rate of addition. Cold-finger was replenished as necessary with dry ice. When 
all the Diazald was used up, diethyl ether (10 mL) was added, slowly, and distillation was 
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continued until distillate was colorless; process continued until distillate colorless. The ether 
solution contains approximately 700 mg (16.6 mmol) of diazomethane. 
Note: All glassware used must be clear-seal joint type. Pipettes are flame polished prior to use. 
To a stirred solution of crude -unsaturated carboxylic acid (4.6 g, 13.14 mmol) in 
diethyl ether (30 mL) was added diazomethane solution at 0 ºC. Addition was continued until 
reaction solution remained yellow. TLC was utilized to monitor reaction progress. TLC plates 
were developed with 25% EtOAc/Hex solution and visualized by UV lamp and anisaldehyde 
stain. Quenched reaction with 3M AcOH in ethyl acetate, colorless solution. Concentrated under 
reduced pressure. Crude material was purified with silica gel chromatography (gradient elution 
7102050% EtOAc/Hex) to afford methyl ester 158 (2.9 g; 56% yield, 12:1 dr, over two 
steps). 
Methyl ester 158. FTIR (thin film/NaCl): 2952, 1739, 1609, 1587, 1504, 1455, 1249, 
1197, 1162, 1087, 1013, 859, 836; 
1
H-NMR (400 MHz; CDCl3): δ 7.06 (d, J = 8.2 Hz, 1H), 6.55 
(dd, J = 8.2, 2.2 Hz, 1H), 6.53 (d, J = 2.2 Hz, 1H), 5.17 (s, 2H), 4.95 (t, J = 1.0 Hz, 1H), 4.81 
(dd, J = 1.8, 1.6 Hz, 1H), 3.95 (d, J = 11.6 Hz, 1H), 3.78 (s, 3H), 3.75 (d, J = 7.3 Hz, 1H), 3.73 
(d, J = 7.2 Hz, 1H), 3.42 (s, 3H), 3.10 (dq, J = 11.6, 6.8 Hz, 1H), 1.57 (s, 3H), 1.21 (d, J = 6.8 
Hz, 3H), 0.96 (d, J = 7.3 Hz, 1H), 0.93 (d, J = 7.3 Hz, 1H), -0.01 (s, 9H); 
13
C-NMR (101 MHz; 
CDCl3): δ 176.5, 158.2, 157.2, 144.5, 128.0, 123.4, 112.8, 107.0, 100.5, 93.1, 66.3, 55.7, 51.4, 
47.7, 41.3, 20.0, 18.1, 16.8, -1.3; HRMS (EI) m/z 417.2068 [calc’d for C21H34O5Si (M+Na)+ 
394.2176]. 
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Preparation of alcohol 159: 
 
Alcohol 159. To a stirred heterogeneous solution of lithium aluminum hydride (0.83 g, 
31.90 mmol) in tetrahydrofuran (150 mL) was added methyl ester 158 (7.2 g, 18.25 mmol) as a 
tetrahydrofuran (30 mL) solution at 0 ºC. Stirred at 0 ºC for 1 hour and followed by warming to 
room temperature, stirred 15 minutes. TLC was utilized to monitor reaction progress. TLC plates 
were developed with 25% EtOAc/Hex solution and visualized by UV lamp and anisaldehyde 
stain. Quenched reaction with H2O (2 mL), 15% NaOH (2 mL) and H2O (6 mL); stirred 30 
minutes at 0 ºC. Added 1 scoop of anhydrous MgSO4. Warmed to room temperature. Filtered 
through sand/celite pad and concentrated under reduced pressure. Organic phase was washed 
with H2O (100 mL), brine (100 mL), dried over anhydrous MgSO4 and concentrated under 
reduced pressure to afford alcohol 159 (6.6 g, 99% yield), viscous colorless oil. No further 
purification was necessary.  
Alcohol 159. FTIR (thin film/NaCl): 3420, 3076, 2890, 1683, 1644, 1607, 1502, 1373, 
1332, 1261, 1080, 936, 850, 757, 694, 664; 
1
H-NMR (300 MHz; CDCl3): δ 7.11 (d, J = 8.3 Hz, 
1H), 6.63 (dd, J = 8.3, 2.4 Hz, 1H), 6.60 (d, J = 2.4 Hz, 1H), 5.20 (s, 2H), 4.94 (s, 1H), 4.88 (t, J 
= 1.5 Hz, 1H), 3.83 (s, 3H), 3.76 (t, J = 8.3 Hz, 3H), 3.55 (d, J = 11.5 Hz, 1H), 3.37 (dd, J = 
11.2, 3.1 Hz, 1H), 3.24 (dd, J = 11.2, 4.6 Hz, 1H), 2.11-2.00 (m, 1H), 1.72 (br s, 1H), 1.61 (s, 
3H), 1.11 (d, J = 6.6 Hz, 3H), 0.96 (t, J = 8.4 Hz, 3H), 0.00 (s, 9H). 
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Preparation of phenol 160: 
 
Phenol 160. To a stirred solution of alcohol 159 (6.1 g, 16.64 mmol) in tetrahydrofuran 
(117 mL) was added tetrabutylammonium fluoride (1M in THF, 117 mL, 116.50 mmol). 
Reaction was refluxed (65 ºC). Aliquots of the reaction were taken and analyzed by 
1
H NMR to 
monitor progress. Quenched with saturated NH4Cl (50 mL). Organic phase was washed with 
H2O (50 mL), brine (50 mL), dried over anhydrous MgSO4 and concentrated under reduced 
pressure. Crude material was purified with silica gel chromatography (gradient elution 
20302050100% EtOAc/Hex) to afford phenol 160 (2.5 g, 64% yield), viscous oil. 
Phenol 160. FTIR (thin film/NaCl): 3322, 3054, 2965, 2723, 1721, 1644, 1596, 1505, 
1465, 1373, 1265, 1197, 1108, 1034, 958, 894, 836, 737, 703; 
1
H-NMR (400 MHz; CDCl3): δ 
7.05 (d, J = 8.2 Hz, 1H), 6.39 (d, J = 2.4 Hz, 1H), 6.37 (dd, J = 8.2, 2.4 Hz, 1H), 5.46 (s, 1H), 
4.94 (s, 1H), 4.89 (t, J = 1.5 Hz, 1H), 3.79 (s, 3H), 3.52 (d, J = 11.5 Hz, 1H), 3.42-3.39 (dd, J = 
11.1, 4.4 Hz, 1H), 3.27 (dd, J = 11.1, 4.4 Hz, 1H), 2.10-2.04 (m, 1H), 1.91 (br s, 1H), 1.60 (s, 
3H), 1.11 (d, J = 6.6 Hz, 3H); 
13
C-NMR (101 MHz; CDCl3): δ 158.2, 155.4, 146.4, 128.9, 122.6, 
111.1, 107.8, 99.3, 66.9, 55.9, 46.0, 37.7, 22.2, 16.4; HRMS (EI) m/z 236.14099 [calc’d for 
C14H20O3 (M+) 236.14124]. 
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Preparation of aldehyde 161: 
 
Aldehyde 161. To a solution of dimethylsulfoxide (1.5 mL, 21.16 mmol) in 
dichloromethane (80 mL) was added oxalyl chloride (0.9 mL, 10.58 mmol) at –78 ºC, drop wise, 
solution stirred for 20 minutes. A solution of alcohol 160 (1.25 g, 5.29 mmol) and triethylamine 
(3.69 mL, 26.45 mmol) in dichloromethane (20 mL) was added via cannula at –78 ºC. Reaction 
was stirred for 1 hour at –78 ºC and warmed to room temperature. TLC was used to monitor 
reaction progress. TLC plates were developed with 50% EtOAc/Hex solution and visualized by 
UV lamp and anisaldehyde stain. Reaction was quenched with saturated NaHCO3 (100 mL). 
Organic phase was washed with H2O (100 mL), brine (100 mL), dried over anhydrous MgSO4 
and concentrated under reduced pressure. Crude material was purified with silica gel 
chromatography (gradient elution 7102050100% EtOAc/Hex) to afford aldehyde 161 
(800 mg, 65% yield).  
Aldehyde 161. FTIR (thin film/NaCl): 3853, 3733, 3583, 3412, 2925, 1716, 1646, 1614, 
1596, 1559, 1540, 1506, 1465, 1456, 1434, 1374, 1294, 1197, 1158, 1120, 1036, 454, 426, 410; 
1
H-NMR (300 MHz; CDCl3): δ 9.35 (d, J = 3.6 Hz, 1H), 6.98 (d, J = 8.3 Hz, 1H), 6.37 (d, J = 
2.5 Hz, 1H), 6.31 (dd, J = 8.3, 2.5 Hz, 1H), 5.08 (s, 1H), 4.92 (t, J = 0.8 Hz, 1H), 4.91 (t, J = 1.6 
Hz, 1H), 3.88 (d, J = 10.9 Hz, 1H), 3.77 (s, 3H), 2.91 (dtt, J = 14.1, 6.9, 3.5 Hz, 1H), 1.61 (dd, J 
= 1.3, 0.8 Hz, 3H), 1.12 (d, J = 6.8 Hz, 3H); 
13
C-NMR (101 MHz; CDCl3): δ 205.1, 155.4, 146.3, 
129.0, 120.5, 115.4, 111.8, 106.9, 98.9, 55.4, 48.7, 44.4, 22.3, 12.5; HRMS (EI) m/z 233.1183 
[calc’d for C14H18O3 (M-H)- 234.1256]. 
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Preparation of spiro lactol 162: 
 
Spiro lactol 162. To a stirred solution of [bis(trifluoroacetoxy)iodo]benzene (151 mg, 
0.35 mmol) in acetonitrile (3 mL) and H2O (1 mL) was added phenol 161 (55 mg, 0.23 mmol) as 
a solution in acetonitrile (1 mL) at room temperature. TLC was used to monitor reaction 
progress. TLC plates were developed with 50% EtOAc/Hex solution and visualized by UV lamp 
and anisaldehyde stain. Acetonitrile was removed under reduced pressure. Diluted with 
dichloromethane (5 mL). Organic phase was washed with H2O (2 mL), brine (2 mL), dried over 
anhydrous Na2SO4 and concentrated under reduced pressure. Crude material was purified with 
silica gel chromatography (gradient elution 20253050100% EtOAc/Hex) to afford 
spiro lactone 162 (30 mg, 52% yield, 1:1 dr) as white solid. 
Spiro lactol 162. FTIR (thin film/NaCl): 3395, 2936, 1720, 1662, 1596, 1508, 1456, 
1369, 1326, 1274, 1228, 1173, 1057, 973, 897, 856, 736; 
1
H-NMR (400 MHz; CDCl3): δ 6.72 (d, 
J = 10.1 Hz, 1H), 6.45 (d, J = 10.1 Hz, 1H), 6.04 (dd, J = 4.2, 1.7 Hz, 1H), 6.02 (dd, J = 4.2, 1.7 
Hz, 1H), 5.59 (d, J = 1.6 Hz, 1H), 5.55 (d, J = 1.7 Hz, 1H), 5.43 (dd, J = 7.1, 4.7 Hz, 1H), 5.32 
(d, J = 5.4 Hz, 1H), 4.95 (s, 1H), 4.92 (s, 1H), 4.72 (s, 1H), 4.70 (s, 1H), 3.84 (s, 3H), 3.79 (s, 
3H), 3.02 (app t, J = 12.5 Hz, 2H), 2.90 (d, J = 7.5 Hz, 1H), 2.55-2.46 (m, 1H), 2.39 (dquintet, J 
= 12.6, 6.4 Hz, 1H), 1.57 (s, 4H), 1.56 (s, 3H), 1.13 (d, J = 6.6 Hz, 3H), 1.07 (d, J = 6.6 Hz, 3H); 
















Preparation of bromide 173: 
 
Aryl bromide 173. Following the procedure of Durst and Lear.
37
 To a stirred solution of 
N,N,N′-trimethylethylenediamine (0.71 mL, 5.50 mmol) in tetrahydrofuran (12 mL) was added 
n-butyllithium (1.5 M, 3.3 mL, 5.00 mmol) at –20 ºC, stirred 20 minutes. p-Anisaldehyde (172) 
(0.61 mL, 5.00 mmol) was added at –20 ºC, stirred 20 minutes. n-Butyllithium (1.5 M, 10.0 mL, 
15.00 mmol) at –20 ºC, stirred 45 minutes. Placed in fridge (–20 ºC) for 23 hours. Removed 
reaction solution from fridge and cooled to–78 ºC. Carbon tetrabromide (5.00 g, 15.00 mmol) 
was added as a solution in tetrahydrofuran (12 mL). Warmed to room temperature. TLC was 
utilized to monitor reaction progress. TLC plates were developed with 20% EtOAc/Hex solution 
and visualized by UV lamp and anisaldehyde stain. Quenched reaction with 10% HCl (25 mL) at 
0 ºC, warmed to room temperature. Aqueous phase was extracted with diethyl ether (10 mL) 
three times. Organic phase was washed with saturated Na2SO3 (75 mL) three times, H2O (100 
mL), brine (100 mL), dried over anhydrous MgSO4 and concentrated under reduced pressure. 
Crude material was purified with silica gel chromatography (gradient elution 571020% 
EtOAc/Hex) to afford aryl bromide 173 (700 mg, 65% yield) as white solid. 
Aryl bromide 173 is a known compound, the 
1
H NMR spectra was obtained and structure 
was confirmed by comparison with spectra published in the literature.
37
  
Aryl bromide 173. 
1
H-NMR (300 MHz; CDCl3): δ 10.22 (s, 1H), 7.89 (d, J = 8.7 Hz, 




i.  n-BuLi, THF, –20 °C
ii. n-BuLi, –20 °C












Preparation of -unsaturated ester 174: 
 
-Unsaturated ester 174. To a stirred heterogeneous solution of sodium hydride (156 
mg, 3.91 mmol) in tetrahydrofuran (12 mL) was added triethyl-2-phosphonopropionate (0.86 
mL, 3.91 mmol) at 0 ºC. Aldehyde 173 (700 mg, 3.26 mmol) was added as a solution in 
tetrahydrofuran (10 mL) at 0 ºC. Reaction was warmed to room temperature and stirred over 
night. TLC was utilized to monitor reaction progress. TLC plates were developed with 10% 
EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain. Reaction was diluted with 
ethyl acetate (20 mL) and quenched with saturated NH4Cl solution (20 mL). Organic phase was 
washed with H2O (20 mL), brine (20 mL), dried over anhydrous MgSO4 and concentrated under 
reduced pressure. Crude material was purified with silica gel chromatography (gradient elution 
5710% EtOAc/Hex) to afford -unsaturated ester 174 (975 mg, 72% yield, 10:1 E/Z) as 
colorless oil.  
-Unsaturated ester 174. 
1
H-NMR (300 MHz; CDCl3): δ 7.68 (d, J = 1.5 Hz, 1H), 
7.25 (d, J = 8.1 Hz, 1H), 7.17 (d, J = 2.6 Hz, 1H), 6.87 (dd, J = 8.4, 2.4 Hz, 1H), 4.28 (q, J = 7.1 
Hz, 2H), 3.82 (s, 3H), 1.99 (d, J = 1.5 Hz, 3H), 1.35 (t, J = 7.1 Hz, 3H). 
















Allylic alcohol 175. To a stirred heterogeneous solution of lithium aluminum hydride 
(133 mg, 3.51 mmol) in tetrahydrofuran (11 mL) was added -unsaturated ester 174 (700 mg, 
2.34 mmol) as a solution in tetrahydrofuran (5 mL) at 0 ºC, upon complete addition the reaction 
was warmed to room temperature. TLC was utilized to monitor reaction progress. TLC plates 
were developed with 10% EtOAc/Hex solution and visualized by UV lamp and anisaldehyde 
stain. Reaction was quenched with H2O (1 mL), 15% NaOH (1 mL), and H2O (3 mL) at 0 ºC. 
Added 1 scoop of anhydrous MgSO4 and warmed to room temperature. Filtered through 
celite/sand pad, rinsed with diethyl ether. Organic phase was washed with H2O (40 mL), brine 
(40 mL), dried over anhydrous MgSO4 and concentrated under reduced pressure to afford allylic 
alcohol 175 (602 mg, quantitative yield) as colorless oil. No further purification was necessary. 
Allylic alcohol 175. 
1
H-NMR (300 MHz; CDCl3): δ 7.19 (d, J = 8.6 Hz, 1H), 7.14 (d, J = 
2.6 Hz, 1H), 6.84 (dd, J = 8.5, 2.6 Hz, 1H), 6.47 (br s, 1H), 4.22 (d, J = 6.2 Hz, 2H), 3.80 (s, 3H), 
1.78 (d, J = 1.4 Hz, 3H), 1.53 (d, J = 6.3 Hz, 1H). 
Preparation of -unsaturated ester 176: 
 
-Unsaturated ester 176. A solution of allylic alcohol 175 (0.817 mg, 3.18 mmol) and 
propionic acid (0.15 mL) in trimethyl orthoacetate (35 mL) was heated to 120 °C and after 24 
hours additional propionic acid (0.15 mL) was added and maintained at reflux for an additional 
24 hours.  All volatiles were removed under reduced pressure and the crude oil was purified with 
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silica gel chromatography (10% EtOAc/hexanes) to afford -unsaturated ester 176 (0.660 g, 
2.11 mmol, 66.3% yield) as colorless oil. 
-Unsaturated ester 176. FTIR (thin film/NaCl): 3083 (m), 2995 (s), 2950 (s), 2915 
(s), 2838 (s), 1746 (s), 1649 (s), 1602 (s), 1565 (s), 1489 (s), 1436 (s), 1369 (s), 1374 (s), 1360 
(s), 1335 (s), 1259 (s), 1158 (s), 1036 (s); 
1
H-NMR (500 MHz; CDCl3): δ 7.10 (d, J = 2.3 Hz, 
1H), 7.10 (d, J = 8.7 Hz, 1H), 6.81 (dd, J = 8.7, 2.6 Hz, 1H), 4.93 (s, 1H), 4.86 (s, 1H), 4.25 (t, J 
= 7.8 Hz, 1H), 3.77 (s, 3H), 3.63 (s, 3H), 2.76 (dd, J = 15.5, 8.7 Hz, 1H), 2.67 (dd, J = 15.5, 7.0 
Hz, 1H), 1.64 (s, 3H); 
13
C-NMR (126 MHz; CDCl3): δ 172.14, 158.58, 145.95, 132.88, 128.52, 
125.24, 117.94, 113.88, 110.86, 55.42, 51.62, 45.92, 38.63, 22.16; HRMS (EI) m/z 312.0354 
[calc’d for C14H17BrO3 (M+) 312.0361]. 
Preparation of carboxylic acid 177: 
 
Carboxylic acid 177. To a stirred solution of -unsaturated ester 176 (0.195 g, 0.623 
mmol) in N,N-dimethylformamide (6.39 mL) was added a premixed solution of sodium 
ethanethiolate (0.142 mL, 1.92 mmol) and sodium hydride (0.0768 g, 60% w/w in mineral oil, 
1.92 mmol) in N,N-dimethylformamide (1.92 mL). Reaction solution was heated to 100 °C and 
maintained overnight. Reaction was quenched with 10% HCl (20 mL) and diluted with ethyl 
acetate (20 mL). Phases were separated. Aqueous phase was washed with ethyl aceate (2 x 20 
mL). Combined organic phase was dried over anhydrous MgSO4 and concentrated reduced 
pressure. Crude material was purified with silica gel chromatography (gradient elution 25→50% 













Carboxylic acid 177. FTIR (thin film/NaCl): 3263 (br), 3085 (m), 2968 (m), 2937 (m), 
1708 (s), 1648 (m), 1606 (s), 1584 (m), 1491 (s), 1432 (s), 1378 (m), 1252 (s), 1214 (s), 1029 
(m); 
1
H-NMR (500 MHz; CDCl3): δ 7.07 (d, J = 2.6 Hz, 1H), 7.05 (d, J = 8.5 Hz, 1H), 6.73 (dd, 
J = 8.5, 2.6 Hz, 1H), 4.96 (s, 1H), 4.88 (s, 1H), 4.23 (t, J = 7.8 Hz, 1H), 2.78 (dd, J = 15.9, 8.8 
Hz, 1H), 2.71 (dd, J = 15.9, 6.9 Hz, 1H), 1.65 (s, 3H); 
13
C-NMR (126 MHz; CDCl3): δ 177.44, 
154.76, 145.65, 132.75, 128.78, 125.21, 119.86, 115.05, 111.20, 45.72, 38.48, 22.22; HRMS (EI) 
m/z 284.0047 [calc’d for C12H13BrO3 (M+) 284.0048]. 
Preparation of bisallylic alcohol 179: 
 
Bisallylic alcohol 179. To a stirred solution of carboxylic acid 177 (0.060 g, 0.210 mmol) 
in dichloromethane (5 mL) was added [bis(trifluoroacetoxy)iodo]benzene (0.104 g, 0.242 mmol) 
at 0 °C, approximately 10 minutes. TLC was utilized to monitor reaction progress. TLC plates 
were developed with 50% EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain.  
Reaction mixture was cooled to -78 °C and diisobutylaluminum hydride (1.05 mL, 1.0 M, 
1.05 mmol) was added and maintained for 15 minutes at -78 °C.  Reaction was quenched with 
saturated Rochelle’s salt solution (10 mL) and stirred vigorously for 12 hours.  Phases were 
separated and the aqueous phase was extracted with dichloromethane (2 x 5 mL). Combined 
organic phase was dried over MgSO4 and concentrated under reduced pressure. Crude material 
was purified with silica gel chromatography (20% EtOAc/hexanes) to yield bisallylic alcohol 













   CH2Cl2, 0 °C
ii. i-Bu2AlH, –78 °C
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Bisallylic alcohol 179. FTIR (thin film/NaCl): 3384 (br), 2923 (m), 2854 (m), 1672 (m), 
1640 (m), 1447 (s), 1377 (s), 1349 (s), 1261 (s), 1241 (s), 1186 (s), 1128 (s), 1086 (s), 1044 (s), 
1000 (s); 
1
H-NMR (500 MHz; CDCl3): δ 6.60 (dd, J = 4.1, 1.9 Hz, 1H), 6.57 (dd, J = 3.6, 1.9 
Hz, 1H), 6.55 (dd, J = 4.3, 1.8 Hz, 1H), 6.50 (dd, J = 3.6, 1.8 Hz, 1H), 6.09 (dd, J = 10.1, 0.8 Hz, 
1H), 6.00-5.99 (m, 1H), 5.99-5.98 (m, 2H), 5.96 (dt, J = 3.4, 1.5 Hz, 2H), 5.95 (t, J = 1.6 Hz, 
1H), 5.93 (dd, J = 3.1, 2.0 Hz, 1H), 5.75 (dd, J = 10.1, 1.0 Hz, 2H), 5.74-5.71 (m, 3H), 5.66 (dd, 
J = 10.0, 1.3 Hz, 2H), 5.59 (t, J = 4.8 Hz, 1H), 5.56 (t, J = 4.7 Hz, 2H), 4.94 (d, J = 0.9 Hz, 1H), 
4.93 (d, J = 1.1 Hz, 1H), 4.86 (d, J = 1.1 Hz, 1H), 4.85 (d, J = 1.3 Hz, 2H), 4.79 (s, 1H), 4.78 (s, 
1H), 4.76 (s, 1H), 4.74 (s, 2H), 4.52-4.46 (m, 2H), 4.41 (s, 3H), 3.63-3.61 (m, 1H), 3.59 (d, J = 
6.4 Hz, 1H), 3.57 (d, J = 6.4 Hz, 1H), 3.54 (d, J = 5.8 Hz, 2H), 3.39 (dd, J = 13.0, 7.6 Hz, 1H), 
3.35 (dd, J = 12.7, 7.3 Hz, 1H), 3.25 (d, J = 3.1 Hz, 1H), 3.17 (d, J = 4.4 Hz, 2H), 2.87-2.86 (m, 
1H), 2.43 (dddd, J = 28.2, 13.1, 7.6, 5.4 Hz, 3H), 2.34 (d, J = 4.9 Hz, 1H), 2.31 (d, J = 4.4 Hz, 
3H), 2.29 (s, 1H), 2.28 (s, 1H), 2.26 (s, 1H), 2.21 (d, J = 6.5 Hz, 1H), 2.18 (d, J = 6.4 Hz, 1H), 
2.14 (d, J = 6.3 Hz, 1H), 2.12 (d, J = 6.3 Hz, 1H), 2.10 (d, J = 6.2 Hz, 1H), 2.07 (d, J = 6.3 Hz, 
1H), 1.71 (s, 2H), 1.70 (s, 3H), 1.61 (s, 11H); 
13
C NMR (126 MHz, CDCl3)  141.27, 140.52, 
135.53, 135.38, 134.90, 134.71, 130.81, 130.08, 130.01, 129.43, 128.88, 128.28, 128.23, 128.04, 
127.93, 127.86, 113.70, 113.25, 112.76, 110.00, 99.07, 98.75, 97.42, 97.09, 82.13, 81.65, 80.82, 
77.20, 64.75, 64.66, 64.51, 64.43, 52.45, 51.92, 49.33, 49.04, 37.15, 36.87, 36.82, 36.71, 22.05, 
22.03; HRMS (EI) m/z 269.0164 [calc’d for C12H13BrO2 [C12H15BrO3(–H2O)] (M+H)+ 268.009]. 


















Dienone 180. To a stirred solution of bisallylic alcohol 179 (0.019 g, 0.0662 mmol) in 
dichloromethane (3 mL) was added Dess-Martin reagent (0.0337 g, 0.0794 mmol) at 0 °C. 
Reaction progress was monitored by TLC. TLC plates were developed with 20% EtOAc/Hex 
solution and visualized by UV lamp and KMnO4 stain. After approximately 10 minutes saturated 
NaHCO3 solution (5 mL) was added. Reaction mixture extracted with diethyl ether (3 x 5 mL).  
Combined organic phase was dried over anhydrous Na2SO4 and concentrated under reduced 
pressure. Crude material was purified with silica gel chromatography (10% EtOAc/Hex) to 
afford dienone 180 (0.016 g, 84% yield) as an inseparable mixture of diastereomers and colorless 
oil. 
Dienone 180. FTIR (thin film/NaCl): 3385 (br), 2924 (m), 2852 (m), 1718 (m), 1671 (m), 
1649 (s), 1623 (m), 1598 (m), 1490 (m), 1437 (s), 1380 (m), 1299 (s), 1262 (m), 1176 (s), 1117 
(m), 1097 (m), 1058 (m), 1012 (s); 
1
H-NMR (500 MHz; CDCl3): δ 7.13 (d, J = 10.2 Hz, 1H), 
6.74 (d, J = 10.0 Hz, 2H), 6.17 (dd, J = 14.8, 10.5 Hz, 2H), 5.88 (t, J = 4.7 Hz, 1H), 5.73 (s, 1H), 
4.91 (d, J = 7.3 Hz, 3H), 4.84 (s, 1H), 4.79 (s, 1H), 3.72 (dd, J = 13.5, 6.2 Hz, 1H), 3.47 (t, J = 
9.9 Hz, 1H), 3.34-3.22 (m, 2H), 2.95 (s, 1H), 2.57 (dt, J = 13.4, 6.6 Hz, 1H), 2.44 (td, J = 13.1, 
4.7 Hz, 2H), 2.31 (td, J = 12.8, 5.9 Hz, 1H), 2.24 (dd, J = 13.0, 6.2 Hz, 2H), 1.62 (s, 7H), 1.25 (d, 
J = 0.4 Hz, 1H); 
13
C-NMR (126 MHz, CDCl3)  199.56, 183.25, 183.15, 150.60, 150.48, 147.81, 
146.79, 146.61, 138.85, 138.66, 138.37, 134.57, 134.12, 126.79, 126.72, 125.28, 116.64, 114.87, 
114.82, 114.31, 114.21, 113.88, 99.91, 98.42, 83.64, 54.42, 51.65, 43.11, 40.25, 37.40, 37.20, 
22.07, 22.01, 16.69; HRMS (EI) m/z 267.0015 [calc’d for C12H11BrO2 [C12H13BrO3(–H2O)] 
(M+H)+ 265.9941]. Note dienone 180 is contaminated with aldehyde 183. 
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Preparation of aldehyde 183: 
 
Aldehyde 183. It was observed that dienone 180 undergoes facile [3,3]-sigmatropic 
rearrangement at room temperature to afford aldehyde 183 (quantitative). 
Aldehyde 183. FTIR (thin film/NaCl): 3385 (br), 2924 (m), 2853 (m), 1710 (s), 1664 
(m), 1589 (m), 1488 (s), 1436 (s), 1176 (s), 1078 (m), 1023 (m); 
1
H-NMR (500 MHz; CDCl3): δ 
9.64 (s, 1H), 6.86 (d, J = 8.7 Hz, 1H), 6.77 (d, J = 8.7 Hz, 1H), 5.32 (t, J = 7.3 Hz, 1H), 5.25 (s, 
1H), 4.99 (s, 1H), 3.64 (s, 2H), 3.19 (d, J = 6.8 Hz, 2H), 1.69 (s, 3H); 
13
C NMR (126 MHz, 
CDCl3)  199.47, 148.53, 146.81, 138.37, 125.26, 116.69, 114.91, 114.33, 43.11, 40.32, 16.67; 
HRMS (EI) m/z 282.9975 [calc’d for C12H13BrO3 (M-H)- 284.0047]. 
Preparation of allylic ester 189: 
 
Allylic ester 189. To a stirred solution of allylic alcohol 175 (602 mg, 2.34 mmol), 
4-(dimethylamino)pyridine (28 mg, 0.23 mmol), pyridine (0.18 mL, 3.51 mmol) in 
dichloromethane (16 mL) was added propionyl chloride (0.42 mL, 4.68 mmol) at 0 ºC. Reaction 
was warmed to room temperature. TLC was used to monitor reaction progress. TLC plates were 
developed with 20% EtOAc/Hex solution and visualized by UV lamp and anisaldehyde stain. 















NaHCO3 solution (20 mL) two times, H2O (50 mL), brine (50 mL), dried over anhydrous MgSO4 
and concentrated under reduced pressure. Crude material was purified with silica gel 
chromatography (gradient elution 71020% EtOAc/Hex) to afford allylic ester 189 (700 mg, 
95% yield) as yellow oil. 
Allylic ester 189. 
1
H-NMR (300 MHz; CDCl3): δ 7.19 (d, J = 8.6 Hz, 1H), 7.14 (d, J = 
2.6 Hz, 1H), 6.84 (dd, J = 8.6, 2.6 Hz, 1H), 6.47 (br s, 1H), 4.67 (d, J = 1.0 Hz, 2H), 3.80 (s, 4H), 
2.42 (q, J = 7.6 Hz, 2H), 1.77 (d, J = 1.4 Hz, 3H), 1.19 (t, J = 7.6 Hz, 3H). 
Preparation of -unsaturated carboxylic acid 190: 
 
-Unsaturated carboxylic acid 190. Following the procedure of Collum et al.
21
 A 
solution of lithium bis(trimethylsilyl)amide (1.2 g, 7.02 mmol) and triethylamine (9.3 mL, 70.2 
mmol) in toluene (30 mL) was stirred for 15 minutes at room temperature; followed by cooling 
to –78 ºC. A precooled solution of allylic ester 189 (733 mg, 2.34 mmol) in toluene (10 mL) was 
added over 1 hour to the reaction solution at –78 ºC, upon complete addition reaction solution 
was stirred for 15 minutes at –78 ºC prior to warming to 30 ºC and stirred for 12 hours. TLC was 
utilized to monitor reaction progress. TLC plates were developed with 20% EtOAc/Hex solution 
and visualized by UV lamp and KMnO4 stain. Reaction was basified with 15% NaOH (25 mL). 
Extracted basified reaction solution with diethyl ether (25 mL) two times. Concentrated HCl was 
added to the aqueous phase, until pH = 3 at 0 ºC. Extracted acidified aqueous phase with diethyl 

















mL), dried over anhydrous MgSO4 and concentrated under reduced pressure to yield -
unsaturated carboxylic acids 190 (411 mg, 56% yield, 10:1 dr) as orange foam. No further 
purification required. 
 -Unsaturated carboxylic acid 190. 
1
H-NMR (300 MHz; CDCl3): δ 11.00 (br s, 1H), 
7.19 (d, J = 8.7 Hz, 1H), 7.09 (d, J = 2.7 Hz, 1H), 6.81 (dd, J = 8.7, 2.7 Hz, 1H), 5.07 (d, J = 0.6 
Hz, 1H), 4.92 (t, J = 1.5 Hz, 1H), 4.01 (d, J = 11.3 Hz, 1H), 3.77 (s, 3H), 3.04 (dq, J = 11.3, 6.8 
Hz, 1H), 2.07 (s, 2H), 1.56 (s, 3H), 1.27 (d, J = 6.9 Hz, 3H). 
Preparation of methyl ester 188: 
 
Methyl ester 188. To a stirred solution of carboxylic acid 190 (500 mg, 1.6 mmol) in 
methanol (11 mL) and ethyl acetate (4 mL) was added (trimethylsilyl)diazomethane (0.96 mL, 
1.20 mmol) at room temperature. TLC was used to monitor reaction progress. TLC plates were 
developed with 20% EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain. 
Reaction was quenched with 3M acetic acid solution in ethyl acetate (15 mL). Solution was 
concentrated under reduced pressure to afford methyl ester 188 (556 mg, quantitative yield) as 
orange oil. No further purification was necessary. 
Methyl ester 188. 
1
H-NMR (300 MHz; CDCl3): δ 7.18 (d, J = 8.7 Hz, 1H), 7.08 (d, J = 
2.7 Hz, 1H), 6.81 (dd, J = 8.8, 2.7 Hz, 1H), 5.07 (d, J = 0.8 Hz, 1H), 4.91 (t, J = 1.5 Hz, 1H), 
4.03 (d, J = 11.4 Hz, 1H), 3.76 (s, 3H), 3.45 (s, 3H), 3.06 (dq, J = 11.4, 6.8 Hz, 1H), 1.59 (t, J = 
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Chapter 3  
Synthesis of a Tetramic Acid 
3.1 Second-Generation Retrosynthetic Analysis 
As outlined in Scheme 3.1 our second-generation retrosynthetic analysis of tetrapetalone 
A (1) envisaged completion of the natural product via glycosylation of aglycon 184 followed by 
subsequent deprotection of the tetramic acid moiety. Aglycon 184 was envisioned as deriving 
from phenolic oxidation applied to tetracycle 185, a compound seen arising from diene 187 via a 
ring closing metathesis and subsequent Friedel-Crafts alkylation. Diene 187 would be assembled 
in a convergent manner by amidation of aryl bromide 188 with protected tetramic acid 99. 
Having successfully established a synthetic route to aryl bromide 188, our primary objective 
became the synthesis of protected tetramic acid 99. To this end, we began our efforts by 
developing a synthesis of protected tetramic acid 99. 
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Scheme 3.1 Second-Generation Retrosynthetic Analysis of Tetrapetalone A 
3.2 Tetramic Acid Introduction 
3.2.1 Naturally Occurring Tetramic Acids 
The tetramic acid (2,4-pyrrolidinedione) ring system 191 has been known since the early 
twentieth century when the first simple derivatives were prepared.
41,42
 It was not until the 1960s 
that this heterocycle was found to be a key structural unit in many natural products (Figure 3.1). 
Pyrrolidine-2,4-diones bearing an acyl substituent at C-3 (i.e. 192–193) are the most commonly 
found tetramic acid derivatives in nature; N-acyl-4-methoxy-3-pyrrolin-2-ones, in other words 
the 4-O-methyl ethers of N-acylated tetramic acids have also been isolated (i.e. 194–195). 
Naturally occurring tetramic acids have attracted a great deal of interest because the majority of 








































































Figure 3.1 Representative Natural Products Containing a Tetramic Acid Moiety 
3.2.2 Structure of the Tetramic Acid Ring 





 were later shown to have resulted only in the formation of the isomer 
2-iminotetronic acid (198) (Figure 3.2).
46,47
 Tetramic acid (196) is a much weaker acid (with a 
pKa = 6.4 in aqueous solution) than its oxygen analog, tetronic acid (201) (with a pKa = 3.76 in 
aqueous solution); consequently tetramic acid (196) is not highly enolizable and exists primarily 
as the 2,4-diketo tautomer (196). Tetramic acids bearing acyl (i.e. 199), or alkoxycarbonyl (i.e. 
200) substituents at C-3 have similar acidity to the tetronic acids. The former have pKa values in 









































































Figure 3.2 Structure of Tetramic Acids and Tetronic Acid  
3.2.3 Synthetic Strategies for Construction of Tetramic Acid Derivatives 
3.2.3.1 Ring Closure by C–N Bond Formation 
Gabriel achieved the first reliable synthesis of a tetramic acid derivative in 1941.
41,48,49
 In 
this work he demonstrated that phthalimidoisobutyryl chloride (203) with diethyl sodium 
malonate gave 204, which upon treatment with concentrated sulfuric acid cyclized to the 
ethoxycarbonyl tetramic acid 205. Williard and Laszlo applied similar methodology to the 
synthesis of dysidin (194),
50
 wherein the acid chloride of N-phthaloylvaline (206) was 
homologated to the intermediate -ketoester with the dilithium dianion of monoethyl malonate 
subsequent O-methylation afforded 207. Exposure to hydrazine resulted in cyclization affording 






































Scheme 3.2 N-Phthalalkylamine Acid Chloride Route 
Hippuric and aceturic acid derivatives have been shown by Sandris and coworkers to be 
versatile building blocks for the synthesis of substituted tetramic acids.
41,51,52
 Reaction of a 
hippuric/aceturic acid derivative 209 with the anion of an active methylene compound 210 
provides the corresponding acetyl derivative 211. Cyclization was performed with excess sodium 
alkoxide and was observed to proceed with simultaneous deprotection of the amide nitrogen to 
afford the substituted tetramic acid 212.  
 
Scheme 3.3 Hippuric and Aceturic Acid Derivatives 
3.2.3.2 Dieckmann Cyclization 
The base induced Dieckmann cyclization of N-acyl--amino esters (i.e. 213), offers a 
convenient route to tetramic acid rings, which is potentially very versatile in terms of the 
possible substitution patterns available. The synthesis of 1-benzyl-2-phenyltetramic acid 215 by 













































R = Ph, Me

















Y = CO2Et, COMe, CN
+
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Scheme 3.4 Dieckmann Cyclization Method for Tetramic Acid Synthesis 
3.2.4 Reactions of the Tetramic Acid Ring 
Reactions of the tetramic acid ring (191) itself can be summarized as follows (Figure 
3.3): (a) reaction with electrophilic species (e.g. aldehydes, bromine or nitrating agents) at C-3, 
(b) with nucleophilic species (e.g. hydrazine) at C-4, (c) acylation at O-4 or, under certain 




























R = Me, Et, nPr, CH2CH2NMe2, CH2CH2SPh
X = Ph, C6H3Me-p, C6H3OMe-p
















3.3 Retrosynthetic Analysis of Tetramic Acid Coupling Partner 
Synthesis of protected tetramic acid 99 would be completed with a Dieckmann 
cyclization of N-acyl--amino ester 218 followed by protection of the vinylogous acid moiety 
and deprotection of the amide. Dieckmann cyclization precursor 218 would be produced via 
acylation of -amino ester 219, derived from oxidation and Wittig olefination of the amino 
alcohol 220. The requisite serine derivative 220 would be prepared via alkylation and subsequent 
hydrolysis of oxazolidine 222, derived from serine methyl ester hydrochloride (223).  
 
Scheme 3.5 Retrosynthetic Analysis of Tetramic Acid Coupling Partner 
3.4 Benzyl Protected Amide Series 
3.4.1 -Vinyl, -Alkyl Quaternary -Amino Ester Synthesis 
In 1984, Seebach and Aebi disclosed a method for the -alkylation of serine with 
self-reproduction of the center of chirality (Scheme 3.6).
55
 It was realized that serine methyl ester 
hydrochloride (223) furnishes the oxazolidine 224 as a mixture of diastereomers (1:1 dr) when 
heated with pivalaldehyde and triethylamine in pentane, with continuous removal of water. 





















































95:5; the major cis diastereomer 225 can be obtained in pure form by recrystallization. 
Alkylation of lithium enolate 226 proceeds with 1,3-asymmetric induction to afford 227, as a 
single diastereomer but in low yield even when lithium-coordinating cosolvents were employed. 
The poor yield of alkylated product is primarily due to a concurrent elimination reaction of the 
enolate leading to the deprotected -unsaturated ester 228. 
 
Scheme 3.6 Seebach’s -Alkylation of Serine 
Colombo and coworkers were able to improve Seebach’s alkylation protocol (Scheme 
3.6), increasing the yield of -alkylation product 227 by employing sodium 
bis(trimethylsilyl)amide to generate enolate 229 (Scheme 3.7).
56
 The sodium counterion of the 















































Scheme 3.7 Colombo’s Modification an Improved -Alkylation of Serine 
In the same report, Colombo and coworkers disclosed a practical synthetic method for the 
enantioselective synthesis of -vinyl, -alkyl, quaternary -amino acids (Scheme 3.8).
56
 
Alkylation product 230 was advanced to amino alcohol 232 via deformylation and hydrolysis of 
oxazolidine 231. The synthetic route required primary amine 232 to be protected as 
benzyloxycarbamate 233. Pyridinium chlorochromate mediated oxidation of alcohol 233 
provided aldehyde 234, exposure to Wittig olefination conditions afforded alkene 235, 
subsequent hydrolysis of the benzyloxycarbamate 235 afforded the desired -vinyl -benzyl 
quaternary -amino acid 236 in excellent yield and >94% enantiomeric excess. 
 
Scheme 3.8 Enantioselective Synthesis of -Vinyl, -Alkyl Quaternary -Amino Acids 
In 1992, Corey and Reichard utilized an aldol reaction with the N-benzylserine derived 
oxazolidine 238 en route to the synthesis of lactacystin (241).
57
 Reductive amination of serine 
methyl ester hydrochloride (223) with benzaldehyde afforded N-benzylserine 237
58

























exposure to pivalaldehyde in the presence para-toluenesulfonic acid in toluene, with continuous 
removal of water, provided oxazolidine 238, as a 9:1 mixture of diastereomers. The 9:1 mixture 
was converted via the lithium enolate-lithium bromide complex with isobutyraldehyde to aldol 
product 239, which was obtained in 77% yield and >98% diastereomeric purity; recrystallization 
from pentane afforded diastereo- and enantiomerically pure 239 in 51% yield. Aminal cleavage 
was achieved upon exposure to trifluoromethanesulfonic acid in methanol affording amino 
alcohol 240 in excellent yield (91%). 
 
Scheme 3.9 Corey’s N-Benzylserine Derived Oxazolidine 
Adopting Corey’s 1,3-oxazolidine 238 (Scheme 3.10) as the chiral template in our 
studies, we focused our synthetic endeavors on the preparation of the requisite -vinyl, -ethyl, 
quaternary -amino ester 247. Following the procedure of Thompson and coworkers,
58
 reductive 
amination of benzaldehyde with serine methyl ester hydrochloride 223 afforded N-benzyl serine 
methyl ester 237. Employing the protocol developed by Seebach and coworkers,
59,60
 
condensation with pivalaldehyde in the presence of catalytic para-toluenesulfonic acid at toluene 
reflux, with continuous removal of water, afforded the desired N-benzyl 1,3-oxazolidine 238 in 
modest yield (63%), as a 9:1 mixture of diastereomers. The 9:1 mixture of diastereomers was 






















































Alkylation of N-benzyl 1,3-oxazolidine 238 with iodoethane proceeded in excellent yield (96%) 
unfortunately; we observed an erosion in the diastereomeric ratio upon alkylation, realizing a 2:1 
mixture of diastereomers. The resulting diastereomers proved difficult to separate by silica gel 
chromatography and thus, the material was carried forward as a mixture of diastereomers. 
N-Benzyl -ethyl 1,3-oxazolidine 244 engaged in methanolysis upon treatment with 
trimethylsilyl trifluoromethanesulfonate in methanol to reveal amino alcohol 245 in good yield 
(67%), Swern oxidation provided aldehyde 246 which was immediately carried directly into 
Wittig olefination affording the desired -vinyl amino ester 247 in modest yield (67%), over two 
steps. 
 
Scheme 3.10 Synthesis of -Vinyl, -Alkyl Quaternary N-Benzyl -Amino Ester 
3.4.2 Dieckmann Cyclization 
With methyl ester 247 on hand we were excited to investigate the key Dieckmann 
cyclization to afford N-benzyl tetramic acid 249. To this end, acylation with propionyl chloride 
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to sodium hydride in refluxing tetrahydrofuran to provide N-benzyl tetramic acid 249 in 
excellent yield (85%), as a 4:1 mixture of diastereomers. 
 
Scheme 3.11 Dieckmann Cyclization 
3.4.3 Unveiling of the Amide via Cleavage of the Benzyl Protecting Group 
Prior to investigating an amidation strategy (i.e. Scheme 3.1) we decided to protect the 
tetramic acid moiety as the vinylogous ester, predicting that elimination of the acidic proton 
would prove beneficial. O-Methylation of tetramic acid 249 was achieved upon treatment with 
potassium carbonate and dimethyl sulfate in refluxing acetone providing vinylogous ester 250 in 
low yield (42%). Cleavage of the benzyl amide proved to be more difficult then predicted and 
upon surveying oxidative cleavage conditions we were delighted to realize that exposure of 
benzyl amide 250 to excess 2,3-dichloro-5,6-dicyano-p-benzoquinone in 1,2-dichloroethane at 
90 C, in a sealed tube, after two days afforded the desired tetramic acid 251 in moderate yield 
(54%). Attempts to optimize the amide deprotection were not fruitful and although the mass 
balance of the reaction was starting material we opted to investigate alternate protecting groups 
for the amide nitrogen. Specifically, we choose to replace the benzyl with the more electron rich 
para-methoxybenzyl, as in theory it should be applicable with all the same chemistry, and more 


























Scheme 3.12 O-Alkylation and Benzyl Amide Cleavage 
3.5 para-Methoxybenzyl Protected Amide Series 
3.5.1 -Vinyl, -Alkyl Quaternary -Amino Ester Synthesis 
In a manner analogous to that of the N-benzyl amide series (i.e. Scheme 3.10) we 
prepared the desired N-para-methoxybenzyl -amino methyl ester 259. Reductive amination was 
conducted in a scalable two-step one pot procedure; condensation of L-serine methyl ester 
hydrochloride (223) with para-anisaldehyde in the presence of triethylamine in methanol 
subsequent concentration under reduced pressure provided imine 252, which was suspended in 
ethanol and exposed to sodium borohydride to afford the desired N-para-methoxybenzyl serine 
methyl ester 253 in good yield (70%).  Following the protocol developed by Seebach and 
coworkers,
59
 N-para-methoxybenzyl serine methyl ester was condensed onto pivalaldehyde upon 
exposure to catalytic para-toluenesulfonic acid at toluene reflux, with continuous removal of 
water, to yield 1,3-oxazolidine 254 in modest yield (60%), as a 10:1 mixture of diastereomers, in 
preference of the thermodynamically more stable cis isomer. Oxazolidine 254 was carried on as 
the mixture, employing the -alkylation conditions developed by Colombo and coworkers.
56
 
Enolization with sodium bis(trimethylsilyl)amide in the presence of iodoethane furnished -ethyl 
1,3-oxazolidene 256 in excellent yield (80%), albeit with poor diastereoselectivity (2:1 dr). 
Amino alcohol 257 was accessed via methanolysis and engaged in Swern oxidation to afford 
aldehyde 258, which was immediately subjected to Wittig olefination to provide the desired -
vinyl, -amino ester 259 in good yield (42%) over three steps. 
Me2SO4
K2CO3























Scheme 3.13 Synthesis of -Vinyl, -Ethyl, -Amino Ester 
3.5.2 Dieckmann Cyclization 
With amine 252 in hand we were enthusiastic to investigate the Dieckmann cyclization. 
To this end, amine 259 was acylated upon exposure to propionyl chloride providing the requisite 
amide 260. We were delighted to find that indeed amide 260 engaged in the desired cyclization 
to furnish N-para-methoxybenzyl tetramic acid 261 in moderate yield (50%), 261 was obtained 
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Scheme 3.14 Dieckmann Cyclization 
3.5.3 Unveiling of the Amide via Cleavage of the N-para-Methoxybenzyl Protecting Group 
As mentioned above in Scheme 3.12, O-methylation of N-para-methoxybenzyl tetramic 
acid 261 was achieved upon treatment with dimethyl sulfate and potassium carbonate in 
refluxing acetone to provide vinylogous ester 262 in good yield (72%) (Scheme 3.15). Oxidative 
cleavage of the N-para-methoxybenzyl amide 262 proved to be much more efficient than the 
benzyl series, exposure to 2,3-dichloro-5,6-dicyano-p-benzoquinone and water in refluxing 
dichloromethane provided tetramic acid 251 in good yield (70%) .  
 
Scheme 3.15 O-Alkylation and N-para-Methoxybenzyl Amide Cleavage 
3.6 Intermolecular Aryl Amidation Strategy  
3.6.1 Copper Catalyzed Aryl Amidation Reactions 
In 2001 Buchwald and coworkers disclosed that the use of diamine ligands allows the 
Goldberg reaction (copper-catalyzed N-arylation of amides) of aryl halides to be performed 


















































Scheme 3.16 Diamine Ligands in Copper Catalyzed Amidation of Aryl Halides 
Buchwald’s early reports established parameters for applying these catalyst systems. The 
best solvents proved to be toluene and 1,4-dioxane, although N,N-dimethylformamide proved 
optimal for very polar amides. Copper iodide gives the highest yields and the advantage of being 
cheap and air stable. The choice of base proved to be of extreme importance in these reactions; 
for aryl iodides potassium phosphate proved to be the best and reactions performed using 
potassium carbonate were found to be much slower. With aryl bromides, which generally react 
more slowly than aryl iodides, potassium phosphate is often unsuccessful but potassium 
carbonate is effective. This disparity is thought to result from the need to match the rate of 
deprotonation of the amide and the rate of the C–N bond formation. If the rate of the 
deprotonation is relatively too high, then deprotonated amide accumulates and forms an 
unreactive cuprate complex 270 (Scheme 3.17). Evidence to support this hypothesis comes from 
the observation that strong bases such as potassium bis(trimethylsilyl)amide are only efficacious 
if added slowly to the reaction mixture. Potassium phosphate and potassium carbonate both 
behave as strong bases in aprotic solvents, but their low solubility ensures slow formation of the 




































Scheme 3.17 Copper Catalyzed Aryl Amidation 
Ligands based on ethylenediamine or cyclohexanediamine provide favorable reactivity. 
Unsubstituted diamines can be used in some cases, however, N,N’-dimethyl-substituted ligands 
generally provide higher rates and avoid undesired N-arylation of the ligand under the reaction 
conditions. Kinetic studies have indicated that the role of the ligand is to prevent the formation of 
the less reactive, multiply ligated cuprate structures.  
The reaction is applicable to a range of electron-rich and electron-deficient aryl and 
heteroaryl bromides, iodides, and in some cases aryl chlorides. Carbamates are also suitable 
coupling partners, but the reaction remains most suitable for lactams and primary amides. 
Acyclic secondary amides are much more challenging, an efficient reaction can only be realized 
for N-aryl or N-methyl amides, except in the case of formamides.  
3.6.2 Lessons from Model Aryl Bromide Substrates  
Although precedent for an aryl amidation with a -substituted lactam proved to be 
deficient in the literature, we were enthusiastic to explore the reactivity of tetramic acid 251 in an 
aryl amidation and push the forefront of the diamine copper catalyst system. To this end we 
screened bases in the aryl amidation of bromobenzene (271) with tetramic acid 251 in the 


































neat bromobenzene (Scheme 3.18). Potassium phosphate afforded amide 272 in the highest yield 
(26%) after twenty-four hours. 
 
Scheme 3.18 Aryl Amidation Base Screen 
We were extremely gratified to find that we could reduce the amount of bromobenzene 
(271), 1:1 stoichiometry, and effectively couple with tetramic acid 251 albeit, in low yield (18%) 
and extended reaction times (Scheme 3.19).  
 
Scheme 3.19 Stoichiometric Aryl Amidation with Tetramic Acid Coupling Partner 
Aryl amidation with an electron rich aryl bromide proved to be advantageous. Exposure 
of 3-bromoanisole (273) and tetramic acid 251 to coupling reaction conditions provided product 
274 in modest yield (35%), after four days (Scheme 3.20). This result delivered confidence that 
aryl bromide 188 (Scheme 3.1) would prove to be an effective coupling partner with tetramic 
























































Scheme 3.20 Amidation of an Electron Rich Aryl Bromide 
To this end, we probed the aryl amidation of 2-bromotoluene (275) and tetramic acid 251 
(Scheme 3.21). Unfortunately, this aryl amidation was to no avail and coupling product 276 was 
not realized. We propose that this coupling was prohibited by the sterics of each coupling 
partner. Although disheartening, this reaction provided insight into the reactivity of tetramic acid 
251 and in general that of -substituted lactams. It appears that the success of an aryl amidation 
between an aryl bromide and lactam is greatly influenced by the steric environments of both 
coupling partners. 
 
Scheme 3.21 Attempted Amidation of ortho-Bromotoluene 
3.6.3 Sterically Encumbered Aryl Bromide Substrates 
Indeed, our aryl amidation observations in the model system held true as we probed more 
advanced aryl bromide substrates (i.e. 277 and 279)
64
 (Scheme 3.22). This prompted us to 


























































Scheme 3.22 Aryl Amidations with Ortho-Substituted Aryl Bromide Substrates 
3.7 Third-Generation Retrosynthetic Analysis 
At this point, we were motivated to investigate the reactivity of aryl bromide 188 toward 
aryl amination cross-coupling methods and revised our retrosynthetic analysis. In an effort to 
reduce the impact of sterics in constructing the C–N bond, we turned to a route wherein the 
tetracycle 281 would arise by Dieckmann cyclization of amide 282 which would, in turn, derive 
from a Friedel-Crafts alkylation of benzazepine 283, the product of a ring closing metathesis 
applied to diene 284. The requisite diene would be furnished by a cross-coupling reaction of aryl 




























































Scheme 3.23 Third Generation Retrosynthetic Analysis 
3.8 Intermolecular Aryl Amination Strategy 
The palladium-catalyzed amination of aryl halides allows the conceptually simple, yet 
powerful, disconnection of an aromatic amine to an aryl halide or pseudo halide and a nitrogen 
nucleophile.
65,66
 The first palladium-catalyzed formation of aryl C–N bonds was disclosed by 
Migita and coworkers in 1983.
67
 More than a decade later Buchwald and coworkers reported a 
new catalytic procedure based on Migita’s amination procedure.
68
 The disadvantage of these 
early methods was that both procedures utilized stoichiometric amounts of heat- and moisture 





discovered that the aminotin species could be replaced with the free amine when a strong base 
(e.g. sodium tert-butoxide or lithium bis(trimethylsilyl) amide) was employed to generate the 
corresponding sodium amide in situ by deprotonating the palladium-coordinated amine. Since 
these initial discoveries there has been great interest in this area and significant improvements in 
substrate scope and catalyst loadings have been realized. Advancements in this area have 
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typically been driven by the implementation of new classes of ligands; i.e. chelating 
diphenylphosphino ligands such as BINAP, dppf, and Xantphos, more electron-rich chelating 
phosphines such as Josiphos, N-heterocyclic carbenes and trialkylphosphines that have served to 
continually increase the substrate scope and to render the reactions more efficient. Despite the 
plethora of systems currently available for palladium-catalyzed C–N couplings, only a limited 
group has seen extensive practical application, reflecting on a combination of the ease of use of a 
catalyst system, its robustness, availability of ligands and substrate scope. Catalysts based on 
dialkylbiaryl phosphines, first described for palladium-catalyzed cross-coupling reactions in 
1998 by Buchwald, compare favorably with other systems in this regard and have been 
extensively applied in the synthesis of biologically active molecules. A catalyst composed of the 
BrettPhos ligand (286) (Table 3.1) has demonstrated excellent reactivity and stability in C–N 
cross-coupling reactions and overcomes many restrictions that previous catalyst systems have 
possessed.
70
 The palladium precatalyst system (287), based on the BrettPhos ligand (286), has 
been shown to quantitatively form the active monoligated palladium(0) complex under the 
reaction conditions,
71
 and has demonstrated the widest scope for primary amines to date. 
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Table 3.1 Cross-Coupling of Aryl Halides and Primary Amines 
 
3.8.1 Allylamine as an Effective Coupling Partner 
To probe the reactivity of aryl bromide 188 towards a palladium-catalyzed C–N 
cross-coupling reaction we conducted studies utilizing allylamine. Exposure of aryl bromide 176 
and allylamine to a catalyst system derived from palladium acetate and BrettPhos (286) resulted 
in no reaction and the aryl bromide 176 was recovered. This outcome leads to the proposal that 
the ortho-substitution of aryl bromide 176 was preventing engagement in the desired aryl 
amination. Thus, we sought to investigate an aryl amination of an aryl bromide possessing less 
steric encumbrance.  




100 °C, 30 min – 24 h
HN
OH
288, X = Cl, 93% yield, 0.25 mol%, 5 ha






290, n = 4, 95% yield, 1 mol%, 20 hb
291, X = 7, 94% yield, 1 mol%, 20 hb




















Scheme 3.24 Cross-Coupling Reaction of ortho-Substituted Aryl Bromide and Allylamine 
In this light, we explored the amination of aryl bromide 294 (Scheme 3.25). Indeed, 
treatment of aryl bromide 294 and allylamine with a catalyst system derived from palladium 
acetate and BrettPhos (286) afforded the desired amine 295 in modest yield (53%). We were 
excited to realize this C–N cross-coupling product, as 295 could be a viable synthetic 
intermediate for tetrapetalone A (1). 
 
Scheme 3.25 Cross-Coupling Reaction of a Simplified Aryl Bromide and Allylamine 
3.8.2 Lithium Enolate Claisen Rearrangement 
Allylic alcohol 296 was unveiled upon subjecting 295 to fluoride mediated silyl ether 
cleavage; subsequent acylation smoothly provided allylic ester 297 in good yield (60%), over 
two steps. We were delighted to find that allylic ester 297 engaged in the desired Claisen 
rearrangement upon enolization with lithium bis(trimethylsilyl)amide/triethylamine and warming 
to room temperature. Treatment of the intermediate carboxylic acid with 
trimethylsilyldiazomethane afforded -unsaturated methyl ester 298 in modest yield (45%) as a 







































Scheme 3.26 Lithium Enolate Claisen Rearrangement 
3.8.3 A Problematic Ring Closing Metathesis 
The formation of carbon–carbon bonds by olefin metathesis has become one of the most 
powerful and broadly applicable methods of modern synthetic chemistry. In particular, ring 
closing metathesis (RCM) reactions promoted by ruthenium based catalysts have been widely 
utilized in the construction of small, medium and large ring systems from acyclic precursors. 
Construction of cyclic, disubstituted olefins from terminal dienes has shown to be effectively 
catalyzed by diphosphine ruthenium complexes such as 299 (Figure 3.4). Synthesis of cyclic 
trisubstituted olefins can be readily achieved using second-generation systems such as 300 and 
the construction of cyclic tetrasubstituted olefins by ring closing metathesis is effectively 



































    PhMe, –78 °C ® rt
2. TMSCHN2
    MeOH, 0 °C ® rt



































In their total synthesis of (–)-cyanthiwigin F (306), Enquist and Stoltz realized a facile 
ring closing metathesis to afford a trisubstituted olefin of a seven membered carbocycle (304) by 




Scheme 3.27 (–)-Cyanthiwigin F Ring Closing Metathesis 
With diene 298 on hand, we investigated construction of the benzazepine ring system by 
ring closing metathesis. No reaction was observed upon exposure of diene 298 to catalyst 302 at 
60 ºC (Table 3.2, entry 1). Increasing the reaction temperature (110 ºC) did not afford the desired 
benzazepine 307; instead enamide 308 was isolated in excellent yield (80%).  
If chelation of the evolving carbene with the amide moiety in 298 occurs to form a stable 
six-membered chelate (i.e. 313, Scheme 3.28, bottom) the catalyst is effectively sequestered, in 
an unproductive complex, rendering the ring closing metathesis ineffective. Furstner and 
coworkers have demonstrated that if the ruthenium is too tightly complexed by polar functional 
groups (such as five- or six-membered chelates), the metathesis reaction can be inhibited and that 
a mild Lewis acid (such as titanium isopropoxide), can be used to compete with the ruthenium 
for chelation of the polar group to effectively release the ruthenium and afford a productive 
RCM.
74
























298 in the presence of excess titanium isopropoxide (Table 3.2, entry 3) unfortunately; we again 
realized enamide 308 in excellent yield (89%).  
Table 3.2 Attempts to from Benzazepine System by Ring Closing Metathesis 
 
Enamide 308 is proposed to arise from an olefin isomerization event (Scheme 3.28, top), 
via a hydrometalation/-hydride sequence, which requires the presence of a coordinately 
unsaturated ruthenium hydride species 314. Coordination of the monosubstituted terminal alkene 
gives the -complex 315, which undergoes a migratory insertion (hydrometalation) to provide 
the -alkyl complex 316. -Hydride elimination leads to -complex 317, from which the 
catalytically active species 314 is regenerated by dissociation of the isomerized alkene 308.  
Ruthenium hydride complexes are formed in some cases as byproducts during the 
preparation of second-generation metathesis catalysts.
75
 If these are present as an impurity in the 
metathesis catalyst, they may be responsible for the observed isomerization reactions. 
Alternatively, ruthenium hydride species may be formed by decomposition of the ruthenium 
















































308 (80% yield, 1.5:1 dr)





pathway we ran the cyclization of 298 in 1,2-dichloroethane,
76
 and catalytic 1,4-benzoquinone;
77
 
to this end the formation of enamide 308 was effectively suppressed, but the desired benzazepine 
307 was not realized. 
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The successful synthesis of a highly functionalized tetramic acid enabled us to investigate 
construction of the desired aryl C–N bond via a copper-catalyzed cross-coupling reaction. The 
tetramic acid proved competent in aryl amidation reactions with simple aryl bromides but the 
introduction of ortho-substitution into the aryl bromide-coupling partner thwarted the desired 
cross-coupling reaction. 
Advanced ortho-substituted aryl bromide intermediates proved to be competent coupling 
partners with primary amines under palladium-catalyzed reaction conditions. This allowed the 
synthesis of a highly functionalized diene. Unfortunately, the diene did not engage in ring 
closing metathesis to afford the benzazepine system.  
3.10 Experimental Section 
3.10.1 Materials and Methods 
Unless stated otherwise, reactions were performed in flame-dried glassware under a 
nitrogen atmosphere. Triethylamine, diisopropylamine, and methanol were dried over anhydrous 
calcium hydride and freshly distilled. 1,4-Dioxane was distilled from sodium, calcium chloride 
and molecular sieve (0.4 nm). Benzene, tetrahydrofuran, dichloromethane, toluene, and diethyl 
ether were dried using a solvent purification system manufactured by Glass Contour Solvent 
Systems, SG Water U.S.A., LLC using technology based upon that originally described by 
Grubbs et al.
78
 Anhydrous N,N-dimethyformamide, acetonitrile, dimethylsulfoxide, 1,2-
dichloroethane was purchased from the Colorado State University Stockroom and supplied by 
Sigma-Aldrich or Fischer Scientific and stored under nitrogen atmosphere. Commercially 
available reagents were obtained from Sigma-Aldrich, Strem, TCI, Combi-Blocks, Acros or 
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Alfa-Aesar and were used as received. All known compounds were identified by comparison of 
NMR spectra to reported in the literature. 
Unless otherwise stated, all reactions were monitored by thin layer chromatography 
(TLC) was using Silicycle glass-backed extra hard layer, 60 Å plates (indicator F-254, 250 m). 
Developed TLC plates were visualized using a 254 nm UV lamp and/or with the appropriate 
stain followed by heating. Typical stains utilized were potassium permanganate, ethanolic 
anisaldehyde and ceric ammonium molybdate. In general, the flash chromatography guidelines 
reported by Still et al
79
 were followed. Silicycle SiliaFlash
® 
P60 (230-400 mesh) silica gel as the 
stationary phase. When reactions were absorbed onto silica gel, the amount of silica gel used was 
equal to two times the weight of the reagents. 
Infrared spectra were obtained using a Nicolet Avatar 320 FTIR or Bruker Tensor27 
FTIR. Samples were analyzed as thin films on NaCl plates (samples was dissolved in CH2Cl2 or 





H) and carbon (
13
C) NMR spectra were recorded on a Varian Inova 
500, Varian Inova 400, Varian Inova 400 auto sampler, or Varian Inova 300 MHz spectrometer. 
Spectra were obtained at 22 °C in CDCl3 unless otherwise noted. Chemical shifts () are reported 
in parts per million (ppm) and are referenced to the internal solvent peak. Coupling constants (J) 
are reported in Hertz (Hz) and are rounded to the nearest 0.1 Hz. Multiplicities are defined as: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, dd = doublet of doublets, dt = doublet 
of triplets, ddd = doublet of doublet of doublets, dddd = doublet of doublet of doublet of 
doublets, br = broad, app = apparent, par = partial. High-resolution mass spectra were obtained 
from the University of Colorado Central Instrument Facility, performed on an Agilent 6210 TOF 
LCMS by Donald L. Dick.  
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3.10.2 Preparative Procedures 
Preparation of N-benzylserine methyl ester 237:  
 
N-benzylserine methyl ester 237. Following the procedure of Thompson et al
58
 N-
benzylserine methyl ester was prepared. L-Serine methyl ester hydrochloride (223) (15.2 g, 97.70 
mmol) was dissolved in methanol (40 mL) and cooled to 0 ºC. Triethylamine (14.3 mL, 102.58 
mmol) was added and the reaction was stirred for 10 minutes and benzaldehyde (10.4 mL, 
102.58 mmol) was added. The reaction mixture was stirred for 3 hours, at which time sodium 
borohydride was added portion wise to the reaction mixture, via addition funnel, over a period of 
1 hour. TLC was used to monitor reaction progress. TLC plates were developed with 100% 
diethyl ether and visualized by UV lamp and KMnO4 stain. The reaction was then partitioned 
between 20% HCl (75 mL) and diethyl ether (20 mL). The organic phase was extracted with 
20% HCl (2x with 80 mL). The combined aqueous phase was washed with diethyl ether (50 
mL). The aqueous layer was then cautiously neutralized with solid NaHCO3. The neutral 
aqueous phase was then extracted with diethyl ether (3x with 80 mL). The combined organic 
phase was washed with H2O (250 mL), brine (250 mL), dried over anhydrous MgSO4 and 
concentrated to afford 237 (14.6 g, 72% yield) as colorless oil. No further purification was 
necessary. 
N-benzylserine methyl ester 237 is a known compound, the 
1
H NMR spectra was 














ii. NaBH4, 0 °C
 127 
N-benzylserine methyl ester 237. 
1
H-NMR (300 MHz; CDCl3): δ 7.39-7.26 (m, 5H), 
3.88 (d, J = 13.0 Hz, 1H), 3.81-3.77 (dd, J = 10.7, 6.4 Hz, 1H), 3.74 (s, 3H), 3.76-3.71 (d, J = 
13.0 Hz, 1H), 3.62 (dd, J = 10.7, 6.4 Hz, 1H), 3.44 (dd, J = 6.3, 4.5 Hz, 1H), 2.48 (s, 2H). 
Preparation of N-benzyl 1,3-oxazolidine 238: 
 
N-Benzyl 1,3-oxazolidine 238. To a stirred solution of N-benzyl serine methyl ester 237 
(14.6 g, 69.78 mmol) in toluene (125 mL) was added pivalaldehyde (15.2 mL, 139.56 mmol), 
para-toluenesulfonic acid (0.7 g, 3.49 mmol). Round bottom flask was fitted with a reflux 
condenser and Dean-Stark trap; reaction was heated to 95 ºC for 24 hours. TLC was used to 
monitor reaction progress. TLC plates were developed with 20% EtOAc/Hex solution and 
visualized by UV lamp and KMnO4 stain. Reaction was diluted with ethyl acetate (100 mL) and 
the washed with saturated NaHCO3 solution (250 mL), H2O (250 mL), brine (250 mL), dried 
over anhydrous MgSO4 and concentrated under reduced pressure. Crude material was purified 
with silica gel chromatography (gradient elution 5710% EtOAc/Hex) to afford 1,3-
oxazolidine 238 (12.3 g, 63% yield, 9:1cis/trans) as colorless oil.  
N-Benzyl 1,3-oxazolidine 238 is a known compound, the 
1
H NMR spectra was obtained 
and structure was confirmed by comparison with spectra published in the literature.
57,59,60
  
N-Benzyl 1,3-oxazolidine 238. 
1
H-NMR (400 MHz; CDCl3): δ 7.44 (d, J = 7.5 Hz, 2H), 
7.31 (t, J = 7.2 Hz, 2H), 7.24 (d, J = 7.2 Hz, 1H), 4.23 (dd, J = 8.5, 3.9 Hz, 1H), 4.15 (s, 1H), 
4.08 (d, J = 14.0 Hz, 1H), 3.91 (dd, J = 8.4, 6.8 Hz, 1H), 3.71 (d, J = 14.0 Hz, 1H), 3.50 (dd, J = 
6.8, 3.4 Hz, 1H), 3.48 (s, 3H), 1.00 (s, 9H); 
13













128.3, 127.4, 105.4, 68.3, 66.3, 61.2, 51.8, 36.8, 25.5; HRMS (EI) m/z 278.1751 [calc’d for 
C16H23NO3 (M+H)+ 278.1758]. 
Preparation of N-benzyl -ethyl 1,3-oxazolidine 244: 
 
N-benzyl -ethyl 1,3-oxazolidine 244. Following the procedure of Colombo et al.
56
 To a 
stirred 0.2 M solution of 1,3-oxazolidine 238 (5.0 g, 18.03 mmol) in tetrahydrofuran (90 mL) 
was added in sequence; 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone (15 mL), 
iodomethane (5.8 mL), and hexanes (15 mL). The resulting solution was cooled to –78 C and 
sodium bis(trimethylsilyl)amide (NaHMDS) (27.10 mL, 27.05 mmol) was added drop wise, two 
20 mL syringes were loaded with NaHMDS (13.5 mL) and set for a addition rate of rate of 0.26 
mL/min with a syringe pump, approximately 52 minutes for complete addition. Reaction turned 
a pale yellow upon addition of NaHMDS. TLC was used to monitor reaction progress. TLC 
plates were developed with 7% EtOAc/Hex solution and visualized by UV lamp and KMnO4 
stain. Note the reaction is a product is a mixture of diastereomers and the lower Rf diastereomer 
co-spots with t starting material. Reaction solution was stirred for 30 minutes at –78 C and then 
warmed to room temperature and stirred overnight; no change by TLC upon stirring over night at 
room temperature. Quenched with saturated NH4Cl (100 mL), diluted with H2O to dissolve salts 
and separated phases. Organic phase was washed with saturated LiCl solution (3 x 50 mL), H2O 
(200 mL) and brine (200 mL). Dried over anhydrous Na2SO4 and concentrated under reduced 
pressure to afford N-benzyl -ethyl 1,3-oxazolidine 244 (5.3 g, 96% yield, 2:1 dr) yellow oil. 
















N-benzyl -ethyl 1,3-oxazolidine 244a (first diastereomer to elute off silica gel column). 
1
H-NMR (400 MHz; CDCl3): δ 7.46 (d, J = 7.6 Hz, 2H), 7.31 (t, J = 7.6 Hz, 2H), 7.21 (t, J = 7.3 
Hz, 1H), 4.57 (d, J = 8.3 Hz, 1H), 4.25 (d, J = 16.5 Hz, 1H), 4.17 (s, 1H), 3.83 (d, J = 16.5 Hz, 
1H), 3.59 (d, J = 8.3 Hz, 1H), 3.48 (s, 3H), 1.78 (app quintet, J = 7.4 Hz, 2H), 0.94 (s, 9H), 0.77 
(t, J = 7.5 Hz, 3H); 
13
C-NMR (101 MHz; CDCl3): δ 173.6, 140.7, 128.1, 127.6, 126.7, 105.4, 
72.7, 71.7, 53.3, 51.6, 37.1, 25.5, 23.5, 9.8; HRMS (EI) m/z 306.2064 [calc’d for C18H27NO3 
(M+H)+ 306.2063]. 
N-benzyl -ethyl 1,3-oxazolidine 244b (second diastereomer to elute off silica gel 
column). 
1
H-NMR (300 MHz; CDCl3): δ 7.38-7.19 (m, 5H), 4.32 (s, 1H), 4.13 (d, J = 8.4 Hz, 
1H), 3.97 (d, J = 16.5 Hz, 1H), 3.84 (d, J = 8.4 Hz, 1H), 3.79 (s, 3H), 3.80-3.74 (d, J = 16.4 Hz, 
1H), 1.65 (dq, J = 14.2, 7.2 Hz, 1H), 1.39 (dq, J = 14.4, 7.2 Hz, 1H), 0.96 (s, 9H), 0.73 (t, J = 7.5 
Hz, 3H). 
Preparation of amino alcohol 245: 
 
Amino alcohol 245. To a stirred solution of N-benzyl -ethyl 1,3-oxazolidine 244 (4.8 g, 
15.72 mmol) in methanol (160 mL) was added trimethylsilyl trifluoromethanesulfonate (11.4 
mL, 62.87 mmol) at room temperature. TLC was used to monitor reaction progress. TLC plates 
were developed with 50% EtOAc/Hex solution doped with 1% triethylamine and visualized by 
UV lamp and KMnO4 stain. Reaction was complete after approximately 1 hour. Neutralized 
reaction solution slowly with saturated NaHCO3 solution. Extracted with diethyl ether (3 x 100 














anhydrous Na2SO4 and concentrated under reduced pressure. Crude material was purified with 
silica gel chromatography (gradient elution 3050% EtOAc/Hex, doped with 1% triethylamine) 
to afford amino alcohol 245 (3.1 g, 76% yield) as a white solid. Note the amino alcohol 245 can 
also be purified by recrystallization from diethyl ether/pentane. 
Amino alcohol 245. 
1
H-NMR (400 MHz; CDCl3): δ 7.34 (d, J = 4.4 Hz, 3H), 7.28 (t, J = 
4.3 Hz, 2H), 3.81 (d, J = 7.7 Hz, 1H), 3.77 (s, 3H), 3.66 (d, J = 12.1 Hz, 1H), 3.65 (d, J = 7.7 Hz, 
1H), 3.61 (d, J = 12.1 Hz, 1H), 2.74 (s, 1H), 2.00 (s, 1H), 1.73 (dtt, J = 22.2, 14.8, 7.4 Hz, 2H), 
0.89 (t, J = 7.5 Hz, 3H); 
13
C-NMR (101 MHz; CDCl3): δ 174.8, 139.9, 128.7, 128.3, 127.5, 66.9, 
62.0, 52.2, 46.9, 26.4, 8.2; HRMS (EI) m/z 238.1438 [calc’d for C13H19NO3 (M+H)+ 238.1437]. 
Preparation of -vinyl amino ester 247: 
 
-Vinyl amino ester 247. Swern oxidation protocol: To a stirred solution of 
dimethylsulfoxide (2.2 mL, 30.36 mmol) in dichloromethane (60 mL) was added oxalyl chloride 
(1.3 mL, 15.17 mmol) at –78 C, slowly. Reaction solution was stirred for 20 minutes at –78 C. 
A solution of amino alcohol 245 (1.8 g, 7.59 mmol) and triethylamine (5.3 mL, 37.95 mmol) in 
dichloromethane (15 mL) was added via cannula at –78 C. Reaction was stirred at –78 C for 1 
hour and warmed to room temperature. TLC was used to monitor reaction progress. TLC plates 
were developed with gradient elution 2030% EtOAc/Hex solution and visualized by UV lamp 
and KMnO4 stain. Quenched reaction with saturated NaHCO3 solution (50 mL). Organic phase 
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under reduced pressure to crude yellow oil. Crude material was carried directly into Wittig 
olefination protocol. 
Wittig olefination protocol: Methyltriphenylphosphonium bromide (5.4 g, 15.18 mmol) 
was dried over night under high vacuum and heated to 110 C. To a stirred heterogeneous 
solution of methyltriphenylphosphonium bromide (5.4 g, 15.18 mmol) in toluene (26 mL) was 
added potassium bis(trimethylsilyl)amide (1.0 M in toluene, 14.4 mL, 14.42 mmol) at room 
temperature. Reaction solution was stirred for 1.5 hours at room temperature; bright yellow 
colored solution. Crude aldehyde (7.59 mmol) as a solution in toluene (10 mL) was added to the 
ylide solution at –78 C via cannula addition. Reaction solution turned a dark orange color. 
Reaction was stirred for 1 hour at –78 C upon complete addition of aldehyde and warmed to 
room temperature. Stirred 2 hours at room temperature. TLC was used to monitor reaction 
progress. TLC plates were developed with gradient elution 20% EtOAc/Hex solution and 
visualized by UV lamp and KMnO4 stain. Quenched reaction with saturated NH4Cl solution (50 
mL) and organic phases were separated. Organic phase was washed with H2O (50 mL), brine (50 
mL), dried over Na2SO4 and concentrated under reduced pressure. Crude material was purified 
with silica gel chromatography (gradient elution 3456% Hex/EtOAc solution) to afford 
-vinyl amino ester 247 (1.2 g, 67% yield, over two steps) as yellow oil. 
-Vinyl amino ester 247. 
1
H-NMR (400 MHz; CDCl3): δ 7.37 (d, J = 7.5 Hz, 2H), 7.32 
(t, J = 7.5 Hz, 2H), 7.25 (t, J = 7.1 Hz, 1H), 6.01 (dd, J = 17.5, 10.8 Hz, 1H), 5.43 (d, J = 17.5 
Hz, 1H), 5.30 (d, J = 10.8 Hz, 1H), 3.76 (s, 3H), 3.62 (d, J = 12.2 Hz, 1H), 3.57 (d, J = 12.2 Hz, 
1H), 1.86 (qq, J = 12.9, 6.6 Hz, 3H), 0.89 (t, J = 7.4 Hz, 3H); 
13
C-NMR (101 MHz; CDCl3): δ 
175.3, 140.7, 138.1, 128.53, 128.37, 127.1, 116.2, 67.5, 52.2, 47.9, 30.1, 8.0; HRMS (EI) m/z 
234.1498 [calc’d for C14H19NO2 (M+H)+ 234.1486]. 
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Preparation of amide 248: 
 
Amide 248. To a stirred solution of amine 247 (703 mg, 3.01 mmol), pyridine (0.50 mL, 
6.03 mL), 4-(dimethylamino)pyridine (18 mg, 0.15 mmol) in dichloromethane (15 mL) was 
added propionyl chloride (0.40 mL, 4.52 mmol) at 0 C. Reaction solution was warmed to room 
temperature, fitted with a reflux condenser and refluxed (40 C). TLC was used to monitor 
reaction progress. TLC plates were developed with gradient elution 50% EtOAc/Hex solution 
and visualized by UV lamp and KMnO4 stain. Quenched reaction with 1M HCl (20 mL) and 
separated phases. Organic phase was washed with 15% NaOH (20 mL), H2O (25 mL), brine (25 
mL), dried over anhydrous MgSO4 and concentrated under reduced pressure. Crude material was 
purified with silica gel chromatography (gradient elution 202530% EtOAc/Hex) to afford 
Dieckmann cyclization precursor 248 (766 mg, 88% yield) as colorless oil. 
Amide 248. 
1
H-NMR (300 MHz; CDCl3): δ 7.51 (d, J = 7.3 Hz, 2H), 7.39 (t, J = 7.5 Hz, 
2H), 7.30-7.26 (m, 1H), 6.03 (dd, J = 17.6, 10.8 Hz, 1H), 5.25 (d, J = 17.1 Hz, 2H), 5.23 (d, J = 
11.3 Hz, 1H), 4.60 (d, J = 19.0 Hz, 1H), 4.52 (d, J = 19.0 Hz, 1H), 3.78 (s, 3H), 2.40-2.01 (m, 
4H), 1.05 (t, J = 7.4 Hz, 3H), 0.86 (t, J = 7.5 Hz, 3H); HRMS (EI) m/z 290.1751 [calc’d for 
C17H23NO3 (M+H)+ 290.1754]. 


































N-Benzyl tetramic acid 249. To a refluxing suspension of sodium hydride (60% 
dispersion in mineral oil) (412 mg, 10.30 mmol) in tetrahydrofuran (35 mL), was added 
dropwise a solution of amide 248 (1.5 g, 5.15 mmol), in tetrahydrofuran (15 mL). Reaction was 
refluxed for 2 days. TLC was used to monitor reaction progress. TLC plates were developed with 
gradient elution 2530% EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain. 
Checking conversion by 
1
H NMR also monitored reaction progress; aliquots were from the 
reaction every 24 hours. Reaction was quenched with addition of saturated NH4Cl solution (25 
mL) and phases were separated. The aqueous phase was extracted with ethyl acetate (2 x 20 mL). 
Combined organic phase was washed with H2O (100 mL), brine (100 mL), dried over anhydrous 
Na2SO4 and concentrated under reduced pressure to afford N-benzyl tetramic acid 249 (1.1 g, 
85% yield, 4:1 dr) as a yellow solid. No further purification was necessary and material was 
carried on directly to methylation. 
N-Benzyl tetramic acid 249. 
1
H-NMR (300 MHz; CDCl3): δ 7.41-7.38 (m, 2H), 7.33-
7.27 (m, 3H), 5.63 (dd, J = 17.4, 10.6 Hz, 1H), 5.27-5.21 (d, J = 10.6 Hz, 1H), 5.20 (d, J = 17.4 
Hz, 1H), 4.73 (d, J = 14.9 Hz, 1H), 4.35 (d, J = 14.9 Hz, 1H), 2.99 (q, J = 7.6 Hz, 1H), 2.13-1.97 
(m, 1H), 1.80-1.63 (m, 1H), 1.32 (d, J = 7.6 Hz, 3H), 0.41 (t, J = 7.3 Hz, 3H), 7.41-7.38 (m, 2H), 
7.33-7.27 (m, 3H), 5.64 (dd, J = 17.4, 10.7 Hz, 3H), 5.31 (d, J = 10.8 Hz, 1H), 5.23 (d, J = 17.4 
Hz, 1H), 4.87 (d, J = 14.9 Hz, 1H), 4.21 (d, J = 14.9 Hz, 1H), 2.77 (q, J = 7.8 Hz, 1H), 2.13-1.97 
(m, 1H), 1.80-1.63 (m, 1H), 1.38 (d, J = 7.8 Hz, 3H), 0.48 (t, J = 7.4 Hz, 3H). HRMS (EI) m/z 
258.1489 [calc’d for C16H19NO2 (M+H)+ 258.1494]. 
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Preparation of vinylogous ester 250: 
 
Vinylogous ester 250. To a stirred heterogeneous solution of N-benzyl tetramic acid 249 
(1.1 g, 4.27 mmol), potassium carbonate (708 mg, 5.12 mmol) in acetone (43 mL), was added 
dimethyl sulfate (0.44 mL). Reaction was fitted with a reflux condenser and refluxed (56 C) 
overnight. TLC was used to monitor reaction progress. TLC plates were developed with gradient 
elution 2530% EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain. Note 
starting material and product have very similar Rf. Conversion was checked 
1
H NMR after 24 
hours. Reaction was cooled to room temperature and partitioned between ethyl acetate (40 mL) 
and 2M NaOH (40 mL). Aqueous phase was extracted with ethyl acetate (2 x 40 mL). Combined 
organic phase was washed with H2O (150 mL), brine (150 mL), dried over anhydrous MgSO4 
and concentrated under reduced pressure. Crude material was purified with silica gel 
chromatography (gradient elution 2530% EtOAc/Hex) to afford vinylogous ester 250 (0.5 g, 
42% yield) as colorless oil. 
Vinylogous ester 250. 
1
H-NMR (300 MHz; CDCl3): δ 7.35 (dd, J = 7.9, 1.5 Hz, 2H), 
7.28-7.20 (m, 3H), 5.48 (dd, J = 18.0, 10.0 Hz, 1H), 5.24 (d, J = 1.0 Hz, 1H), 5.21-5.19 (m, 1H), 
4.59 (d, J = 15.3 Hz, 1H), 4.18 (d, J = 15.1 Hz, 1H), 4.00 (s, 3H), 2.05 (s, 3H), 1.82 (dq, J = 
14.3, 7.2 Hz, 1H), 1.59 (dt, J = 14.2, 7.1 Hz, 1H), 0.37 (t, J = 7.3 Hz, 3H); HRMS (EI) m/z 
272.1645 [calc’d for C16H19NO2 (M+H)+ 272.1646]. 
Me2SO4
K2CO3












Preparation of tetramic acid 251: 
 
Tetramic acid 251. DDQ mediated benzyl amide cleavage protocol: To a vial equipped 
with a magnetic stir bar was added in sequence N-benzyl tetramic acid 250 (20 mg, 0.07 mmol), 
1,2-dichloroethane (1.4 mL) and 2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ) (80 mg, 0.35 
mmol). Reaction vial was sealed and heated to 90 C for two days. TLC was used to monitor 
reaction progress. TLC plates were developed with 80% EtOAc/Hex solution and visualized by 
UV lamp and KMnO4 stain. Reaction was cooled to room temperature and quenched with 
saturated NaHCO3 (3 mL) and phases were separated. Organic phase was concentrated under 
reduced pressure and purified with silica gel chromatography (gradient elution 205080% 
EtOAc/Hex) to afford tetramic acid 251 (7 mg, 54% yield) as tan solid. 
 
DDQ mediated para-methoxybenzyl amide cleavage protocol: To a round bottom flask 
equipped with a magnetic stir bar was added in sequence: N-para-methoxybenzyl tetramic acid 
262 (322 mg, 1.07 mmol), dichloromethane (20 mL), H2O (2 mL) and 2,3-dichloro-5,6-dicyano-
p-benzoquinone (DDQ) (1.2 g, 5.34 mmol), fitted with a west condenser and reaction was 
refluxed (50 C) for two days. TLC was used to monitor reaction progress. TLC plates were 
developed with 80% EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain. 































saturated NaHCO3 (20 mL) and phases were separated. Aqueous phase was extracted with 
dichloromethane (2 x 10 mL). Combined organic phase was washed with H2O (75 mL), brine 
(75 mL), dried over anhydrous Na2SO4 and concentrated under reduced pressure. Crude material 
was and purified with silica gel chromatography (gradient elution 205080% EtOAc/Hex) to 
afford tetramic acid 251 (129 mg, 70% yield) as white solid. 
Tetramic acid 251. 
1
H-NMR (300 MHz; CDCl3): δ 5.83 (dd, J = 17.3, 10.5 Hz, 1H), 
5.34 (s, 1H), 5.26 (dd, J = 17.3, 0.8 Hz, 1H), 5.13 (dd, J = 10.5, 0.8 Hz, 1H), 4.04 (s, 3H), 1.97 
(s, 3H), 1.71 (app septuplet, J = 7.5 Hz, 2H), 0.80 (t, J = 7.4 Hz, 3H). 
Preparation of para-methoxybenzyl serine methyl ester 253: 
 
para-Methoxybenzyl serine methyl ester 253. To a stirred solution of L-serine methyl 
ester hydrochloride (223) (50.0 g, 321.38 mmol) in methanol (640 mL) was added triethylamine 
(45 mL, 321.38 mmol) and p-anisaldehyde (27 mL, 224.97 mmol) at room temperature. The 
reaction solution was stirred at room temperature for 1 hour and concentrated under reduced 
pressure to yield the crude imine as a white solid. The imine was suspended in ethanol (500 mL) 
and sodium borohydride (12 g, 321.38 mmol) was added portion wise via addition funnel over 
30 minutes at room temperature. The heterogeneous reaction mixture was stirred at room 
temperature for 24 hours. TLC was used to monitor reaction progress. TLC plates were 
developed with 100% Et2O and visualized by UV lamp and KMnO4 stain.  Ethanol was removed 
under reduced pressure and the residue was dissolved in 1M HCl (500 mL) at 0 C. The acidic 
solution was washed with ethyl acetate (250 mL). The acidic phase was then brought to ph = 10 
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organic phase was dried over anhydrous MgSO4 and concentrated under reduced pressure to 
afford N-para-methoxybenzylserine methyl ester 253 (51.8, 70% yield) as orange oil. No further 
purification was necessary.  
N-para-Methoxybenzyl serine methyl ester 253. FTIR (thin film/NaCl): 3404, 2999, 
2953, 2837, 1737, 1643, 1613, 1585, 1513, 1464, 1421, 1321, 1303, 1249, 1177, 1106, 1058, 
1033, 810, 734; 
1
H-NMR (300 MHz; CDCl3): δ 7.23 (d, J = 8.7 Hz, 2H), 6.86 (d, J = 8.7 Hz, 
2H), 3.80 (d, J = 12.7 Hz, 1H), 3.79 (s, 3H), 3.76 (dd, J = 10.7, 6.4 Hz, 1H), 3.74 (s, 3H), 3.66 
(d, J = 12.7 Hz, 1H), 3.59 (dd, J = 10.7, 6.4 Hz, 1H), 3.42 (dd, J = 6.4, 4.5 Hz, 1H), 2.53 (br s, 
2H); HRMS (EI) m/z 240.123 [calc’d for C12H17NO4 (M+H)+ 239.1158]. 
Preparation of N-para-methoxybenzyl 1,3-oxazolidine 254: 
 
N-para-Methoxybenzyl 1,3-oxazolidine 254. To a stirred solution of N-para-
methoxybenzyl serine methyl ester 253 (53 g, 222.70 mmol) in toluene (450 mL) was added 
pivalaldehyde (48 mL, 445.40 mmol), para-toluenesulfonic acid (2.1 g, 11.14 mmol). Round 
bottom flask was fitted with a reflux condenser and Dean-Stark trap; reaction was heated to 160 
ºC for 24 hours. TLC was used to monitor reaction progress. TLC plates were developed with 
5% EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain. Reaction was washed 
with saturated NaHCO3 solution (500 mL), H2O (500 mL), brine (500 mL), dried over anhydrous 
MgSO4 and concentrated under reduced pressure. Crude material was purified with silica gel 
chromatography (eluent 5% EtOAc/Hex) to afford N-para-methoxybenzyl 1,3-oxazolidine 254 













 N-para-Methoxybenzyl 1,3-oxazolidine 254. FTIR (thin film/NaCl): 2954, 1735, 1612, 
1585, 1512, 1484, 1463, 1396, 1359, 1244, 1085, 1059, 1035, 970, 887, 823; 
1
H-NMR (400 
MHz; CDCl3): δ  7.34 (d, J = 8.6 Hz, 2H), 6.84 (d, J = 8.7 Hz, 2H), 4.20 (dd, J = 8.5, 3.9 Hz, 
1H), 4.11 (s, 1H), 3.99 (d, J = 13.8 Hz, 1H), 3.87 (dd, J = 8.5, 6.8 Hz, 1H), 3.77 (s, 3H), 3.62 (d, 
J = 12.7 Hz, 1H), 3.48 (app q, J = 3.6 Hz, 1H), 3.48 (s, 3H), 0.99 (s, 9H); 
13
C-NMR (101 MHz; 
CDCl3): δ 172.7, 158.9, 130.5, 130.0, 113.5, 105.1, 68.1, 65.9, 60.4, 55.2, 51.6, 36.7, 25.4; 
HRMS (EI) m/z 308.1856 [calc’d for C17H25NO4 (M+H)+ 307.1784]. 
Preparation of N-para-methoxybenzyl -ethyl 1,3-oxazolidine 256: 
 
N-para-Methoxybenzyl -ethyl 1,3-oxazolidine 256. Following the procedure of 
Colombo et al.
56
 To a stirred 0.5 M solution of 1,3-oxazolidine 254 (62 g, 201.70 mmol) in 
tetrahydrofuran (400 mL) was added in sequence: 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-
pyrimidinone (60 mL), iodoethane (65 mL, 806.8 mmol), and hexanes (60 mL). The resulting 
solution was cooled to –78 C and sodium bis(trimethylsilyl)amide (NaHMDS) (1 M in THF, 
303 mL, 302.55 mmol) was added dropwise with an addition funnel. Reaction turned a pale 
yellow upon complete addition of NaHMDS. TLC was used to monitor reaction progress. TLC 
plates were developed with 20% EtOAc/Hex solution and visualized by UV lamp and KMnO4 
stain. Note: reaction product is a mixture of two diastereomers, the lower Rf diastereomer 
co-spots, just above, starting material. Upon complete addition of NaHMDS reaction solution 
was stirred for 30 minutes at –78 C then warmed to room temperature and stirred overnight. 
















separated phases. Aqueous phase was extracted with ethyl acetate (3 x 200 mL) Combined 
organic phase was washed with saturated LiCl solution (200 mL), H2O (250 mL) and brine (250 
mL). Dried over anhydrous MgSO4 and concentrated under reduced pressure to afford 
N-para-methoxybenzyl -ethyl 1,3-oxazolidine 256 (59.6 g, 88% yield, 2:1 dr) yellow oil. 
Diastereomers proved difficult to separate and were moved forward together, with no further 
purification. 
N-para-Methoxybenzyl -ethyl 1,3-oxazolidine 256 (2:1 mixture of diastereomers). 
FTIR (thin film/NaCl): 2958, 1728, 1612, 1585, 1510, 1460, 1394, 1359, 1300, 1243, 1036, 968, 
930, 886, 862, 823, 753; HRMS (EI) m/z 336.2169 [calc’d for C19H29NO4 (M+H)+ 335.2097]. 
Preparation of amino alcohol 257: 
 
Amino alcohol 257. To a stirred solution of N-para-methoxybenzyl -ethyl 
1,3-oxazolidine 256 (13 g, 37.40 mmol) in methanol (60 mL) was added trimethylsilyl 
trifluoromethanesulfonate (14 mL, 74.80 mmol) at room temperature. Reaction was stirred at 
room temperature overnight. TLC was used to monitor reaction progress. TLC plates were 
developed with 80% EtOAc/Hex solution doped with 1% triethylamine and visualized by UV 
lamp and KMnO4 stain. Neutralized reaction solution slowly with saturated NaHCO3 solution 
(100 mL). Extracted with diethyl ether (3 x 75 mL). Combined organic phase was washed with 
H2O (100 mL), brine (100 mL), dried over anhydrous Na2SO4 and concentrated under reduced 














EtOAc/Hex, doped with 1% triethylamine) to afford amino alcohol 257 (7.2 g, 72% yield) as a 
white solid.  
Amino alcohol 257. 
1
H-NMR (300 MHz; CDCl3): δ 7.25 (d, J = 5.5 Hz, 2H), 6.87 (d, J = 
8.7 Hz, 2H), 3.80 (s, 3H), 3.78-3.76 (m, 1H), 3.76 (s, 3H), 3.62-3.48 (m, 3H), 2.78 (br s, 1H), 
1.92 (br s, 1H), 1.81-1.61 (m, 2H), 0.87 (t, J = 7.5 Hz, 3H). 
Preparation of -vinyl amino ester 259: 
 
-Vinyl amino ester 259. Swern oxidation protocol: To a stirred solution of 
dimethylsulfoxide (7.4 mL, 104.76 mmol) in dichloromethane (200 mL) was added oxalyl 
chloride (4.4 mL, 52.38 mmol) at –78 C, slowly. Reaction solution was stirred for 20 minutes at 
–78 C. A solution of amino alcohol 257 (7.0 g, 26.19 mmol) and triethylamine (18.4 mL, 
130.95 mmol) in dichloromethane (30 mL) was added via cannula at –78 C. Reaction was 
stirred at –78 C for 1 hour and warmed to room temperature. TLC was used to monitor reaction 
progress. TLC plates were developed with gradient elution 80% EtOAc/Hex solution and 
visualized by UV lamp and KMnO4 stain. Quenched reaction with saturated NaHCO3 solution 
(200 mL). Organic phase was washed with H2O (200 mL), brine (200 mL), dried over anhydrous 
Na2SO4 and concentrated under reduced pressure to crude yellow oil. Crude material was carried 
directly into Wittig olefination protocol. 
Wittig olefination protocol: Methyltriphenylphosphonium bromide (14.0 g, 39.29 mmol) 
was dried over night under high vacuum and heated to 110 C. To a stirred heterogeneous 
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added potassium bis(trimethylsilyl)amide (0.5 M in toluene, 73 mL, 36.67 mmol) at room 
temperature. Reaction solution was stirred for 1.5 hours at room temperature; bright yellow 
colored solution. Crude aldehyde (26.19 mmol) as a solution in toluene (30 mL) was added to the 
ylide solution at –78 C via cannula addition. Reaction solution turned a dark orange color. 
Reaction was stirred for 1 hour at –78 C upon complete addition of aldehyde and warmed to 
room temperature. Stirred 2 hours at room temperature. TLC was used to monitor reaction 
progress. TLC plates were developed with gradient elution 35% EtOAc/Hex solution and 
visualized by UV lamp and KMnO4 stain. Quenched reaction with saturated NH4Cl solution (100 
mL) and organic phases were separated. Organic phase was washed with H2O (100 mL), brine 
(100 mL), dried over Na2SO4 and concentrated under reduced pressure. Crude material was 
purified with silica gel chromatography (gradient elution 51015% Hex/EtOAc solution; 
doped with 1% triethylamine) to afford -vinyl amino ester 259 (4.0 g, 58% yield, over two 
steps) as yellow oil. 
-Vinyl amino ester 259. 
1
H-NMR (300 MHz; CDCl3): δ 7.28 (d, J = 8.7 Hz, 2H), 6.86 
(d, J = 8.7 Hz, 2H), 6.00 (dd, J = 17.5, 10.8 Hz, 1H), 5.41 (dd, J = 17.5, 1.3 Hz, 1H), 5.29 (dd, J 
= 10.8, 1.3 Hz, 1H), 3.80 (s, 3H), 3.75 (s, 3H), 3.54 (d, J = 11.9 Hz, 1H), 3.49 (d, J = 11.8 Hz, 
1H), 1.87 (tt, J = 14.3, 7.2 Hz, 2H), 0.88 (t, J = 7.4 Hz, 3H). 
Preparation of amide 260: 
 
Amide 260. To a stirred solution of amine 259 (3.4 g, 12.91 mmol), pyridine (2.1 mL, 


















added propionyl chloride (1.70 mL, 19.37 mmol) at 0 C. Reaction solution was warmed to room 
temperature, and stirred for two days. TLC was used to monitor reaction progress. TLC plates 
were developed with gradient elution 40% EtOAc/Hex solution and visualized by UV lamp and 
KMnO4 stain. Quenched reaction with 1M HCl (75 mL) and separated phases. Organic phase 
was washed with 15% NaOH (75 mL), H2O (75 mL), brine (75 mL), dried over anhydrous 
MgSO4 and concentrated under reduced pressure. Crude material was purified with silica gel 
chromatography (gradient elution 253035% EtOAc/Hex) to afford amide 260 (3.4 g, 88% 
yield) as colorless oil. 
Amide 260. 
1
H-NMR (300 MHz; CDCl3): δ 7.43 (d, J = 8.6 Hz, 2H), 6.93 (d, J = 8.7 Hz, 
2H), 6.03 (dd, J = 17.6, 10.7 Hz, 1H), 5.26 (d, J = 15.4 Hz, 1H), 5.23 (d, J = 11.0 Hz, 1H), 4.54 
(d, J = 17.6 Hz, 1H), 4.50 (d, J = 17.7 Hz, 1H), 3.81 (s, 3H), 3.77 (s, 2H), 2.39-2.01 (m, 4H), 
1.05 (t, J = 7.4 Hz, 3H), 0.85 (t, J = 7.5 Hz, 3H). 
Preparation of N-para-methoxybenzyl tetramic acid 261: 
 
N-para-Methoxybenzyl tetramic acid 261. To a refluxing suspension of sodium hydride 
(60% dispersion in mineral oil) (1.8 g, 45.57 mmol) in tetrahydrofuran (50 mL), was added 
dropwise a solution of amide 260 (5.1 g, 15.19 mmol), in tetrahydrofuran (50 mL). Reaction was 
refluxed for 2 days. TLC was used to monitor reaction progress. TLC plates were developed with 
gradient elution 2550% EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain. 
Checking conversion by 
1
H NMR also monitored reaction progress; aliquots were from the 

















mL) and phases were separated. The aqueous phase was extracted with ethyl acetate (2 x 50 mL). 
Combined organic phase was washed with H2O (200 mL), brine (200 mL), dried over anhydrous 
Na2SO4 and concentrated under reduced pressure. Crude material was purified with silica gel 
chromatography (gradient elution 103050% EtOAc/Hex) followed by trituration with 
hexanes to afford N-para-Methoxybenzyl tetramic acid 261 (2.12 g, 50% yield, 3:1 dr) as a white 
solid.  
N-para-Methoxybenzyl tetramic acid 261. FTIR (thin film/NaCl): 2935, 2836, 2708, 
1770, 1612, 1513, 1431, 1405, 1353, 1302, 1246, 1218, 1176, 1145, 1111, 1096, 1039, 1013, 
992, 964, 927, 861, 845, 821, 791, 767, 734, 616, 591, 541; 
1
H-NMR (400 MHz; CDCl3): δ 7.32 
(d, J = 8.7 Hz, 2H), 6.81 (d, J = 8.7 Hz, 2H), 5.62 (dd, J = 17.4, 10.6 Hz, 1H), 5.24 (d, J = 10.6 
Hz, 1H), 5.17 (d, J = 17.4 Hz, 1H), 4.65 (d, J = 14.8 Hz, 1H), 4.30 (d, J = 14.8 Hz, 1H), 3.78 (s, 
3H), 2.96 (q, J = 7.6 Hz, 1H), 2.07 (dq, J = 14.6, 7.3 Hz, 1H), 1.70 (dq, J = 14.6, 7.3 Hz, 3H), 
1.29 (d, J = 7.6 Hz, 3H), 0.41 (t, J = 7.3 Hz, 3H); 7.31 (d, J = 8.7 Hz, 2H), 6.81 (d, J = 8.7 Hz, 
2H), 5.63 (dd, J = 17.4, 10.7 Hz, 1H), 5.30 (d, J = 10.7 Hz, 1H), 5.21 (d, J = 17.4 Hz, 1H), 4.80 
(d, J = 14.8 Hz, 1H), 4.15 (d, J = 14.8 Hz, 1H), 3.78 (s, 3H), 2.74 (q, J = 7.8 Hz, 1H), 2.00 (dq, J 
= 14.5, 7.3 Hz, 1H), 1.69 (dq, J = 14.6, 7.3 Hz, 1H), 1.35 (d, J = 7.8 Hz, 3H), 0.48 (t, J = 7.3 Hz, 
3H); 
13
C-NMR (101 MHz; CDCl3): δ 210.8, 209.6, 173.6, 173.3, 159.1, 136.4, 135.9, 130.47, 
130.38, 129.9, 118.6, 118.1, 113.9, 55.3, 44.9, 43.45, 43.34, 43.19, 27.0, 26.3, 12.7, 9.7, 7.96, 
7.77; HRMS (EI) m/z 288.1594 [calc’d for C17H21NO3 (M+H)+ 287.1521]. 
















Vinylogous ester 262. To a stirred heterogeneous solution of N-para-methoxybenzyl 
tetramic acid 261 (2.8 g, 9.74 mmol), potassium carbonate (1.62 g, 11.69 mmol) in acetone (195 
mL), was added dimethyl sulfate (1.1 mL, 11.69 mmol). Reaction was fitted with a reflux 
condenser and refluxed (56 C) 24 hours. TLC was used to monitor reaction progress. TLC 
plates were developed with gradient elution 253540% EtOAc/Hex solution and visualized 
by UV lamp and KMnO4 stain. Note starting material and product have very similar Rf, product 
has lower Rf then starting material. Conversion was checked 
1
H NMR after 12 hours. Reaction 
was cooled to room temperature and volume of acetone reduced under pressure. Residue was 
partitioned between ethyl acetate (50 mL) and 2M NaOH (50 mL). Aqueous phase was extracted 
with ethyl acetate (3 x 25 mL). Combined organic phase was washed with H2O (100 mL), brine 
(100 mL), dried over anhydrous Na2SO4 and concentrated under reduced pressure. Crude 
material was purified with silica gel chromatography (gradient elution 205080% 
EtOAc/Hex) to afford vinylogous ester 262 (2.1 g, 72% yield) as yellow oil. 
Vinylogous ester 262. 
1
H-NMR (300 MHz; CDCl3): δ 7.29-7.26 (d, J = 8.7 Hz, 2H), 
6.79 (d, J = 8.7 Hz, 2H), 5.47 (dd, J = 17.0, 11.0 Hz, 1H), 5.25-5.18 (d, J = 17.0 Hz, 1H), 5.20 
(d, J = 9.1 Hz, 1H), 4.54 (d, J = 15.1 Hz, 1H), 4.12 (d, J = 15.1 Hz, 1H), 3.99 (s, 3H), 3.78 (s, 
3H), 2.04 (s, 3H), 1.80 (app tq, J = 14.3, 7.2 Hz, 1H), 1.59 (dq, J = 14.2, 7.2 Hz, 1H), 0.37 (t, J = 
7.3 Hz, 3H). 
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 145 
Base Screen. A vial equipped with a magnetic stir bar was charged with tetramic acid 
251 (42 mg, 0.23 mmol), copper iodide (10 mg, 0.05 mmol), trans-N,N’-dimethyl-cyclohexane-
1,2-diamine (265) (14 L, 0.09 mmol), base [K2CO3 (64 mg, 0.46 mmol) or Cs2CO3 (150 mg, 
0.46 mmol) or K3PO4 (98 mg, 0.46 mmol)], and bromobenzene (271) (0.5 M, 0.50 mL), briefly 
evacuated, and backfilled with nitrogen. Vial was quickly sealed, minimizing exposure to 
external atmosphere, and reaction was stirred at 156 C for 24 hours. The reaction solution was 
cooled to room temperature and then filtered through a pad of silica gel and sand prepared in a 
medium pipette, eluting with 1:1 ethyl acetate-dichloromethane (5 mL). The filtrate was 
concentrated under reduced pressure and purified with silica gel chromatography (gradient 
elution 51020% EtOAc/Hex) to afford aryl amide 272 [K2CO3 (1.2 mg, 2% yield); Cs2CO3 
(11.1 mg, 19 % yield); K3PO4 (15.1 mg, 26% yield)] as colorless oil. 
General Aryl Amidation Procedure. Following the procedure of Buchwald et al.
62
 A 
vial equipped with a magnetic stir bar was charged with tetramic acid 251 (50 mg, 0.28 mmol), 
copper iodide (12 mg, 0.06 mmol), K3PO4 (119 mg, 0.56 mmol), briefly evacuated, and 
backfilled with nitrogen. trans-N,N’-Dimethyl-cyclohexane-1,2-diamine (265) (19 L, 0.12 
mmol) was added a solution in toluene (0.3 mL) followed by the addition of aryl bromide (271 or 
273) (0.28 mmol). Vial was quickly sealed, minimizing exposure to external atmosphere, and 
reaction was stirred at 156 C for 24 hours. The reaction solution was cooled to room 
temperature and then filtered through a pad of silica gel and sand prepared in a medium pipette, 
eluting with 1:1 ethyl acetate-dichloromethane (5 mL). The filtrate was concentrated under 
reduced pressure and purified with silica gel chromatography (gradient elution 51020% 
EtOAc/Hex) to afford aryl amide 272 (13 mg, 18% yield) as a colorless oil or aryl amide 274 (28 
mg, 35% yield) as colorless oil, respectively. 
 146 
Aryl amide 272. 
1
H-NMR (300 MHz; CDCl3): δ 7.45 (d, J = 8.2 Hz, 2H), 7.31 (t, J = 7.9 
Hz, 2H), 7.15 (t, J = 7.3 Hz, 1H), 5.87 (dd, J = 17.4, 10.9 Hz, 1H), 5.31 (d, J = 10.3 Hz, 1H), 
5.33-5.27 (d, J = 17.4 Hz, 1H), 4.07 (s, 3H), 2.09 (s, 3H), 2.00 (dq, J = 14.4, 7.2 Hz, 1H), 1.76 
(dq, J = 14.3, 7.1 Hz, 1H), 0.67 (t, J = 7.3 Hz, 3H). 
Aryl amide 274. 
1
H-NMR (300 MHz; CDCl3): δ 7.20 (t, J = 8.1 Hz, 1H), 7.13 (t, J = 2.2 
Hz, 1H), 7.06 (ddd, J = 8.1, 2.0, 0.9 Hz, 1H), 6.70 (ddd, J = 8.2, 2.5, 0.9 Hz, 1H), 5.88 (dd, J = 
17.8, 10.5 Hz, 1H), 5.32 (d, J = 11.3 Hz, 1H), 5.31 (dd, J = 17.0 Hz, 1H), 4.07 (s, 3H), 3.77 (s, 
3H), 2.08 (s, 3H), 1.99 (dt, J = 14.4, 7.2 Hz, 1H), 1.82 (dq, J = 14.3, 7.2 Hz, 1H), 0.65 (t, J = 7.3 
Hz, 3H). 
Preparation of alcohol 318: 
 
Alcohol 318. To a stirred heterogeneous solution of lithium aluminum hydride (78 mg, 
2.04 mmol) in tetrahydrofuran (10 mL) was added methyl ester 188 (556 mg, 1.70 mmol) was a 
solution in tetrahydrofuran (7 mL), dropwise via cannula, at 0 C. Upon complete addition 
reaction was warmed to room temperature. TLC was used to monitor reaction progress. TLC 
plates were developed with gradient elution 40% EtOAc/Hex solution and visualized by UV 
lamp and KMnO4 stain. Upon completion reaction was cooled to 0 C and very slowly quenched 
with H2O (100 L), 15% NaOH (100 L) and H2O (300 L), stirred for 30 minutes. Added a 
scoop of anhydrous MgSO4, warmed to room temperature and stirred for 45 minutes. Filtered 
solution through a celite/sand pad, filtrated was washed with saturated NH4Cl solution (20 mL), 















under reduced pressure to afford alcohol 318 (500 mg, 98% yield) as colorless oil. No further 
purification was necessary. 
Alcohol 318. 
1
H-NMR (300 MHz; CDCl3): δ 7.20 (d, J = 8.7 Hz, 1H), 7.09 (d, J = 2.7 
Hz, 1H), 6.84 (dd, J = 8.7, 2.7 Hz, 1H), 5.03 (d, J = 0.7 Hz, 1H), 4.87 (dd, J = 2.7, 1.3 Hz, 1H), 
3.77 (s, 3H), 3.62 (d, J = 11.4 Hz, 1H), 3.41 (d, J = 10.2 Hz, 1H), 3.25 (t, J = 8.5 Hz, 1H), 2.25-
2.12 (m, 1H), 1.62 (s, 3H), 1.19 (br s, 1H), 1.10 (d, J = 6.6 Hz, 3H). 
Preparation of TBDPS-ether 277: 
 
TBDPS-ether 277. To a stirred solution of alcohol 318 (500 mg, 1.67 mmol), 
4-(dimethylamino)pyridine (21 mg, 0.17 mmol) and pyridine (0.27 mL, 3.34 mmol) in 
dichloromethane (7.4 mL) was added tert-butyl(chloro)diphenylsilane (0.65 mL, 2.51 mmol) at 
room temperature. Stirred for 24 hours at room temperature. TLC was used to monitor reaction 
progress. TLC plates were developed with gradient elution 20% EtOAc/Hex solution and 
visualized by UV lamp and KMnO4 stain. Reaction did not go to completion but was quenched 
with 1 M HCl (10 mL) after 24 hours. Organic phase was washed with H2O (15 mL), brine (15 
mL), dried over anhydrous MgSO4 and concentrated under reduced pressure. Crude material was 
purified with silica gel chromatography (gradient elution 123% EtOAc/Hex) to afford 
TBDPS-ether 277 (194 mg, 22% yield) as colorless oil.  
TBDPS-ether 277. 
1
H-NMR (300 MHz; CDCl3): δ 7.63-7.60 (m, 2H), 7.47 (dd, J = 7.9, 
1.4 Hz, 4H), 7.42-7.35 (m, 4H), 7.31 (t, J = 6.0 Hz, 2H), 7.09 (d, J = 2.7 Hz, 1H), 6.97 (d, J = 8.7 

















3H), 3.74 (d, J = 11.3 Hz, 1H), 3.41 (dd, J = 10.0, 3.5 Hz, 1H), 3.39-3.34 (m, 1H), 2.26-2.13 (m, 
1H), 1.58 (s, 3H), 1.16 (d, J = 6.5 Hz, 3H), 1.03 (s, 9H). 
Preparation of TIPS-ether 279: 
 
TIPS-ether 279. To a stirred solution of allylic alcohol 175 (86 mg, 0.33 mmol), 
imidazole (228 mg, 3.34 mmol) in dichloromethane (3 mL) was added triisopropylsilyl chloride 
(0.22 mL, 1.00 mmol) at room temperature. Reaction was stirred overnight at room temperature. 
TLC was used to monitor reaction progress. TLC plates were developed with gradient elution 
2% EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain. Quenched with saturated 
NH4Cl solution (5 mL), diluted with H2O (2 mL) and separated phases. Aqueous phase was 
extracted with diethyl ether (2 x 5 mL). Combined organic phase was dried over anhydrous 
MgSO4 and concentrated under reduced pressure. Crude material was purified with silica gel 
chromatography (gradient elution Hex12% EtOAc/Hex) to afford TIPS-ether 279 (121 mg, 
98% yield) as colorless oil. 
TIPS-ether 279. 
1
H-NMR (300 MHz; CDCl3): δ 7.20 (d, J = 8.5 Hz, 1H), 7.13 (d, J = 
2.6 Hz, 1H), 6.83 (dd, J = 8.5, 2.6 Hz, 1H), 6.58 (s, 1H), 4.28 (s, 2H), 3.79 (s, 3H), 1.71 (s, 3H), 















Preparation of TBS-ether 294: 
 
TBS-ether 294. To a stirred solution of allylic alcohol 175 (6:1 E/Z) (500 mg, 1.94 
mmol), 4-(dimethylamino)pyridine (24 mg, 0.19 mmol), imidazole (264 mg, 3.88 mmol) in 
dichloromethane (2 mL) was added tert-butyldimethylsilyl chloride (440 mg, 2.92 mmol) at 
room temperature. TLC was used to monitor reaction progress. TLC plates were developed with 
gradient elution 2% EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain.  
Reaction was stirred at room temperature for 3 hours. Reaction was diluted with 
dichloromethane (2 mL) followed by hydrolysis with H2O (5 mL) and separation of phases. 
Organic phase was washed with brine (5 mL), dried over anhydrous MgSO4 and concentrated 
under reduced pressure directly onto silica gel (approximately 1.5 g). Purified with silica gel 
chromatography (gradient elution12% EtOAc/Hex) to afford TBS-ether 294 (643 mg, 89% 
yield, 6:1 E/Z) as colorless oil. 
TBS-ether 294. FTIR (thin film/NaCl): 2925, 1688, 1597, 1566, 1462, 1389, 1361, 1235, 
1181, 1086, 939, 841, 777, 669; 
1
H-NMR (400 MHz; CDCl3): δ 7.19 (d, J = 8.6 Hz, 1H), 7.14 
(d, J = 2.6 Hz, 1H), 6.83 (dd, J = 8.6, 2.6 Hz, 1H), 6.50 (s, 1H), 4.20 (s, 2H), 3.80 (s, 3H), 1.71 
(d, J = 1.4 Hz, 3H), 0.95 (s, 9H), 0.13 (s, 6H); 7.43 (d, J = 8.6 Hz, 1H), 7.07 (d, J = 2.6 Hz, 1H), 
6.88 (dd, J = 8.6, 2.6 Hz, 1H), 4.13 (s, 2H), 3.79 (s, 3H), 1.96 (d, J = 1.5 Hz, 3H), 0.89 (s, 9H), 
0.12 (s, 6H); 
13
















124.8, 123.0, 117.7, 113.4, 113.22, 113.15, 68.2, 64.4, 62.8, 55.7, 26.15, 26.08, 21.6, 18.6, 15.0, 
-5.05, -5.12; HRMS (EI) m/z 389.0967 [calc’d for C17H27BrO3Si (M+H)+ 386.0913]. 
Preparation of aryl amine 295: 
 
Aryl amine 295. A sealed tube reaction vessel equipped with a magnetic stir bar was 
charged with Pd(OAc)2 (7 mg, 0.03 mmol), BrettPhos (286) (16 mg, 0.03 mmol) and Cs2CO3 
(352 mg, 1.08 mmol), briefly evacuated, and backfilled with nitrogen. 1,4,-Dioxane (2 mL) 
(deoxygenated prior to use by sparging with nitrogen for 1 hour) was added followed by the 
addition of allylamine (0.21 mL, 2.69 mmol) and aryl bromide 294 (200 mg, 0.54 mmol) as a 
solution in 1,4-dioxane (2 mL). Reaction vessel was sealed with minimal exposure of reaction 
solution to external atmosphere and heated to 100 C. TLC was used to monitor reaction 
progress. TLC plates were developed with gradient elution 2% EtOAc/Hex solution and 
visualized by UV lamp and KMnO4 stain. Reaction was cooled to room temperature after 24 
hours diluted with dichloromethane (10 mL) and quenched with saturated NH4Cl solution (10 
mL) followed by separation of the phases. Organic layer was washed with H2O (10 mL), brine 
(10 mL), dried over anhydrous MgSO4 and concentrated under reduced pressure directly onto 
silica gel (approximately 300 mg). Purified with silica gel chromatography (gradient elution 
125% EtOAc/Hex) to afford aryl amine 295 (100 mg, 53% yield) as yellow oil. Crude 
material was also successfully be advanced to cleavage of TBS-ether and purified there after. 




















Preparation of allylic alcohol 296: 
 
Allylic alcohol 296. To a stirred solution of TBS-ether 295 (344 mg, 0.99 mmol) in 
tetrahydrofuran (2 mL) was added tetrabutylammonium fluoride (1 M in THF, 1.5 mL, 1.46 
mmol) at 0 C and stirred for 1 hour. Reaction was warmed to room temperature and stirred over 
night. TLC was used to monitor reaction progress. TLC plates were developed with gradient 
elution 40% EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain. Reaction was 
diluted with ethyl acetate (10 mL) and quenched with saturated NH4Cl solution (10 mL), phase 
were separated. Organic phase was washed with brine (20 mL), dried over anhydrous MgSO4 
and absorbed directly onto silica gel (approximately 350 mg) under reduced pressure. Purified 
with silica gel chromatography (gradient elution 2550% EtOAc/Hex) to afford allylic alcohol 
296 (200 mg, 87% yield) as colorless oil.  
Allylic alcohol 296. 
1
H-NMR (400 MHz; CDCl3): δ 6.94 (d, J = 8.2 Hz, 1H), 6.27 (dd, J 
= 8.3, 2.3 Hz, 1H), 6.21 (d, J = 2.4 Hz, 1H), 5.99-5.89 (m, 1H), 5.27 (dd, J = 17.2, 1.5 Hz, 1H), 
5.16 (dd, J = 10.3, 1.4 Hz, 1H), 4.20 (s, 2H), 3.79 (s, 3H), 1.75 (s, 3H); 
13
C-NMR (101 MHz; 
CDCl3): δ 160.0, 146.9, 139.5, 135.4, 130.4, 120.5, 116.3, 116.0, 101.1, 97.3, 68.5, 55.2, 46.5, 















Preparation of allylic ester 297: 
 
Allylic ester 297. To a stirred solution of allylic alcohol 296 (200 mg, 0.86 mmol), 
4-(dimethylamino)pyridine (catalytic quantity, flake), triethylamine (0.5 mL, 3.43 mmol) in 
dichloromethane (8 mL) was added propionyl chloride (0.2 mL, 2.15 mmol) at 0 C, stirred for 5 
minutes. Reaction was warmed to room temperature and stirred. TLC was used to monitor 
reaction progress. TLC plates were developed with gradient elution 10% EtOAc/Hex solution 
and visualized by UV lamp and KMnO4 stain. Quenched with saturated NH4Cl solution (10 mL) 
and separated phases. Organic phase was washed with H2O (10 mL) and brine (10 mL), dried 
over anhydrous MgSO4 and filtered. Filtrated was absorbed directly onto silica gel 
(approximately 200 mg) under reduced pressure. Purified with silica gel chromatography 
(gradient elution 102030% EtOAc/Hex) to afford allylic ester 297 (200 mg, 70 % yield) as 
colorless oil. 
Allylic ester 297. 
1
H-NMR (400 MHz; CDCl3): δ 7.26 (d, J = 8.4 Hz, 1H), 6.87 (dd, J = 
8.6, 2.7 Hz, 1H), 6.63 (d, J = 2.7 Hz, 1H), 6.24 (s, 1H), 5.83 (tdd, J = 11.7, 11.0, 6.1 Hz, 1H), 
5.05 (d, J = 8.7 Hz, 1H), 5.02 (d, J = 15.6 Hz, 1H), 4.57 (s, 2H), 4.53 (dd, J = 14.5, 6.1 Hz, 1H), 
3.79 (s, 3H), 3.77-3.74 (dd, J = 14.5, 6.1 Hz, 1H), 2.36 (q, J = 7.6 Hz, 2H), 1.99 (dq, J = 15.8, 
7.8 Hz, 1H), 1.88 (dq, J = 15.7, 7.7 Hz, 1H), 1.79 (s, 2H), 1.15 (t, J = 7.6 Hz, 3H), 1.00 (t, J = 
7.5 Hz, 3H); 
13





















127.7, 123.4, 118.2, 115.0, 113.3, 69.3, 55.6, 51.7, 27.7, 27.4, 15.5, 9.5, 9.3; HRMS (EI) m/z 
346.202 [calc’d for C20H27NO4 (M+H)+ 346.2013]. 
Preparation of -unsaturated methyl ester 298: 
 
-Unsaturated methyl ester 298. A vial fitted with a magnetic stir bar was charged 
with lithium bis(trimethylsilyl)amide (60 mg, 0.36 mmol), toluene (1 mL) and triethylamine (0.5 
mL, 3.60 mmol), solution was cooled to –78 C and allylic ester 297 (20 mg, 0.06 mmol) was 
added a solution in toluene (200 L), dropwise. Reaction was warmed to room temperature and 
allowed to stir overnight. TLC was used to monitor reaction progress. TLC plates were 
developed with 50% EtOAc/Hex solution and visualized by UV lamp and KMnO4 stain. 
Reaction was hydrolyzed with H2O (1 mL), stirring vigorously. Solution was acidified with 12 M 
HCl to pH = 1. Acidic solution Acidic solution was extracted with ethyl acetate (3 x 2 mL). 
Combined organic phase was washed with brine (5 mL), dried over anhydrous Na2SO4 and 
concentrated to crude oil. 
To a stirred solution of crude carboxylic acid (0.06 mmol) in methanol (0.5 mL) was 
added trimethylsilyldiazomethane (2 M in hexanes, 0.10 mL, 0.18 mmol), dropwise, at 0 C. 
Reaction was stirred for 15 minutes at 0 C. Reaction was warmed to room temperature and 
stirred for 1 hour. Reaction was warmed to room temperature and allowed to stir overnight. TLC 
was used to monitor reaction progress. TLC plates were developed with 50% EtOAc/Hex 
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mL) and concentrated under reduced pressure. Crude material was purified with silica gel 
chromatography (gradient elution 1025% EtOAc/Hex) to afford -unsaturated methyl ester 
298 (10 mg, 45% yield, 3:1 anti/syn, over two steps). 
-Unsaturated methyl ester 298. 
1
H-NMR (400 MHz; CDCl3): δ 7.28 (d, J = 5.3 Hz, 
1H), 6.86 (dd, J = 8.7, 2.8 Hz, 1H), 6.52 (d, J = 2.7 Hz, 1H), 5.98-5.90 (m, 1H), 5.12 (d, J = 9.0 
Hz, 1H), 5.09 (d, J = 14.3 Hz, 1H), 4.86 (s, 1H), 4.80 (s, 1H), 3.77 (s, 3H), 3.60 (d, J = 11.9 Hz, 
1H), 3.48 (s, 3H), 3.06 (ddd, J = 19.8, 12.9, 6.9 Hz, 1H), 1.89 (dq, J = 15.9, 7.8 Hz, 1H), 1.67 
(dq, J = 15.9, 7.8 Hz, 1H), 1.50 (s, 3H), 1.20 (d, J = 6.9 Hz, 3H), 0.96 (t, J = 7.4 Hz, 3H), 7.30 
(d, J = 8.7 Hz, 1H), 6.86 (dd, J = 8.7, 2.8 Hz, 1H), 6.60 (d, J = 2.7 Hz, 1H), 5.98-5.90 (m, 1H), 
5.07 (d, J = 14.4 Hz, 1H), 5.05 (d, J = 5.3 Hz, 1H), 4.94 (s, 1H), 4.92 (s, 1H), 3.77 (s, 3H), 3.62 
(d, J = 14.7 Hz, 1H), 3.48 (s, 3H), 3.06 (ddd, J = 19.8, 12.9, 6.9 Hz, 6H), 2.20 (dq, J = 16.0, 7.8 
Hz, 1H), 2.00 (dt, J = 16.0, 7.8 Hz, 1H), 1.49 (s, 3H), 1.19 (d, J = 6.7 Hz, 3H), 1.10 (t, J = 7.4 
Hz, 3H); 
13
C-NMR (101 MHz; CDCl3): δ 176.13, 176.05, 174.34, 174.24, 158.48, 158.41, 
142.8, 142.5, 142.20, 142.04, 133.8, 133.4, 130.6, 130.2, 129.1, 128.7, 118.33, 118.15, 116.68, 
116.52, 116.1, 115.8, 113.41, 113.33, 55.5, 52.8, 51.73, 51.70, 51.2, 50.71, 50.54, 40.90, 40.71, 
28.3, 27.5, 20.8, 18.4, 17.6, 17.34, 17.20, 14.4, 9.7, 9.5. 
Preparation of enamide 308: 
 
Enamide 308. Toluene used in procedure was pulled fresh from the still and 
deoxygenated immediately prior to use by sparging with nitrogen for 1 hour. To a stirred solution 






















L, 0.04 mmol) at room temperature and stirred for 5 minutes. Diene/titanium(IV) 
isopropoxide/toluene solution was transferred to a stirred solution of precatalyst 302 (1 mg, 
0.001 mmol) in toluene (1 mL) and reaction was refluxed (110 C) for 24 hours. Reaction was 
cooled to room temperature and concentrated under reduced pressure. Residue was purified with 
silica gel chromatography (gradient elution 5101520% EtOAc/Hex) to afford enamide 
308 (6 mg, 89% yield, 2:1 dr) as colorless residue.   
Enamide 308. FTIR (thin film/NaCl): 3380, 2939, 1736, 1675, 1610, 1577, 1501, 1457, 
1372, 1243, 1227, 1164, 1089, 1059, 1037; 
1
H-NMR (400 MHz; CDCl3): δ 7.44 (d, J = 14.3 Hz, 
1H), 7.38 (d, J = 8.6 Hz, 1H), 6.92 (dd, J = 8.6, 2.6 Hz, 1H), 6.57 (d, J = 2.5 Hz, 1H), 4.81 (s, 
2H), 4.41 (dq, J = 14.0, 6.9 Hz, 1H), 3.79 (s, 3H), 3.54 (d, J = 11.7 Hz, 1H), 3.47 (s, 3H), 3.05 
(tt, J = 13.0, 6.6 Hz, 2H), 1.87 (dq, J = 16.0, 7.8 Hz, 2H), 1.69 (d, J = 6.6 Hz, 3H), 1.45 (s, 3H), 
1.15 (d, J = 6.8 Hz, 3H), 0.96 (t, J = 7.3 Hz, 3H); 7.38 (d, J = 8.6 Hz, 1H), 7.33 (d, J = 16.4 Hz, 
1H), 6.92 (dd, J = 8.6, 2.6 Hz, 1H), 6.59 (d, J = 2.6 Hz, 1H), 4.81 (s, 1H), 4.74 (s, 1H), 4.14 (td, 
J = 13.8, 7.1 Hz, 1H), 3.79 (s, 3H), 3.47 (d, J = 5.3 Hz, 1H), 3.47 (s, 3H), 3.05 (tt, J = 13.0, 6.6 
Hz, 3H), 2.20 (td, J = 15.6, 8.1 Hz, 1H), 2.01 (dt, J = 16.0, 7.8 Hz, 1H), 1.69 (d, J = 6.6 Hz, 3H), 
1.45 (s, 3H), 1.15 (d, J = 6.8 Hz, 3H), 0.96 (t, J = 7.3 Hz, 3H); 
13
C NMR (101 MHz; CDCl3): δ 
175.8, 172.2, 159.2, 158.6, 142.1, 130.6, 129.2, 127.1, 116.1, 115.8, 114.0, 109.0, 55.5, 51.6, 
50.4, 40.4, 28.9, 17.7, 17.0, 15.4, 9.3; HRMS (EI) m/z 360.2175 [calc’d for C21H29NO4 (M+H)+ 
360.2169]
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Chapter 4  
Turning to Ring Closing Metathesis 
4.1 Fourth-Generation Retrosynthetic Analysis 
As outlined in Scheme 4.1, our fourth-generation retrosynthetic analysis of tetrapetalone 
A (1) envisaged completion of the natural product via glycosylation of aglycon 319. Aglycon 
319 was envisioned as deriving from a Friedel-Crafts alkylation applied to aldehyde 321 and 
phenolic oxidation to install the C(15)-hydroxyl group. Construction of the C–N bond of 
benzazepine 321 would be achieved by application of an intramolecular cross-coupling reaction 
applied to tetramic acid 322. Tetramic acid 322 would derive from hydrolysis of lactone 323 
subsequent to implementation of ring closing metathesis applied to diene 324. Diene 324 would 
be procured by coupling carboxylic acid 190 and tetramic acid 326.  
160 
 
Scheme 4.1 Fourth-Generation Retrosynthetic Analysis 
4.2 Olefin Metathesis 
4.2.1 Olefin Types and Rules for Selectivity as Derived from Cross Metathesis 
Olefin cross metathesis is a convenient route to functionalized and higher olefins from 
simple alkene substrates.
80
 Olefin cross metathesis has gained prominence due to the availability 
of catalysts with varied activities. These catalysts have expanded the variety of olefin types and 
functional groups that are amenable to olefin metathesis and have demonstrated the ability to 
































































































Figure 4.1 Olefin Categorization and Rules for Selectivity 
A growing body of empirical evidence has allowed the prediction of olefin reactivity, 
described as a gradient scale of the relative propensity for an olefin to undergo 
homodimerization, along with the subsequent reactivity of the resulting homodimers. The 
general model for olefin metathesis is comprised of four distinct olefin types, which can be used 
to predict both selective and nonselective cross metathesis reactions (Figure 4.1). In general, a 
reactivity gradient exists from most active olefin type (Type I olefin) to least active olefin Type 
(Type IV), with sterically unhindered electron-rich olefins categorized as Type I and increasingly 
sterically hindered/or electron-deficient olefins falling into Types II through IV. Grubbs and 
coworkers have disclosed a general model based on the categorization of olefin reactivity, which 
can be utilized to predict both selective and nonselective cross metathesis reactions for a number 
of commercially available metathesis catalysts with varying activities and has been described 
specifically for catalyst 328 (Table 4.1).
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Type I - Rapid homodimerization, homodimers consumable
Type II - Slow homerdimerization, homodimers sparingly consumable
Type III - No homodimerization

















Reaction between two olefins of Type I - statistical CM
Reaction between two olefins of same Type (non-Type 1) = non-selective CM
Reaction between olefins of two different Types = selective CM
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Table 4.1 Olefin Categories for Selective Cross Metathesis with Grubbs II Catalyst 
 
4.2.2 Construction of Medium-Sized Rings by Ring Closing Metathesis  
Not every ring size is accessible with the same ease because of enthalpic (increasing ring 
strain in the transition state) and entropic influences (probability of the chain ends meeting).
81
 
Medium-sized rings are the most difficult to prepare. Among the many cyclization reactions 
available, olefin metathesis (ring closing metathesis) has gained tremendous popularity due in 
part to the involvement of relatively stable double bonds. This advantage facilitates synthesis and 
handling of the cyclization precursors.  
To date there are many elegant applications of ring closing metathesis to the synthesis of 







































1º allylic alcohols, esters
allyl boronate esters
allyl halides





















4º allylic carbons (all alkyl substit.)














 For medium-sized rings, it is beneficial to use conformational constraints 
or stereoelectronic effects to promote cyclization. These constraints are achieved either by using 
preexisting rings (cyclic conformational constraints) or acyclic conformational constraints. 
(gauche effect). For example, Westermann and coworkers demonstrated that the attachment of 
olefinic side chains to lactams facilitates RCM cyclization.  Specifically, they found that the 
seven membered bicyclic lactam 333 was produced in excellent yield (95%) upon exposure of 
332 to Grubbs I (327) catalyst in dichloromethane at room temperature (Scheme 4.2a).
82
 Besides 
using a ring in order to limit the conformational freedom of a chain, appropriately positioning 
substituents on an acyclic chain can increase propinquity of the two olefinic groups and improve 
the cyclization. Crimmins and coworkers reported on the use of the gauche effect of 1,2-
dioxygen substituents to facilitate ring closure, exposure of 334 to Grubbs I (327) in 






Scheme 4.2 Conformational Control Employed for Construction of Medium-Sized Rings 
4.3 Initial Ring Closing Metathesis Inquiry 
4.3.1 Secondary Amide Substrate 
The proposed cyclization of diene 324 (Scheme 4.1) by ring closing metathesis represents 
an extremely challenging scenario as both olefins are Type III (1,1-disubstituted and fully 
substituted allylic carbons, respectively) but having the synthetic precursors on hand we felt that 
this cyclization was worth investigating. To this end vinylogous ester 251 was hydrolyzed to the 
requisite tetramic acid 337 and subjected to dicyclohexylcarbodiimide (DCC) mediated 









































Scheme 4.3 Diene Synthesis 
Exposure of diene 338 to Grubbs II catalyst (328) or Hoveyda-Grubbs catalyst (330) did 
not afford lactone 323 and only starting material was observed (Table 4.2). Variation of the 
reaction conditions (temperature, solvent and reaction concentration) did not alter the outcome. 
To ensure that the catalyst was not being sequestered by the amide moiety of diene 338, we 
opted to investigate a diene in which the amide was protected. 





























































































4.3.2 Tertiary Amide Substrate 
Carboxylic acid 190 was subjected to DCC mediated esterification with N-para-
methoxybenzyl tetramic acid 261 to provide diene 339 in moderate yield (49%) (Scheme 4.4). 
 
Scheme 4.4 DCC Mediated Esterification 
Diene 339, when subjected to Grubbs II catalyst (328) or the Hoveyda-Grubbs catalyst 
(330) in toluene at 80 ºC, did not engage in the desired cyclization to afford lactone 323. 
Recognizing the difficulty of initiating the catalytic process on either of the Type III olefins of 
diene 338 and 339 we decided to investigate a relay ring closing metathesis strategy.  
 
Scheme 4.5 Attempted Cyclization by Ring Closing Metathesis 
4.4 Relay Ring Closing Metathesis 
Despite the many successful applications, in some cases cyclization by ring closing 
metathesis can be less than satisfactory, due to low reactivity and/or low selectivity. The 
development of methods to overcome these shortcomings is ongoing in many laboratories, and 
relay ring closing metathesis (RRCM) is one such development.
84
  
The foundation of this strategy rests on the fact that although initiation of the catalytic 























































intramolecular reaction of a ruthenium alkylidene onto such an alkene is often attainable (i.e. 344 
to 342), as is the subsequent intramolecular reaction of the previously inaccessible alkylidene 
(i.e. 342 to 340). Thus, in this scenario the term relay refers to the intermolecular generation of 
an accessible alkylidene followed by its intramolecular relay to an inaccessible but desired 




Scheme 4.6 Relay Ring Closing Metathesis to afford Tetrasubstituted Olefin 
The relay RCM strategy employs a temporary tether containing a sterically 
unencumbered olefin; the Type I olefin provides a site for the catalytic cycle to initiate (i.e. 343 
to 344) (Scheme 4.7). The Type I olefin is positioned such that a kinetically favored 
five-membered metallacycle (346) forms and sets the stage for ruthenium delivery onto the 
































concomitant extrusion of cyclopentene 347 and then undergoes the desired ring closing 
metathesis to afford tetrasubstituted olefin 340. 
 
Scheme 4.7 Relay Ring Closing Metathesis to Afford a Tetrasubstituted Olefin 
4.5 Relay RCM Investigation to Afford Eight-Membered Lactone  
We envisaged constructing the desired lactone 323 via relay ring closing metathesis 
applied to triene 348 (Scheme 4.8). Triene 348 would be prepared by the coupling of carboxylic 























Scheme 4.8 Lactone Retrosynthetic Analysis 
4.5.1 Synthesis of Relay Ring Closing Metathesis Triene 
Ozonolysis of olefin 176 followed by subsequent dimethylsulfide mediated reduction 
afforded ketone 350 in good yield (72%) (Scheme 4.9). Installation of the tether required for 
relay metathesis was achieved by employing ylide 351
86
 in a salt free Wittig olefination of 
ketone 350 to provide diene 352, albeit in low yield (33%) but with excellent stereoselectivity 
(>20:1 Z:E). Saponification proceeded smoothly to furnish carboxylic acid 353 which upon 
exposure to oxalyl chloride gave rise to an intermediate acid chloride that underwent base 







































Scheme 4.9 Installation of Tether at 1,1-Disubstituted Olefin Site 
4.5.2 Relay Ring Closing Metathesis Investigation 
With triene 354 in hand we were excited to investigate a relay ring-closing metathesis 
strategy to achieve lactone 323 (Scheme 4.8). Upon exposure to various metathesis catalysts it 
was observed that triene 354 did not engage in the desired ring closing metathesis event to afford 
the lactone 323 (Table 4.3). Instead, we observed loss of the tether to afford diene 355, and 
dimerization of the starting triene to provide dimer 356. Observation of the truncated product, 
diene 355, indicates that the relay ring closing metathesis was successful but that the desired ring 






Me i. O3, CH2Cl2, –78 ºC 

















    2,6-lutidene
    CH2Cl2, 0 ºC ® rt
(71% yield)
2. 261, Et3N





















Table 4.3 Relay RCM Catalyst Survey 
 
 In a productive scenario the initial cross metathesis of the ruthenium alkylidene with the 
Type I olefin of triene 354 provides carbene 357 which subsequently undergoes ring closing 
metathesis to afford the desired 1,1-disubstitued carbene 360 with concomitant expulsion of 
cyclopentene (359) (Scheme 4.10). An intramolecular engagement of carbene 360 in ring closing 
metathesis would afford lactone 323 via metallacycle 361. Alternatively, carbene 360 can 
participate in cross metathesis with the Type I olefin of triene 354 to deliver diene 355 and 
carbene 357. In theory, the intramolecular process should be faster than the intermolecular 
process. Thus, we propose that carbene 361 may be unable to adopt a productive conformation 
































entry catalyst product (% yield)
2 330 355 (43%)
356 (14%)
1 328 355 (91%)























Scheme 4.10 Proposed Mechanism for Formation of Lactone and Diene Side Product 
4.6 Relay RCM to Afford an Eight-Membered Cyclic Ether  
To introduce greater conformational freedom during the ring closing metathesis event we 
decided to investigate a system wherein an ether linkage would reside in backbone connecting 
the two olefin moieties (e.g. 364, Scheme 4.11). The latter was seen as arising from the ring 
closing metathesis of triene 364, which in turn, would be derived via coupling of tetramic acid 
261 with alcohol 365 under Mitsunobu conditions. To this end our synthetic endeavors focused 
























































































Scheme 4.11 Ether Linked Triene Retrosynthetic Analysis 
4.6.1 Synthesis of Relay Ring Closing Metathesis Triene 
To arrive at triene 364, methyl ester 176 was advanced via lithium aluminum hydride 
mediated reduction to the primary alcohol 366 followed by subsequent silylation to furnish 
TBS-ether 367 which, upon exposure to ozone followed by dimethylsulfide, underwent oxidative 
cleavage to afford ketone 368 in good yield (47%) over three steps (Scheme 4.12). Installation of 
the relay metathesis tether was achieved by employing phosphorus ylide 351
87
 in a salt free 
Wittig olefination of ketone 368 to provide diene 369 in good yield (67%) as essentially a single 
olefin isomer (>20:1 Z:E). Exposure of 369 to tetrabutylammonium fluoride unveiled the 
primary alcohol 365, which upon coupling with tetramic acid 261 under Mitsunobu conditions 
(i.e., diethyl azodicarboxylate and triphenylphosphine), furnished ether 364 in moderate yield 





































Scheme 4.12 Synthesis of Triene with an Ether Backbone 
4.6.2 Relay Ring Closing Metathesis Investigation 
In a productive scenario the initial cross metathesis of the ruthenium alkylidene species 
with the Type I olefin of triene 364 provides carbene 373 which upon ring closing metathesis 
affords the 1,1-disubstitued carbene 375 with concomitant expulsion of cyclopentene (359) 
(Scheme 4.14). Carbene 375 can engage in ring closing metathesis via metallacycle 376 to afford 
the desired cyclic ether 363.  Alternatively, carbene 375 can participate in an undesired 
competing pathway, cross metathesis with the Type I olefin of triene 364 to deliver a truncated 
product, diene 370, and regenerate carbene 373. The latter was the favored pathway with ester-
linked triene 354 (Table 4.3 and Scheme 4.10). 
With triene 364 in hand, we were excited to investigate a relay ring closing metathesis 
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catalysts and reaction conditions we were unable to realize the desired ether 363. As in the 
previous substrate (i.e. 354) (Table 4.3 and Scheme 4.10), we observed formation of a truncated 
product, diene 370 indicating that the relay metathesis is successful but that the desired ring 
closing metathesis to afford the eight-membered cyclic ether 363 does not occur (Scheme 4.13).  
 
Scheme 4.13 Macrocyclization by Ring Closing Metathesis 
Surprisingly, exposure of triene 364 to Grubbs II catalyst (328) afforded the 
thirteen-membered macrocycle 371, albeit in low yield (16%) (Scheme 4.13). Indicating that in 
this system there is a competing pathway carbene 373 can undergo a macrocyclization via 
metallacycle 377 to afford the thirteen-membered cyclic ether 371. Although, macrocycle 371 
was an undesired product it demonstrated that the hindered, Type III olefin attached to the 
tetramic acid moiety of triene 364 was capable of engaging in a productive ring closing 
metathesis event. Clearly, the ether backbone was having a positive influence on cyclization as a 
macrocyclization product was not observed in our previous substrate (354) (Table 4.4 and 


















































































































































4.7 Relay RCM – Focusing on the Tetramic Acid Olefin 
An alternate synthetic route to the desired cyclic ether 363 (Scheme 4.15) was envisaged 
wherein the application of a relay ring closing metathesis would be applied to triene 378. The 
latter would derive from the coupling of alcohol 366 with tetramic acid 379 under Mitsunobu 
conditions.  
 
Scheme 4.15 Retrosynthetic Analysis - Tether Attached to Tetramic Acid Moiety 
4.7.1 Synthesis of Relay Ring Closing Metathesis Triene 
In a manner analogous to that described in Chapter 3, the desired tetramic acid 379 was 
prepared from alcohol 257 which, when subjected to Swern oxidation furnishes aldehyde 258. 
Immediate exposure of 258 to phosphorus ylide 351 in toluene at reflux produces diene 380 in 
excellent yield (75%), as essentially one olefin isomer (>20:1 Z/E), over two steps (Scheme 
4.16). Acylation of amine 380 with propionyl chloride provided amide 381 and subsequent 
treatment with sodium hydride in tetrahydrofuran at reflux induces Dieckmann cyclization to 
provide tetramic acid 379 in modest yield (32%) over two steps, as a mixture of two 



































Mitsunobu alkylation of tetramic acid 379 with primary alcohol 366 afforded triene 378 in low 
yield (20%) but provided enough material to investigate the relay ring closing metathesis. 
 
Scheme 4.16 Synthesis of Triene with Tether Attached to Tetramic Acid Moiety 
4.7.2 Relay Ring Closing Metathesis Investigation 
In a productive scenario the initial cross metathesis of the ruthenium alkylidene species 
with the Type I olefin of triene 378 provides carbene 384, subsequent ring closing metathesis 
proceeding via metallacycle 385 affords the directly inaccessible carbene 386 upon concomitant 
expulsion of cyclopentene (359) (Scheme 4.18). Cyclization of carbene 386 via metallacycle 387 
would afford the desired cyclic ether 363.  
With triene 378 in hand we were excited to investigate a relay ring closing metathesis 
approach to afford cyclic ether 363 (Scheme 4.15). Unfortunately, exposure of triene 378 to the 
unhindered Hoveyda-Grubbs catalyst (331) did not afford the desired cyclic ether 363; only the 
diene 370 (19% yield) and starting material dimer 382 (40% yield) were obtained (Scheme 4.17). 




















































the initially inaccessible carbene 386 but that the desired cyclization to afford the 
eight-membered cyclic ether 363 does not occur (Scheme 4.18).  
 
Scheme 4.17 Attempted Relay Ring Closing Metathesis 
Unfortunately, as was observed with the two previous substrates (i.e., 354 and 364) the 
preferred pathway for carbene 386 is not the desired ring closing metathesis but an unproductive 
cross metathesis with the Type I olefin of triene 378 to afford the undesired diene 370. We 
propose that the desired pathway is prohibitively high in energy and or that carbene 386 does not 
have enough conformational freedom to adopt a productive conformation that allows for the 
formation of metallacycle 387 and thus cyclic ether 363. 
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Scheme 4.18 Proposed Mechanism for Formation of Cyclic Ether and Diene 
4.8 Conclusion 
Although the desired ring closing metathesis to afford an eight-membered lactone or 
ether was not realized the relay ring closing metathesis investigations provided insight into the 
reactivity of the olefin moieties attached to the aryl bromide and tetramic acid coupling partners. 
The relay ring closing metathesis experiments demonstrated that both olefins are capable of 
participating in a ring closing metathesis. We propose that the desired ring closing metathesis 
events did not occur due to a conformation constraint that prohibited formation of the desired 
eight-membered ring. Thus, we propose that a successful ring closing metathesis may be realized 
upon synthesis of a substrate that employs a higher order of conformational control forcing the 











































































valuable and reliable synthetic strategy to initiate the catalytic cycle and control the site of 
initiation. 
4.9 Experimental Section 
4.9.1 Materials and Methods 
Unless stated otherwise, reactions were performed in flame-dried glassware under a 
nitrogen atmosphere. Triethylamine, diisopropylamine, and methanol were dried over anhydrous 
calcium hydride and freshly distilled. 1,4-Dioxane was distilled from sodium, calcium chloride 
and molecular sieve (0.4 nm). Benzene, tetrahydrofuran, dichloromethane, toluene, and diethyl 
ether were dried using a solvent purification system manufactured by Glass Contour Solvent 
Systems, SG Water U.S.A., LLC using technology based upon that originally described by 
Grubbs et al.
88
 Anhydrous N,N-dimethyformamide, acetonitrile, dimethylsulfoxide, 1,2-
dichloroethane was purchased from the Colorado State University Stockroom and supplied by 
Sigma-Aldrich or Fischer Scientific and stored under nitrogen atmosphere. Commercially 
available reagents were obtained from Sigma-Aldrich, Strem, TCI, Combi-Blocks, Acros or 
Alfa-Aesar and were used as received. All known compounds were identified by comparison of 
NMR spectra to reported in the literature. 
Unless otherwise stated, all reactions were monitored by thin layer chromatography 
(TLC) was using Silicycle glass-backed extra hard layer, 60 Å plates (indicator F-254, 250 m). 
Developed TLC plates were visualized using a 254 nm UV lamp and/or with the appropriate 
stain followed by heating. Typical stains utilized were potassium permanganate, ethanolic 
anisaldehyde and ceric ammonium molybdate. In general, the flash chromatography guidelines 
reported by Still et al
89
 were followed. Silicycle SiliaFlash
® 
P60 (230-400 mesh) silica gel as the 
182 
stationary phase. When reactions were absorbed onto silica gel, the amount of silica gel used was 
equal to two times the weight of the reagents. 
Infrared spectra were obtained using a Nicolet Avatar 320 FTIR or Bruker Tensor27 
FTIR. Samples were analyzed as thin films on NaCl plates (samples was dissolved in CH2Cl2 or 





H) and carbon (
13
C) NMR spectra were recorded on a Varian Inova 
500, Varian Inova 400, Varian Inova 400 auto sampler, or Varian Inova 300 MHz spectrometer. 
Spectra were obtained at 22 °C in CDCl3 unless otherwise noted. Chemical shifts () are reported 
in parts per million (ppm) and are referenced to the internal solvent peak. Coupling constants (J) 
are reported in Hertz (Hz) and are rounded to the nearest 0.1 Hz. Multiplicities are defined as: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, dd = doublet of doublets, dt = doublet 
of triplets, ddd = doublet of doublet of doublets, dddd = doublet of doublet of doublet of 
doublets, br = broad, app = apparent, par = partial. High-resolution mass spectra were obtained 
from the University of Colorado Central Instrument Facility, performed on an Agilent 6210 TOF 
LCMS by Donald L. Dick.  
4.9.2 Preparative Procedures 
Preparation of tetramic acid 337: 
  
Tetramic acid 337. To a stirred solution of vinylogous ester 251 (50 mg, 0.28 mmol) in 
methanol (4.2 mL) was added 2 M HCl (1.4 mL, 2.80 mmol) at room temperature. Reaction was 
















with 80% EtOAc/Hex and visualized by UV lamp and KMnO4 stain. Reaction was cooled to 
room temperature and diluted with dichloromethane (4 mL). Organic phase was washed with 
saturated NaHCO3 (5 mL), brine (5 mL), dried over anhydrous Na2SO4 and concentrated to yield 
tetramic acid 337 (14 mg, 19% yield, 1.5:1 dr) as yellow oil. No further purification necessary. 
Tetramic acid 337. 
1
H-NMR (300 MHz; CDCl3): δ 6.90 (s, 1H), 5.84 (dd, J = 17.1, 10.4 
Hz, 1H), 5.38 (d, J = 18.8 Hz, 1H), 5.29 (d, J = 10.4 Hz, 1H), 2.94 (q, J = 7.7 Hz, 1H), 1.92 (dq, 
J = 19.5, 6.0 Hz, 1H), 1.75 (dq, J = 14.7, 7.3 Hz, 1H), 1.29 (d, J = 7.7 Hz, 3H), 0.85 (t, J = 7.5 
Hz, 3H).; 6.98 (s, 1H), 5.91 (dd, J = 17.2, 10.5 Hz, 1H), 5.38 (d, J = 17.1 Hz, 1H), 5.27 (d, J = 
10.6 Hz, 1H), 2.77 (q, J = 7.8 Hz, 1H), 1.92 (dq, J = 19.5, 6.0 Hz, 1H), 1.75 (dq, J = 14.7, 7.3 
Hz, 1H), 1.33 (d, J = 7.8 Hz, 3H), 0.91 (t, J = 7.5 Hz, 3H). 
Preparation of diene 338: 
  
Diene 338. To a stirred solution of carboxylic acid 190 (28 mg, 0.09 mmol), tetramic acid 
337 (14 mg, 0.08 mmol) and 4-(dimethylamino)pyridine (3 mg, 0.02 mmol) in dichloromethane 
(0.8 mL) was added dicyclohexylcarbodiimide (21 mg, 0.10 mmol) at 0 ºC. Reaction was stirred 
for 10 minutes at 0 ºC, warmed to room temperature and stirred over night. TLC was used to 
monitor reaction progress. TLC plates were developed with 35% EtOAc/Hex; visualized by UV 
lamp and KMnO4 stain. Reaction was diluted with dichloromethane (2 mL) and quenched with 
saturated NH4Cl (2 mL). Organic phase was washed with H2O (2 mL), brine (2 mL), dried over 



























silica gel chromatography (gradient elution 15101520253035% EtOAc/Hex) to 
afford diene 338 (8.5 mg; 23% yield) as colorless oil. 
Diene 338. 
1
H-NMR (400 MHz; CDCl3): δ 7.24 (d, J = 8.9 Hz, 1H), 7.11 (d, J = 3.5 Hz, 
1H), 6.85 (dd, J = 8.7, 2.3 Hz, 1H), 5.79 (s, 1H), 5.53 (dd, J = 17.3, 10.6 Hz, 1H), 5.19 (d, J = 
17.3 Hz, 1H), 5.13 (d, J = 2.7 Hz, 1H), 5.00 (d, J = 10.5 Hz, 1H), 4.96 (s, 1H), 4.10 (d, J = 11.6 
Hz, 1H), 3.76 (s, 3H), 3.25 (td, J = 12.5, 5.7 Hz, 1H), 1.61 (s, 3H), 1.60 (q, J = 11.0 Hz, 1H), 
1.47 (q, J = 7.1 Hz, 1H), 1.26 (s, 3H), 0.70 (td, J = 7.4, 3.8 Hz, 3H); 
13
C-NMR (101 MHz; 
CDCl3): δ 172.3, 170.0, 161.0, 159.0, 142.4, 136.36, 136.25, 131.86, 131.81, 128.7, 126.07, 
125.98, 118.73, 118.66, 115.82, 115.65, 115.1, 114.9, 113.8, 65.4, 55.7, 53.2, 42.56, 42.38, 27.5, 
19.5, 19.3, 17.1, 7.78, 7.60, 7.54; HRMS (EI) m/z 462.1273 [calc’d for C23H28BrNO4 (M+H)+ 
462.1274]. 
Preparation of diene 339: 
  
Diene 339. To a stirred solution of carboxylic acid 190 (50 mg, 0.16 mmol), tetramic acid 
261 (30 mg, 0.18 mmol) and 4-(dimethylamino)pyridine (3 mg, 0.02 mmol) in dichloromethane 
(1.6 mL) was added dicyclohexylcarbodiimide (37 mg, 0.18 mmol) at 0 ºC. Reaction was stirred 
for 10 minutes at 0 ºC, warmed to room temperature and stirred over night. TLC was used to 
monitor reaction progress. TLC plates were developed by gradient elution 1540% EtOAc/Hex; 
visualized by UV lamp and KMnO4 stain. Reaction was diluted with dichloromethane (2 mL) 



























(4 mL), dried over anhydrous Na2SO4 and concentrated under reduced pressure. Crude material 
was purified with silica gel chromatography (gradient elution 102040% EtOAc/Hex) to 
afford diene 339 (46 mg; 49% yield) as colorless oil. 
Diene 339. 
1
H-NMR (300 MHz; CDCl3): δ 7.24-7.18 (m, 3H), 7.11-7.06 (m, 1H), 6.83-
6.75 (m, 3H), 5.28-4.93 (m, 5H), 4.39 (dd, J = 15.0, 1.5 Hz, 1H), 4.18 (dd, J = 15.1, 7.1 Hz, 1H), 
4.04 (dd, J = 11.6, 2.0 Hz, 1H), 3.78 (d, J = 0.9 Hz, 1H), 3.76 (s, 6H), 3.75 (d, J = 1.6 Hz, 3H), 
3.24-3.13 (m, 1H), 1.58 (s, 3H), 1.61-1.50 (m, 2H), 1.32 (dd, J = 6.8, 2.4 Hz, 3H), 1.24 (s, 3H), 
0.32 (q, J = 7.7 Hz, 3H). 
Preparation of ketone 350: 
  
Ketone 350. Alkene 176 (250 mg, 0.798 mmol) was dissolved in dichloromethane (8 
mL) and cooled to –78 ºC. Ozone was bubble through solution until saturation was achieved. 
TLC was used to monitor reaction progress. TLC plates were developed with 15% EtOAc/Hex; 
visualized by UV lamp and KMnO4 stain. Oxygen was bubbled through solution for 10 minutes 
and dimethylsulfide (1.17 mL, 16.0 mmol) was added to solution. Reaction was warmed to room 
temperature and stirred overnight. Solution was concentrated under reduced pressure and crude 
material was purified with silica gel chromatography (eluent 5% EtOAc/Hex) to afford ketone 
350 (175 mg, 72% yield) as colorless oil. 
Ketone 350. 
1
H-NMR (300 MHz; CDCl3): δ 7.16 (d, J = 2.6 Hz, 1H), 7.00 (d, J = 8.6 Hz, 
1H), 6.82 (dd, J = 8.7, 2.6 Hz, 1H), 4.66 (dd, J = 9.7, 4.9 Hz, 1H), 3.79 (s, 3H), 3.66 (s, 3H), 3.11 
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Preparation of (5-Hexen-1-yl)triphenylphosphonium iodide 390:  
  
Alkyl iodide 389. Following the procedure of Hiersemann and Helmboldt.
90
 To a stirred 
solution of triphenylphosphine (83 g, 314.78 mmol) in dichloromethane (200 mL) at 0 ºC was 
added iodine (80 g, 314.78 mmol) and imidazole (21.4 g, 314.78 mmol). After being stirred for 
15 minutes, 5-hexen-1-ol (388) (10 g, 99.84 mmol) was added dropwise at 0 ºC to the reaction 
mixture and stirring was continued at room temperature for 4 hours. TLC was used to monitor 
reaction progress. TLC plates were developed with 5% EtOAc/Hex; visualized by KMnO4 stain.  
Dichloromethane was evaporated under reduced pressure and the residue diluted with pentane. 
The resulting suspension was filtered through celite; and the celite was carefully rinsed with 
pentane. The filtrate was concentrated under reduced pressure and purified with silica 
chromatography (gradient elution pentane1% Et2O/pentane) to afford alkyl iodide 3389 (16 g, 
76% yield) as colorless oil. 
Alkyl iodide 389 is a known compound 
1




Alkyl iodide 389. 
1
H-NMR (300 MHz; CDCl3): δ 5.79 (ddt, J = 17.0, 10.3, 6.7 Hz, 1H), 
5.06-4.99 (m, 1H), 4.99-4.95 (m, 1H), 3.20 (t, J = 7.0 Hz, 2H), 2.08 (q, J = 7.1 Hz, 2H), 1.84 (dt, 
J = 14.8, 7.3 Hz, 2H), 1.50 (quintet, J = 7.4 Hz, 2H). 
(5-Hexen-1-yl)triphenylphosphonium iodide 390. A solution of alkyl iodide 389 (3.0 g, 
14.28 mmol) and triphenylphosphine (3.6 g, 13.57 mmol) in benzene (15 mL) in a commercially 
available glass pressure tube with a Teflon screw-cap was heated to 120 ºC for 12 hours. 













a small quantity of benzene to afford the Wittig salt 390 (6.0 g, 90% yield) as yellowish white 
solid. 
(5-Hexen-1-yl)triphenylphosphonium iodide 390. 
1
H-NMR (400 MHz; CDCl3): δ 7.87-
7.78 (m, 10H), 7.73-7.68 (m, 5H), 5.68 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H), 4.96-4.91 (m, 1H), 
4.91-4.87 (m, 1H), 3.80-3.72 (m, 2H), 2.09 (q, J = 7.0 Hz, 2H), 1.79 (dt, J = 14.8, 7.3 Hz, 2H), 
1.69-1.59 (m, 2H); 
13
C-NMR (101 MHz; CDCl3): δ 137.8, 135.2, 133.96, 133.87, 130.70, 
130.57, 118.8, 118.0, 115.5, 33.1, 29.40, 29.26, 23.4, 22.9, 21.97, 21.92. 
Preparation of diene 352: 
 
Diene 352. Ylide 351 solution in toluene (0.1 M). To a stirred solution of Wittig salt 390 
(1.0 g, 2.12 mmol) in toluene (13.6 mL) was added potassium bis(trimethylsilyl)amide (0.5 M in 
toluene, 3.4 mL, 1.70 mmol) at –78 ºC. Reaction mixture was stirred for 5 minutes at –78 ºC, 
warmed to room temperature and stirred 90 minutes. Solution turned orange upon warming. 
Allowed solution to stand with out stirring so that potassium iodide settled on the bottom of the 
round bottom flask. 
To a stirred solution of ketone 350 (262 mg, 0.83 mmol) in toluene (29 mL) was added 
ylide 351 (0.1 M in toluene, 12.5 mL, 1.25 mmol) in a commercially available glass pressure 
tube with a Teflon screw-cap and heated to 120 ºC for 12 hours. Reaction mixture was cooled to 
room temperature and quenched with saturated NH4Cl solution (15 mL). Organic phase was 















reduced pressure. TLC plates were developed with 15% EtOAc/Hex; visualized by UV lamp and 
CAM stain. Crude material was purified with silica gel chromatography (gradient elution 
51015% EtOAc/Hex) to afford diene 352 (105 mg, 33% yield, >20:1 Z:E) as colorless oil. 
Diene 352. 
1
H-NMR (400 MHz; CDCl3): δ 7.10 (d, J = 2.6 Hz, 1H), 7.07 (d, J = 8.7 Hz, 
1H), 6.81 (dd, J = 8.6, 2.7 Hz, 1H), 5.81 (ddt, J = 17.0, 10.3, 6.7 Hz, 1H), 5.31 (t, J = 7.2 Hz, 
1H), 5.00 (dq, J = 17.1, 1.7 Hz, 1H), 4.96-4.93 (m, 1H), 4.22 (t, J = 8.0 Hz, 1H), 3.78 (s, 3H), 
3.63 (s, 3H), 2.74 (dd, J = 15.3, 8.9 Hz, 1H), 2.65 (dd, J = 15.3, 7.1 Hz, 1H), 2.08-2.02 (m, 4H), 
1.50 (s, 3H), 1.46 (t, J = 7.4 Hz, 2H). 
Preparation of carboxylic acid 353: 
 
Carboxylic acid 353. Methyl ester 352 (34 mg, 0.09 mmol) was dissolved in methanol (3 
mL) and lithium hydroxide (3.5 M in H2O, 3 mL) was added. Vial was sealed and heated to 80 
ºC for 24 hours. Reaction solution was cooled to room temperature and acidified. The acidic 
aqueous phase was extracted with diethyl ether (3 x 3 mL). Combined organic phase was dried 
over anhydrous Na2SO4 and concentrated to yield carboxylic acid 353 (26 mg, 79% yield). 
Carboxylic acid 353. 
1
H-NMR (300 MHz; CDCl3): δ 7.10 (d, J = 2.6 Hz, 1H), 7.07 (d, J 
= 8.7 Hz, 1H), 6.81 (dd, J = 8.7, 2.7 Hz, 1H), 5.87-5.75 (m, 1H), 5.33 (t, J = 7.1 Hz, 1H), 5.03-
4.96 (m, 1H), 4.95-4.92 (m, 1H), 4.19 (t, J = 7.9 Hz, 1H), 3.77 (s, 3H), 2.71 (t, J = 7.4 Hz, 2H), 















Preparation of triene 354:  
 
Triene 354. To a stirred solution of carboxylic acid 353 (113 mg, 0.31 mmol) and 
2,6-lutidene (43 L, 0.37 mmol) in dichloromethane (2 mL) was added oxalyl chloride (28.6 L, 
0.34 mmol) at 0 ºC. Warmed to room temperature and stirred 2 hours. Reaction solution was 
cooled to 0 ºC and a solution of tetramic acid 261 (177 mg, 0.62 mmol) and triethylamine (172 
L, 1.23 mmol) in dichloromethane (2 mL). Reaction mixture was warmed to room temperature 
and stirred 4 hours. TLC was used to monitor reaction progress. TLC plates were developed with 
15% EtOAc/Hex; visualized by UV lamp and KMnO4 stain. Reaction mixture was quenched 
with saturated NH4Cl solution (5 mL). Organic phase was washed with H2O (5 mL), brine (5 
mL), dried over anhydrous Na2SO4 and concentrated under reduced pressure. Crude material was 
purified with silica gel chromatography (gradient elution 51020% EtOAc/Hex) to afford 
triene 354 (140 mg, 71% yield). 
Triene 354. 
1
H-NMR (300 MHz; CDCl3): δ 7.26 (s, 3H), 7.11-7.06 (m, 2H), 6.79-6.76 
(m, 3H), 5.79 (ddt, J = 17.0, 10.3, 6.7 Hz, 1H), 5.40-5.29 (m, 2H), 5.18-5.08 (m, 2H), 5.02-4.92 
(m, 2H), 4.44 (d, J = 14.8 Hz, 1H), 4.26-4.20 (m, 2H), 3.77 (s, 6H), 2.85 (dt, J = 8.1, 4.1 Hz, 
2H), 2.04 (q, J = 6.0 Hz, 4H), 1.67-1.57 (m, 6H), 1.52-1.42 (m, 6H), 0.40-0.35 (m, 3H). 
1. (COCl)2
    2,6-lutidene
    CH2Cl2, 0 ºC ® rt
2. 261, Et3N

















Preparation of alkene 355 and dimer 356: 
 
Alkene 355 and dimer 356. Prior to use toluene was pulled freshly from solvent system 
and then deoxygenated by sparging with nitrogen at reflux for 30 minutes. To a round bottom 
flask was added catalyst (5 mg, 0.008 mmol), toluene (39 mL) and substrate and substrate as a 
solution in toluene (1 mL). Round bottom flask was fitted with a condenser, a needle attached to 
nitrogen line was inserted through septum down condenser into the reaction solution and a vent 
needle was inserted into septum. Nitrogen pressure was increased to establish a slow and steady 
bubbling of nitrogen through reaction solution and heated to 80 ºC. TLC was used to monitor 
reaction progress. TLC plates were developed with 40% EtOAc/Hex; visualized by UV lamp and 
KMnO4 stain. Reaction was cooled to room temperature and quenched with dimethylsulfoxide 




































































under reduced pressure and resulting residue purified with silica gel chromatography (gradient 
elution 2040% EtOAc/Hex) to afford alkene 355 and dimer 356. 
Alkene 355. 
1
H-NMR (300 MHz; CDCl3): δ 7.26-7.23 (m, 3H), 7.11-7.08 (m, 2H), 6.83-
6.76 (m, 3H), 5.35 (dd, J = 18.0, 9.9 Hz, 1H), 5.35 (dd, J = 18.1, 9.9 Hz, 1H), 5.19-5.13 (d, J = 
18.4 Hz, 1H), 5.13 (d, J = 9.3 Hz, 1H), 4.96 (s, 1H), 4.87 (d, J = 4.1 Hz, 1H), 4.44 (d, J = 15.0 
Hz, 1H), 4.26 (t, J = 8.0 Hz, 1H), 4.26-4.21 (d, J = 15.0 Hz, 1H), 3.77 (s, 6H), 2.95-2.78 (m, 2H), 
1.80-1.59 (m, 2H), 1.65 (s, 3H), 1.62-1.61 (d, J = 4.6 Hz, 3H), 0.38 (td, J = 7.2, 2.9 Hz, 3H); 
HRMS (EI) m/z 568.1695 [calc’d for C30H34BrNO5 (M+H)+ 568.1693]. 
Dimer 356. 
1
H-NMR (300 MHz; CDCl3): δ 7.26-7.23 (m, 7H), 7.08 (d, J = 10.8 Hz, 4H), 
6.78 (d, J = 8.4 Hz, 6H), 5.39-5.28 (m, 4H), 5.18-5.07 (m, 4H), 4.46-4.41 (m, 2H), 4.24-4.19 (m, 
4H), 3.77 (s, 12H), 2.85-2.82 (m, 4H), 1.61-1.58 (m, 10H), 1.51 (s, 6H), 0.39-0.34 (m, 4H); 
HRMS (EI) m/z 1243.4252 [calc’d for C68H80Br2N2O10 (M+H)+ 1243.4252]. 
Preparation of alcohol 366: 
 
Alcohol 366. To a stirred heterogeneous solution of lithium aluminum hydride (160 mg, 
3.51 mmol) in tetrahydrofuran (27.5 mL) was added methyl ester 176 (1.1 g, 3.51 mmol) as a 
solution in tetrahydrofuran (7.5 mL) over 40 minutes with a syringe pump. TLC was used to 
monitor reaction progress. TLC plates were developed with 15% EtOAc/Hex; visualized by UV 













H2O (0.6 mL) at 0 ºC. Anhydrous MgSO4 (2 scoops) was added, warmed to room temperature 
and stirred over night. Solution was filtered through a sand/celite pad and concentrated under 
reduced pressure. Crude material was purified with silica gel chromatography (eluent 10% 
EtOAc/Hex) to afford alcohol 366 (800 mg, 80% yield) as colorless oil).  
Alcohol 366. FTIR (thin film/NaCl): 3362, 2940, 1645, 1602, 1565, 1490, 1439, 1373, 
1283, 1236, 1181, 1037, 894, 857, 839, 816; 
1
H-NMR (400 MHz; CDCl3): δ 7.12 (d, J = 8.7 Hz, 
1H), 7.10 (d, J = 2.7 Hz, 1H), 6.83 (dd, J = 8.7, 2.7 Hz, 1H), 4.93 (d, J = 0.7 Hz, 1H), 4.91 (dd, J 
= 2.2, 1.4 Hz, 1H), 3.89-3.85 (m, 1H), 3.78 (s, 3H), 3.59 (dd, J = 5.4, 1.5 Hz, 1H), 3.57-3.56 (m, 
1H), 2.14 (dq, J = 13.5, 6.8 Hz, 1H), 1.87 (ddt, J = 13.6, 8.9, 6.0 Hz, 1H), 1.61 (s, 3H); 
13
C NMR 
(101 MHz; CDCl3): δ 158.5, 147.2, 134.2, 128.9, 125.7, 117.7, 114.4, 110.8, 61.2, 55.6, 46.1, 
36.9, 22.0; HRMS (EI) m/z 285.0474 [calc’d for C13H17BrO2 (M+H)+ 284.0412]. 
Preparation of TBS-ether 367:  
 
TBS-ether 367. To a stirred solution of alcohol 366 (500 mg, 285.18 mmol) and 
imidazole (238 mg, 3.50 mmol) in dichloromethane (4 mL) was added tert-butyldimethylsilyl 
chloride (396 mg, 2.63 mmol) at room temperature. TLC was used to monitor reaction progress. 
TLC plates were developed with 40% EtOAc/Hex; visualized by UV lamp and KMnO4 stain. 
Reaction solution was hydrolyzed with H2O (5 mL) and phases were separated. Organic phase 















pressure to afford TBS-ether 367 (697 mg, 99% yield). Crude material was advanced directly to 
ozonolysis with no further purification. 
TBS-ether 367. 
1
H-NMR (300 MHz; CDCl3): δ 7.12 (d, J = 8.7 Hz, 1H), 7.09 (d, J = 2.7 
Hz, 1H), 6.82 (dd, J = 8.7, 2.6 Hz, 1H), 4.88 (dd, J = 1.6, 0.9 Hz, 2H), 3.85 (t, J = 7.2 Hz, 2H), 
3.78 (s, 3H), 3.62-3.48 (m, 3H), 2.05 (td, J = 13.4, 7.3 Hz, 1H), 1.93-1.83 (m, 1H), 1.61 (s, 2H), 
0.87 (s, 9H), 0.00 (s, 6H). 
Preparation of ketone 368: 
 
Ketone 368: Alkene 367 (697 mg, 1.75 mmol) was dissolved in dichloromethane (20 
mL) and cooled to –78 ºC. Ozone was bubble through solution until saturation was achieved. 
TLC was used to monitor reaction progress. TLC plates were developed with 5% EtOAc/Hex; 
visualized by UV lamp and KMnO4 stain. Oxygen was bubbled through solution for 10 minutes 
and dimethylsulfide (1.00 mL, 8.75 mmol) was added to solution. Reaction was warmed to room 
temperature and stirred overnight. Solution was concentrated under reduced pressure and crude 
material was purified with silica gel chromatography (gradient elution 234% EtOAc/Hex) to 
afford ketone 368 (400 mg, 57% yield) as colorless oil. 
Ketone 368. 
1
H-NMR (300 MHz; CDCl3): δ 7.14 (d, J = 2.6 Hz, 1H), 7.05 (d, J = 8.7 Hz, 
1H), 6.83 (dd, J = 8.6, 2.7 Hz, 1H), 4.40 (t, J = 7.1 Hz, 1H), 3.79 (s, 3H), 3.59-3.46 (m, 2H), 2.26 
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Preparation of diene 369: 
 
Diene 369. Ylide 351 (0.1 M in toluene): To a stirred solution of Wittig salt 390 (289 mg, 
0.61 mmol) in toluene (4.8 mL) was added potassium bis(trimethylsilyl)amide (0.5 M in toluene, 
1.2 mL, 0.60 mmol) at –78 ºC. Reaction mixture was stirred for 5 minutes at –78 ºC, warmed to 
room temperature and stirred 2 hours. Solution turned orange upon warming. Allowed solution 
to stand with out stirring so that potassium iodide settled on the bottom of the vial. 
To ketone 368 (50 mg, 0.12 mmol) was added ylide 351 (0.1 M in toluene, 2.4 mL, 0.24 
mmol) in a commercially available glass pressure tube with a Teflon screw-cap and heated to 
110 ºC for 12 hours. Reaction mixture was cooled to room temperature and quenched with 
saturated NH4Cl solution (3 mL). Organic phase was washed with H2O (3 mL), brine (3 mL), 
dried over anhydrous Na2SO4 and concentrated under reduced pressure. TLC plates were 
developed with 5% EtOAc/Hex; visualized by UV lamp and CAM stain. Crude material was 
purified with silica gel chromatography (gradient elution 12% EtOAc/Hex) to afford diene 369 
(37.3 mg, 67% yield, >20:1 Z:E) as colorless oil. 
Diene 369. 
1
H-NMR (300 MHz; CDCl3): δ 7.11 (d, J = 9.1 Hz, 1H), 7.09 (d, J = 2.9 Hz, 
1H), 6.82 (dd, J = 8.6, 2.6 Hz, 1H), 5.82 (ddt, J = 17.0, 10.3, 6.7 Hz, 1H), 5.35 (t, J = 7.2 Hz, 
1H), 5.04-4.88 (m, 2H), 3.78 (s, 3H), 3.63-3.48 (m, 2H), 2.10-1.98 (m, 5H), 1.90-1.79 (m, 2H), 














Preparation of alcohol 365:  
 
Alcohol 365. To a stirred solution of TBS-ether 369 (37.3 mg, 0.08 mmol) in 
tetrahydrofuran (0.68 mL) was added tetrabutylammonium fluoride (1 M in tetrahydrofuran, 0.32 
mL, 0.28 mmol) at room temperature. TLC was used to monitor reaction progress. TLC plates 
were developed with 20% EtOAc/Hex; visualized by UV lamp and KMnO4 stain. Reaction was 
quenched with saturated NH4Cl solution (1 mL) and phases were separated. Organic phase was 
dried over Na2SO4 and concentrated under reduced pressure. Residue was purified with silica gel 
chromatography (eluent 20% EtOAc/Hex) to afford alcohol 365 (28 mg, 99% yield) as colorless 
oil.  
Alcohol 365. FTIR (thin film/NaCl): 3943, 3436, 3054, 2940, 2839, 2253, 1639, 1603, 
1565, 1491, 1464, 1440, 1422, 1265, 1235, 1182, 1036, 909, 862, 843, 735, 705, 650, 427; 
1
H-
NMR (400 MHz; CDCl3): δ 7.09 (d, J = 8.8 Hz, 1H), 7.08 (d, J = 2.8 Hz, 1H), 6.82 (dd, J = 8.7, 
2.7 Hz, 1H), 5.80 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H), 5.38 (t, J = 7.2 Hz, 1H), 4.99 (dq, J = 17.1, 
1.8 Hz, 1H), 4.94 (ddt, J = 10.2, 2.1, 1.1 Hz, 1H), 3.78-3.76 (m, 1H), 3.76 (s, 3H), 3.56 (t, J = 6.6 
Hz, 2H), 2.17-2.01 (m, 6H), 1.88-1.79 (m, 1H), 1.60-1.43 (m, 2H), 1.46 (s, 3H); 
13
C NMR (101 
MHz; CDCl3): δ 158.3, 139.0, 136.3, 134.6, 128.9, 125.7, 125.4, 117.7, 114.6, 114.0, 61.3, 55.6, 












Preparation of triene 364: 
 
Triene 364. Alcohol 365 (20 mg, 0.057 mg) and triphenylphosphine (22 mg, 0.085 
mmol) were dissolved in tetrahydrofuran (0.6 mL) and diethyl azodicarboxylate (DEAD) (40% 
solution in toluene, 39 l, 0.085 mmol) was added at room temperature and stirred for 10 
minutes. Tetramic acid 261 (24.4 mg, 0.085 mmol) was added as a solution in tetrahydrofuran at 
room temperature and stirred overnight. TLC was used to monitor reaction progress. TLC plates 
were developed with 40% EtOAc/Hex; visualized by UV lamp and KMnO4 stain. 
Tetrahydrofuran was evaporated under reduced pressure and residue was purified with silica gel 




H-NMR (300 MHz; CDCl3): δ 7.28-7.16 (m, 3H), 7.07 (dd, J = 4.7, 3.5 Hz, 
1H), 6.83-6.76 (m, 3H), 5.80 (ddtd, J = 17.0, 10.2, 6.8, 0.9 Hz, 1H), 5.46 (dd, J = 17.8, 10.3 Hz, 
1H), 5.33 (q, J = 5.7 Hz, 1H), 5.24-5.16 (m, 2H), 5.02-4.92 (m, 2H), 4.53 (dd, J = 15.1, 4.7 Hz, 
1H), 4.22 (t, J = 7.8 Hz, 1H), 4.12 (dt, J = 14.7, 7.1 Hz, 2H), 3.83 (d, J = 7.0 Hz, 1H), 3.77 (s, 
3H), 3.77 (s, 3H), 2.13-2.01 (m, 2H), 2.04 (q, J = 7.1 Hz, 4H), 1.92 (d, J = 0.9 Hz, 3H), 1.95-
1.82 (m, 2H), 1.58 (dt, J = 14.0, 7.0 Hz, 1H), 1.50-1.43 (m, 1H), 1.43 (s, 3H), 0.34 (d, J = 1.0 
























Preparation of alkene 370 and macrocycle 371:  
 
Alkene 370 and macrocycle 371. Toluene was pulled fresh from solvent still and 
degassed prior to use by sparging with nitrogen for 2 hours. To a 3-neck round bottom flask was 
added Grubbs II (328) (22 mg, 0.025 mmol) and system was flushed with nitrogen, toluene (35 
mL) was added, nitrogen sparging of the solution was initiated and heated to 80 ºC. At 80 ºC 
triene 364 (21 mg, 0.034 mmol) was added as a solution in toluene (1.8 mL) by slow addition 
(syringe pump, 0.03 mL/min). TLC was used to monitor reaction progress. TLC plates were 
developed with 40% EtOAc/Hex; visualized by UV lamp and ceric ammonium molybdate 
(CAM) stain. After 60 minutes, (complete addition of triene 364) conversion to two new 
compounds was observed. Reaction was cooled to room temperature and stirred open to external 
atmosphere over night. Toluene volume was reduced under pressure and solution was purified 
directly with silica gel chromatography (gradient elution 510152025% EtOAc/Hex) to 




H-NMR (400 MHz; CDCl3): δ 7.27 (d, J = 8.6 Hz, 2H), 7.11-7.09 (m, 2H), 
6.84-6.81 (m, 1H), 6.78 (d, J = 8.6 Hz, 2H), 5.51-5.42 (m, 1H), 5.23-5.17 (m, 2H), 4.93 (s, 1H), 
4.88 (d, J = 5.5 Hz, 1H), 4.53 (dd, J = 15.1, 8.5 Hz, 1H), 4.26-4.20 (m, 1H), 4.18-4.09 (m, 2H), 


































2.01-1.94 (m, 1H), 1.92 (s, 3H), 1.88-1.82 (m, 1H), 1.58 (s, 3H), 0.35 (td, J = 7.2, 2.8 Hz, 3H); 
HRMS (EI) m/z 554.1897 [calc’d for C30H37BrNO4 (M+H)+ 554.19]. 
Macrocycle 371. 
1
H-NMR (400 MHz; CDCl3): δ 7.26 (d, J = 8.5 Hz, 2H), 7.11 (d, J = 
4.4 Hz, 1H), 7.10 (d, J = 1.4 Hz, 1H), 6.83-6.79 (m, 1H), 6.78 (d, J = 8.5 Hz, 2H), 5.63 (dt, J = 
14.6, 7.4 Hz, 2H), 5.06 (d, J = 15.8 Hz, 1H), 4.47 (ddd, J = 9.2, 5.3, 3.7 Hz, 1H), 4.40 (d, J = 
15.1 Hz, 1H), 4.25 (d, J = 15.1 Hz, 1H), 4.00 (dd, J = 11.7, 3.6 Hz, 1H), 3.81 (dd, J = 9.5, 4.1 
Hz, 1H), 3.78 (s, 3H), 3.77 (s, 3H), 2.19-2.10 (m, 4H), 2.07-2.04 (m, 1H), 2.03-1.97 (m, 3H), 
1.93 (t, J = 7.0 Hz, 1H), 1.89 (s, 3H), 1.64 (t, J = 7.0 Hz, 1H), 1.38 (s, 3H), 0.46 (t, J = 7.2 Hz, 
3H); HRMS (EI) m/z 594.2212 [calc’d for C33H41BrNO4 (M+H)+ 594.2213]. 
Preparation of diene 380: 
 
Diene 380. Swern Oxidation: To a stirred solution of dimethylsulfoxide (0.8 mL, 11.24 
mmol) in dichloromethane (20 mL) was added oxalyl chloride (0.47 mL, 5.61 mmol) at –78 ºC. 
Reaction solution was stirred for 20 minutes and alcohol 257 (750 mg, 2.81 mmol) as a solution 
in dichloromethane (5 mL) dropwise via cannula. Reaction solution was stirred for 1 hour at –78 
ºC and then warmed to room temperature. TLC was used to monitor reaction progress. TLC 
plates were developed with 30% EtOAc/Hex; visualized by UV lamp and KMnO4 stain. 
Reaction solution was quenched with saturated NaHCO3 solution (50 mL) and phases were 




















Na2SO4 and concentrated to afford aldehyde 258 as yellow oil, which was immediately carried 
into the Wittig olefination. 
Ylide 351 preparation: To a stirred heterogeneous solution of phosphonium salt 390 (3.8 
g, 8.00 mmol) in toluene (50 mL) was added potassium bis(trimethylsilyl)amide (0.5 M in 
toluene, 12.8 mL, 6.4 mmol) at room temperature. Solution was stirred for 3 hours. Stirring was 
stopped and potassium iodide salts and excess phosphonium salt 390 were allowed to settle to 
the bottom of the round bottom flask to yield a homogenous, red/orange solution of ylide 351 
(0.1 M in toluene). 
Wittig olefination: To a stirred solution of ylide 351 (0.1 M in toluene, 57 mL, 5.62 
mmol) was added aldehyde 258 (2.81 mmol) as a solution in toluene (84 mL) dropwise via 
cannula at –78 ºC. Reaction was stirred and warmed to room temperature. TLC was used to 
monitor reaction progress. TLC plates were developed with 30% EtOAc/Hex; visualized by UV 
lamp and KMnO4 stain. Reaction was diluted with ethyl acetate (100 mL) and quenched with 
saturated NaHCO3 solution (100 mL) followed by separation of the phases. Aqueous phase was 
extracted with ethyl acetate (2 x 50 mL). Combined organic phase was washed with H2O (100 
mL) and brine (100 mL), dried over anhydrous MgSO4 and concentrated under reduced pressure. 
Crude material was purified with silica gel chromatography (eluent 15% EtOAc/Hex) to yield 
diene 380 (697 mg, 75% yield, over two steps, >20:1 Z:E) as colorless oil. 
Diene 380. FTIR (thin film/NaCl): 3074, 2932, 2836, 1730, 1640, 1612, 1585, 1512, 
1458, 1441, 1301, 1247, 1173, 1126, 1037, 995, 911, 823, 808, 410; 
1
H-NMR (400 MHz; 
CDCl3): δ 7.25 (d, J = 8.5 Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 5.80 (ddt, J = 17.0, 10.3, 6.7 Hz, 
1H), 5.56 (d, J = 4.5 Hz, 1H), 5.55 (d, J = 4.3 Hz, 1H), 5.00 (dq, J = 17.1, 1.7 Hz, 1H), 4.94 (dt, 
200 
J = 10.2, 0.9 Hz, 1H), 3.79 (s, 3H), 3.74 (s, 3H), 3.54 (d, J = 11.9 Hz, 1H), 3.48 (d, J = 11.9 Hz, 
1H), 2.29 (dd, J = 13.6, 5.8 Hz, 2H), 2.06 (q, J = 7.4 Hz, 2H), 1.93 (dq, J = 14.4, 7.2 Hz, 1H), 
1.83 (dt, J = 14.1, 7.1 Hz, 1H), 1.78 (br s, 1H), 1.45 (quintet, J = 7.6 Hz, 2H), 0.86 (t, J = 7.4 Hz, 
3H); 
13
C NMR (101 MHz; CDCl3): δ 176.1, 158.7, 138.8, 134.3, 132.9, 129.5, 129.0, 114.7, 
113.9, 66.5, 55.4, 52.1, 47.5, 33.7, 31.5, 29.0, 28.0, 8.4; HRMS (EI) m/z 332.2216 [calc’d for 
C20H29NO3 (M+H)+ 332.222]. 
Preparation of amide 381: 
 
Amide 381. To a stirred solution of amine 380 (1.3 g, 3.92 mmol), pyridine (1.6 mL, 
19.60 mmol), 4-(dimethylamino)pyridine (24 mg, 0.19 mmol) in dichloromethane (5 mL) was 
added propionyl chloride (1.4 mL, 15.68 mmol) at 0 ºC. Reaction was stirred 20 minutes at 0 ºC 
prior to warming to room temperature. Stirred 2 ½ days at room temperature.  TLC was used to 
monitor reaction progress. TLC plates were developed with 30% EtOAc/Hex; visualized by UV 
lamp and KMnO4 stain. Reaction solution was diluted with dichloromethane (5 mL) and 
quenched with saturated NaHCO3 solution (5 mL) followed by separation of the phases. 
Aqueous phase was extracted with dichloromethane (3 x 5 mL). Combined organic phase was 
washed with H2O (50 mL), brine (50 mL), dried over anhydrous MgSO4 and concentrated under 
reduced pressure. Crude material was purified with silica gel chromatography (gradient elution 



















H-NMR (300 MHz; CDCl3): δ 7.40 (d, J = 8.7 Hz, 2H), 6.91 (d, J = 8.7 Hz, 
2H), 5.76 (ddt, J = 17.0, 10.3, 6.7 Hz, 1H), 5.59 (d, J = 12.5 Hz, 1H), 5.38 (dt, J = 12.4, 7.1 Hz, 
1H), 5.02-4.92 (m, 2H), 4.64 (d, J = 18.2 Hz, 1H), 4.58 (d, J = 18.3 Hz, 1H), 3.79 (s, 3H), 3.74 
(s, 3H), 2.35-1.98 (m, 8H), 1.41 (quintet, J = 7.5 Hz, 2H), 1.02 (t, J = 7.4 Hz, 3H), 0.87 (t, J = 
7.5 Hz, 3H); HRMS (EI) m/z 388.2477[calc’d for C23H33NO4 (M+H)+ 388.2482]. 
Preparation of tetramic acid 379: 
 
Tetramic acid 379. Sodium hydride (60% in mineral oil) was washed with pentane (3 x 
2 mL) and dried under high vacuum. To a stirred heterogeneous solution of washed sodium 
hydride (75 mg, 1.83 mmol) in tetrahydrofuran (5 mL) was added amide 381 (177 mg, 0.46 
mmol) as a solution in tetrahydrofuran (5 mL) at 65 ºC down interior of condenser. TLC was 
used to monitor reaction progress. TLC plates were developed with 40% EtOAc/Hex; visualized 
by UV lamp and KMnO4 stain. After 24 hours reaction was cooled to room temperature and 
diluted with ethyl acetate (10 mL), quenched with saturated NH4Cl solution (10 mL) and phases 
were separated. Organic phase was washed with H2O (20 mL) and brine (20 mL), dried over 
anhydrous MgSO4 and concentrated under reduced pressure. Crude material was purified with 
silica gel chromatography (gradient elution 5101520% EtOAc/PhMe) to afford tetramic 















Tetramic acid 379. 
1
H-NMR (300 MHz; CDCl3): δ 7.32 (d, J = 8.7 Hz, 2H), 6.81 (d, J = 
8.7 Hz, 2H), 5.79-5.62 (m, 1H), 5.54 (dt, J = 11.6, 7.3 Hz, 1H), 5.25 (dt, J = 11.3, 1.9 Hz, 1H), 
5.02-4.90 (m, 3H), 3.99 (d, J = 14.6 Hz, 1H), 3.79 (s, 3H), 2.85 (q, J = 7.5 Hz, 1H), 1.97 (q, J = 
7.3 Hz, 4H), 1.74-1.50 (m, 4H), 1.37 (d, J = 7.5 Hz, 3H), 0.53 (t, J = 7.4 Hz, 3H); 7.34 (d, J = 8.8 
Hz, 2H), 6.81 (d, J = 9.2 Hz, 2H), 5.79-5.62 (m, 1H), 5.54 (dd, J = 14.6, 11.6 Hz, 1H), 5.18 (dt, J 
= 8.3, 1.9 Hz, 1H), 4.98-4.93 (m, 2H), 4.71 (d, J = 14.5 Hz, 1H), 4.20 (d, J = 14.7 Hz, 1H), 3.79 
(s, 3H), 2.95 (q, J = 7.7 Hz, 1H), 1.90-1.81 (m, 4H), 1.74-1.50 (m, 4H), 1.33 (d, J = 7.7 Hz, 3H), 
0.40 (t, J = 7.3 Hz, 3H); HRMS (EI) m/z 356.2215 [calc’d for C22H29NO3 (M+H)+ 356.222]. 
Preparation of triene 378: 
 
Triene 378. To a stirred solution of triphenylphosphine (504 mg, 1.92 mmol) in 
tetrahydrofuran (20 mL) was added diethyl azodicarboxylate (DEAD) (40% solution in toluene, 
0.80 mL, 1.92 mmol) and alcohol 366 (457 mg, 1.60 mmol) as a solution in tetrahydrofuran (6 
mL) and stirred for 10 minutes at room temperature. Tetramic acid 379 (570 mg, 1.60 mmol) 
was added as a solution in tetrahydrofuran (6 mL) and stirred at room temperature. TLC was 
used to monitor reaction progress. TLC plates were developed with a gradient elution 100% 
CH2Cl2  5% EtOAc/CH2Cl2; visualized by UV lamp and KMnO4 stain. Reaction solution was 
concentrated under reduced pressure and purified with silica gel chromatography (gradient 



















purified a second time with silica gel chromatography (gradient elution 100% CH2Cl2  5% 
EtOAc/ CH2Cl2) to afford triene 378 (211 mg, 21% yield). 
Triene 378. FTIR (thin film/NaCl): 2932, 1663, 1620, 1512, 1491, 1439, 1403, 1334, 
1303, 1244, 1035; 
1
H-NMR (400 MHz; CDCl3): δ 7.30 (d, J = 8.6 Hz, 2H), 7.09 (dd, J = 8.6, 0.7 
Hz, 1H), 7.09 (d, J = 2.7 Hz, 1H), 6.82 (dd, J = 8.7, 2.7 Hz, 1H), 6.77 (d, J = 8.7 Hz, 2H), 5.71 
(ddq, J = 17.0, 10.3, 6.8 Hz, 1H), 5.46 (dt, J = 11.5, 7.2 Hz, 1H), 5.10 (dd, J = 11.5, 3.0 Hz, 1H), 
4.98-4.88 (m, 4H), 4.67 (dd, J = 14.9, 4.9 Hz, 1H), 4.26-4.10 (m, 2H), 3.96 (dd, J = 14.9, 3.8 Hz, 
1H), 3.86 (t, J = 7.1 Hz, 1H), 3.78 (s, 3H), 3.77 (s, 3H), 2.17 (dq, J = 13.9, 6.8 Hz, 1H), 2.02-
1.89 (m, 2H), 1.92 (d, J = 2.7 Hz, 3H), 1.84-1.66 (m, 2H), 1.58 (d, J = 2.9 Hz, 3H), 1.60-1.52 (m, 
2H), 1.35-1.22 (m, 3H), 0.27-0.23 (m, 3H); 
13
C NMR (101 MHz; CDCl3): δ 173.5, 167.7, 
158.77, 158.69, 146.2, 136.5, 133.7, 131.2, 130.5, 128.7, 128.1, 125.7, 117.9, 114.8, 114.3, 
113.5, 111.2, 102.3, 69.1, 67.8, 55.7, 55.4, 45.87, 45.78, 42.8, 34.10, 34.02, 33.57, 33.54, 29.9, 
28.68, 28.66, 26.92, 26.89, 22.01, 21.87, 8.68, 8.66, 6.65, 6.62; HRMS (EI) m/z 646.2332 [calc’d 
for C35H44BrNO4 (M+Na)+ 621.2454]. 
Preparation of diene 370 and dimer 382: 
 
204 
Diene 370 and dimer 382. Toluene was pulled fresh from solvent still and degassed 
prior to use by sparging with nitrogen for 2 hours. To a round bottom flask was added toluene 
(30 mL) followed by the addition of triene 378 (20 mg, 0.032 mmol) as a solution in toluene (1.8 
mL); the substrate solution was heated to 80 ºC and catalyst 331 (4 mg, 0.0064 mmol, 20 mol%) 
was added as a solution in toluene (1 mL). TLC was used to monitor reaction progress. TLC 
plates were developed with a gradient elution 40% EtOAc/Hex; visualized by UV lamp and 
KMnO4 stain. After 2 hours at 80 ºC starting material remained by TLC. Reaction was heated to 
reflux (110 ºC) and catalyst 331 (an additional 40 mol%, 12 mg, 0.021 mmol) as a solution in 
toluene (3 mL) was added. Stirring at reflux was continued for 15 hours. Reaction solution was 
cooled to room temperature and concentrated under reduced pressure. Residue was purified by 
silica gel chromatography (gradient elution 2040% EtOAc/Hex) to afford recovered starting 




H-NMR (300 MHz; CDCl3): δ 7.29 (d, J = 8.3 Hz, 4H), 7.10-7.07 (m, 4H), 
6.82 (dd, J = 8.6, 2.2 Hz, 2H), 6.77 (d, J = 8.7 Hz, 4H), 5.48-5.42 (m, 2H), 5.30-5.23 (m, 2H), 
5.12-5.06 (m, 2H), 4.92-4.90 (m, 2H), 4.88-4.86 (m, 2H), 4.72-4.65 (m, 2H), 4.25-4.08 (m, 4H), 
3.94-3.88 (m, 2H), 3.87-3.83 (m, 2H), 3.77 (s, 12H), 2.20-2.09 (m, 2H), 1.91 (s, 6H), 2.01-1.67 
(m, 12H), 1.57 (s, 6H), 1.57-1.43 (m, 4H), 1.27-1.20 (m, 6H), 0.23 (t, J = 6.8 Hz, 6H); HRMS 
(EI) m/z 1215.4666 [calc’d for C68H84N2O8 (M+H)+ 1215.4667]. 
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Chapter 5  
An Indanone Coupling Partner 
5.1 Fifth-Generation Retrosynthetic Analysis 
As outlined in Scheme 5.1, our fifth-generation retrosynthetic analysis of tetrapetalone A 
(1) envisaged completion of the natural product via a glycosylation and decarboxylation 
sequence of aglycon 391, which was envisioned as deriving from a Dieckmann condensation 
applied to amide 393 and phenolic oxidation to install the C(15)-hydroxyl group. Benzazepine 
393 would be achieved upon application of ring closing metathesis to diene 394 derived from 
acylation of amine 396. Construction of the C–N bond of diene 394 conceived to be 
accomplished by an intermolecular aryl amination between indanol 397 and the appropriately 
functionalized amine 398 or 399. With a synthetic route in hand to prepare amine 398 and 
knowledge that amine 399 had been prepared previously
91,92
; we focused our synthetic endeavors 
on the synthesis of an indanol coupling partner. 
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Scheme 5.1 Fifth-Generation Retrosynthetic Analysis 
5.1.2 An Indanol Coupling Partner - Retrosynthetic Analysis 
Inspired by the work of Snyder and coworkers
93
, the synthesis of indanol 397 was seen as 
proceeding via protection of a secondary alcohol (400) that was in turn envisioned as arising 
from the addition of water to benzylic carbocation 401 (Scheme 5.2). Construction of the 
C(7)-C(8) bond of 401 via a cationic cyclization involving intermediate alkene 402, would be 
initiated upon ionization of benzylic alcohol 403. The requisite benzylic alcohol 403 would be 




























































































(398) R = CH2CH3





Scheme 5.2 Retrosynthetic Analysis of Indanol Coupling Partner 
5.2 Looking into a Cation-Based Cyclization 
5.2.1 Synthesis of a Cyclization Substrate 
Electrophilic aromatic bromination of commercially available 
3,5-dimethoxybenzaldehyde (405) furnished aryl bromide 406 in low yield (32%) (Scheme 5.3). 
Wittig olefination was employed to furnish alkene 407 in good yield (70%) as a 1:1 mixture of 
olefin isomers. Lithium-halogen exchange followed by trapping of the resultant aryl anion 408 
with methacrolein provided the desired benzylic alcohol 409, although in low yield (38%) 




































Scheme 5.3 Synthesis of a Cyclization Precursor 
5.2.2 Acid Catalyzed Cyclization 
In a productive scenario, acid mediated ionization of benzylic alcohol 409 would furnish 
carbocation 410 subsequent 5-exo-trig cyclization, favored in accordance with Baldwin’s rules, 
would provide indane 411 concomitant addition of water would afford desired indanol 412 
(Scheme 5.4). 
 
Scheme 5.4 Proposed Cationic Cyclization 
Following the cationic cyclization procedure of Snyder et al.,
93
 benzylic alcohol 409 was 
exposed to trifluoroacetic acid and slowly warmed to room temperature, unfortunately the 
































































Acid mediated ionization of benzylic alcohol 409 affords carbocation 410, which is subsequently 
trapped in a 6-endo-trig cyclization, favored in accordance with Baldwin’s rules, to afford 
secondary carbocation 414, which would undergo a facile 1,2-hydride shift and aromatization 
sequence to furnish naphthalene 413 (Scheme 5.6).  
 
Scheme 5.5 Acid Mediated Cyclization 
 
Scheme 5.6 Proposed Mechanism for Naphthalene Formation 
5.3 An Alternative Cyclization Strategy 
In order to selectively construct the C(7)–C(8) bond by a cyclization strategy, we turned 
our attention to the indanone 416, which upon reduction would provide direct access to the 
desired indanol coupling partner 397 (Scheme 5.7). We envisaged accessing indanone 416 via 
SN2’ cyclization of enolate 417 which would derive from ketone 418, a substrate which appeared 






















































Scheme 5.7 Revised Retrosynthetic Analysis of Indanol Coupling Partner 
5.4 Investigation of a Model System 
In order to investigate the desired cyclization in an expedient fashion, we opted to start 
with the previously synthesized aryl bromide 294, lacking only a halogen from our desired 
system. En route to cyclization substrate 424, aryl bromide 294 was subjected to lithium-halogen 
exchange followed by trapping of the resultant aryl anion with propionaldehyde to furnish 
benzylic alcohol 420 proceeded in moderate yield (64%.). Subsequent exposure of 420 to 
manganese dioxide oxidation proved to be slow but effectively provided access to ketone 421. 
Tetrabutylammonium fluoride mediated silyl ether cleavage unveiled allylic alcohol 422 which 
was acylated with methyl chloroformate to provide allylic carbonate 423 in modest yield (41%), 
over two steps. Lithium bis(trimethylsilyl)amide mediated enolization of ketone 423 in the 
presence of trimethylsilyl chloride furnished silyl enol ether 424 in excellent yield (98%) as 



































Scheme 5.8 Synthesis of Cyclization Precursor 
5.4.1 Lewis Acid Mediated Cyclization 
Silyl enol ethers have proven to be extraordinarily versatile substrates for a wide variety 
of synthetic reactions, including aldol reaction, Michael reactions, [4+2] cycloaddition reactions, 
alkylations, acylations, oxidative processes, etc.
94
 The Lewis acid catalyzed reactions of silyl 
enol ethers with electrophiles are an extremely important application of silyl enol ethers in 
organic chemistry. Under the influence of Lewis acids, silyl enol ethers react not only with 
carbonyl compounds, such as aldehydes and ketones, but also acetals, orthoesters, azomethine 
functions, and -halo ethers and sulfides. It is known that allylic bromides, chloromethyl methyl 
ether, and allylic acetates react with silyl enol ethers in the presence of Lewis acids.
95-97
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In a productive cyclization, we envisioned that activation of the allylic carbonate 425 via 
Lewis acid coordination would facilitate the intramolecular SN2’ displacement by the silyl enol 
ether to construct the desired carbon-carbon bond of indanone 427 (Scheme 5.9). One could also 
conceive concomitant aryl methyl ether cleavage under the reaction conditions to effectively 
afford phenol 428 in a one-pot procedure. 
 
Scheme 5.9 Proposed Mechanism for Lewis Acid Facilitated Cyclization 
With cyclization precursor 424 on hand we were excited to investigate a Lewis acid 
facilitated cyclization. Gratifyingly, exposure of allylic carbonate 424 to boron tribromide 
afforded the desired indanone 427 as a single diastereomer, albeit in modest yield (59%) 
(Scheme 5.10). We were very excited by this result as it proved we could construct the requisite 
carbon-carbon bond to furnish an indanone core and that upon optimization of the reaction 









































Scheme 5.10 Lewis Acid Facilitated Cyclization 
5.4.2 Tsuji-Trost Allylic Alkylation 
Metal-catalyzed asymmetric allylic substitution, which involves the attack of diverse 
nucleophiles at an allylic metal intermediate or SN2’-type allylic substitutions, has been 
investigated with great intensity. The benefits of this method include high levels of asymmetric 
induction, tolerance of a wide range of functional groups and a great flexibility in the type of 
bonds that can be formed. For example, H-, C-, N-, O- and S-centered nucleophiles can be 
employed. Many ligands have been designed for the benchmark allylic alkylation of 
diphenylallyl acetate with malonate.
99-108
 
In effort to pursue an enantio- and diastereoselective indanone synthesis we decided to 
investigate an intramolecular Tsuji-Trost allylic alkylation. Under neutral reaction conditions we 
envisioned cyclization to proceed via oxidative addition of allyl carbonate 424 to palladium(0) to 
provide -allylpalladium carbonate 429, which upon subsequent decarboxylation would afford 
-allylpalladium methoxide 430 (Scheme 5.11). Concomitant carbon-carbon bond formation and 
silyl enol ether cleavage would furnish indanone 427 along with an equivalent of methoxysilane 

















Scheme 5.11 Proposed Intramolecular Tsuji-Trost Allylic Alkylation 
Indeed exposure of allylic carbonate 424 to Tsuji’s neutral reaction conditions
109,110
 based 
on a catalytic system derived from palladium tris(dibenzylideneacetone)dipalladium(0) and 
ethylenebis(diphenylphosphine) (Diphos) afforded the desired indanone in excellent yield (80%), 
as essentially a single diastereomer (Scheme 5.12). Successful cyclization to afford model 
indanone 427 prompted us to investigate a system that possessed a handle on the aromatic core 




























Scheme 5.12 Intramolecular Tsuji-Trost Allylic Alkylation 
5.5 Synthesis of a Highly Functionalized Cyclization Precursor 
Silylation of commercially available 3-bromo-5-chlorophenol (431) provided TIPS-ether 
432, which underwent ortho-lithiation upon exposure to lithium diisopropylamide (LDA) 
subsequent trapping of the resultant aryl anion with N,N-dimethylformamide followed by 
hydrolysis afforded aldehyde 433 in excellent yield (96%) yield over two steps.
111,112
 
Methylation followed by Horner Wadsorth Emmons olefination furnished -unsaturated ester 
435 in high yield (93%), as a single olefin isomer (>20:1 E/Z), over two steps. 
Diisobutylaluminum hydride mediated reduction furnished allylic alcohol 436, silylation 
provided TBS-ether 437 in excellent yield (94%), over two steps. Chemoselective 
lithium-bromine exchange and subsequent trapping of the resultant aryl anion with 
propionaldehyde provided benzylic alcohol 438 in high yield (84%). Swern oxidation afforded 
ketone 439, subsequent tetrabutylammonium fluoride mediated silyl ether cleavage unveiled 
allylic alcohol 440 in high yield (80%), over two steps. Acylation of the allylic alcohol smoothly 
furnished allylic carbonate 442 in 86% yield. Lithium bis(trimethylsilyl)amide mediated 
enolization in the presence of trimethylsilyl chloride afforded the desired silyl enol ether 442 in 
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Scheme 5.13 Synthesis of Highly Functionalized Cyclization Precursor 
5.5.1 Intramolecular Tsuji-Trost Allylic Alkylation 
With the successful application of a Tsuji-Trost allylic alkylation to model system 424 
(Scheme 5.12), we were excited to probe the reactivity of 442 in such a reaction. To our dismay 










i. LDA, THF, –78 ºC
ii. DMF, –78 ºC
(99% yield)











MeMgBr, THF, 70 ºC
(93% yield, >20:1 E/Z;




























i. nBuLi, THF, –78 ºC
ii. propionaldehyde
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precursor 424 resulted in a 1:1 mixture of starting material (442) and ketone 441. Switching the 
reaction solvent to 1,4-dioxane and increasing the reaction temperature (entries 2 and 3, Table 
5.1) proved successful and afforded the desired indanone 443, albeit in low yield (23%) yield; as 
a mixture of diastereomers (5:1 dr). Observing that an increase in reaction temperature proved to 
be successful with substrate 442 we decided it would be beneficial to run the reaction in a higher 
boiling solvent. An initial solvent screen proved futile; toluene (entry 4) provided a mixture of 
starting material 442 and ketone 441 and N,N-dimethylformamide (entry 5) resulted in complete 
conversion to ketone 441.  
Table 5.1 Effect of Solvent on the Palladium(0)-Catalyzed Reaction 
 
The relative stereochemistry of indanones 427 and 443 was inferred from 
1
H NMR 
spectroscopy via chemical shift and splitting pattern comparisons with the indanone 85 reported 
by Sarpong and coworkers (Table 5.2).
113




























21 443 (24%, 5:1 dr)b
4 100 18 442 : 441 mixtureaPhMe
aReaction analyzed by 1H NMR.
bIsolated yield.
5 100 15 441 (100%)aDMF
2 1,4-dioxane 80 19 443 (23%, 5:1 dr)b
+
1 65 24 442 (50%): 441 (50%)aTHF
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palladium(0)-catalyzed cyclization provides the desired relative stereochemistry, corresponding 
to that of Tetrapetalone A (1), as the major diastereomer. 
Table 5.2 Chemical Shift and Splitting Pattern Comparison 
 
5.5.2 Intramolecular Tsuji-Trost Allylic Alkylation – Ketone Substrate 
Our initial investigations into a palladium(0)-catalyzed cyclization furnished the desired 
indanone in low yield; however, since the latter is the result of undesired silyl ether hydrolysis 
and not starting material decomposition we decided to probe an allylic alkylation as applied 
directly to ketone 441. Hou and coworkers have demonstrated the intermolecular 
palladium(0)-catalyzed allylic alkylation of ketone enolates with monosubstituted allyl substrates 
to proceed with high regio-, diastereo-, and enantioselectivity.
114
 Our initial investigation in the 
reaction of ketone 441 using lithium bis(trimethylsilyl)amide as base and lithium chloride as a 
stoichiometric additive in the presence of Pd2(dba)3 and Diphos failed to provide 443 instead we 
observed the formation of furan 444 in 78% yield (entry 1, Table 5.2). In an attempt to promote 




























(d, J = 8.0 Hz)
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(dq, J = 7.5 Hz, 3.0 Hz)
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(d, J = 7.7 Hz)
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(d, J = 3.1 Hz)
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syn- 85 trans- 85
3c 3.44
(d, J = 4.3 Hz)
2.45
(dq, J = 7.3 Hz, 4.3 Hz)
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bis(trimethylsilyl)amide (entries 2 and 3, Table 5.2) were employed as base in the reaction of 
ketone 441, with both bases complete conversion to furan 444 was observed. 
Table 5.3 Pd-Catalyzed Reaction of Ketone with Strong Base 
 
Interestingly when a reversible base was employed in the reaction of ketone 441 we 
observed only products resulting from C-alkylation (Scheme 5.14). Exposure of ketone 441 to 
cesium carbonate in the presence of Pd(dba)2 and Diphos afforded a complex mixture of 
products, that consisted of indanone 443, ketone 445, enone 446, and tricycle 447.  
 











































































5.6 Successful Aryl Amination with Indanone Coupling Partner 
With indanone 443 on hand we were eager to investigate the feasibility of conducting a 
palladium-catalyzed aryl amination on such an elaborated aryl chloride 443. To this end an initial 
exploration proved successful exposure of aryl chloride 443 to a palladium(0)-catalyst derived 
from BrettPhos (286) and BrettPhos precatalyst (287) furnished aryl amine 444 in 12% yield, the 
mass balance of the reaction appears to be indanone 427. The successful coupling, albeit with 
much room for improvement, provides confidence that this synthetic route has promise. 
 
Scheme 5.15 Pd-Catalyzed Aryl Amination 
5.7 Conclusion 
Although still in its infancy, forward progress following the fifth-generation 
retrosynthetic analysis (Scheme 5.1) has thus far proven to be the most successful. Critically 
important to decisions to pursue this route further is the direct and high yielding route leading to 
a highly functionalized cyclization precursor. Initial investigations into a palladium-catalyzed 
cyclization have proved fruitful, furnishing the desired indanone in low yield; however, since the 
latter is the result of undesired silyl ether hydrolysis and not starting material decomposition, 
there is much room for reaction development and optimization. With the advanced aryl chloride 
we were able to conduct an exploratory aryl amination and to our delight found that we could 













BrettPhos (286) (5 mol%)
BrettPhos Precat. (287)(5 mol%)
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couple a functionalized primary amine with an indanone or indanol coupling partner. As the 
remainder of the material recovered did not posses the aryl chloride, this suggests that there is a 
path for reaction optimization.  
 
 223 
5.8 Experimental Section 
5.8.1 Materials and Methods 
Unless stated otherwise, reactions were performed in flame-dried glassware under a 
nitrogen atmosphere. Triethylamine, diisopropylamine, and methanol were dried over anhydrous 
calcium hydride and freshly distilled. 1,4-Dioxane was distilled from sodium, calcium chloride 
and molecular sieve (0.4 nm). Benzene, tetrahydrofuran, dichloromethane, toluene, and diethyl 
ether were dried using a solvent purification system manufactured by Glass Contour Solvent 
Systems, SG Water U.S.A., LLC using technology based upon that originally described by 
Grubbs et al.
115
 Anhydrous N,N-dimethyformamide, acetonitrile, dimethylsulfoxide, 1,2-
dichloroethane was purchased from the Colorado State University Stockroom and supplied by 
Sigma-Aldrich or Fischer Scientific and stored under nitrogen atmosphere. Commercially 
available reagents were obtained from Sigma-Aldrich, Strem, TCI, Combi-Blocks, Acros or 
Alfa-Aesar and were used as received. All known compounds were identified by comparison of 
NMR spectra to reported in the literature. 
Unless otherwise stated, all reactions were monitored by thin layer chromatography 
(TLC) was using Silicycle glass-backed extra hard layer, 60 Å plates (indicator F-254, 250 m). 
Developed TLC plates were visualized using a 254 nm UV lamp and/or with the appropriate 
stain followed by heating. Typical stains utilized were potassium permanganate, ethanolic 
anisaldehyde and ceric ammonium molybdate. In general, the flash chromatography guidelines 
reported by Still et al
116
 were followed. Silicycle SiliaFlash
® 
 P60 (230-400 mesh) silica gel as 
the stationary phase. When reactions were absorbed onto silica gel, the amount of silica gel used 
was equal to two times the weight of the reagents. 
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Infrared spectra were obtained using a Nicolet Avatar 320 FTIR or Bruker Tensor27 
FTIR. Samples were analyzed as thin films on NaCl plates (samples was dissolved in CH2Cl2 or 





H) and carbon (
13
C) NMR spectra were recorded on a Varian Inova 
500, Varian Inova 400, Varian Inova 400 auto sampler, or Varian Inova 300 MHz spectrometer. 
Spectra were obtained at 22 °C in CDCl3 unless otherwise noted. Chemical shifts () are reported 
in parts per million (ppm) and are referenced to the internal solvent peak. Coupling constants (J) 
are reported in Hertz (Hz) and are rounded to the nearest 0.1 Hz. Multiplicities are defined as: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, dd = doublet of doublets, dt = doublet 
of triplets, ddd = doublet of doublet of doublets, dddd = doublet of doublet of doublet of 
doublets, br = broad, app = apparent, par = partial. High-resolution mass spectra were obtained 
from the University of Colorado Central Instrument Facility, performed on an Agilent 6210 TOF 
LCMS by Donald L. Dick.  
5.8.2 Preparative Procedures 
Preparation of aryl bromide 406: 
  
Aryl bromide 406. Following the procedure of Scheidt et al.
117
 2,3-
Dimethoxybenzaldehyde (405) (100 mg, 0.60 mmol) was added to a vial fitted with a magnetic 
stir bar and dissolved in acetic acid (0.5 mL). The resulting colorless solution was cooled to 0 ºC. 
A solution of bromine (32 L, 0.63 mmol) in acetic acid (0.5 mL) was added dropwise at 0 ºC. 













reaction had solidified and water (2 mL) was added. The solid was collected by vacuum filtration 
and rinsed with water. The solid was then dissolved in dichloromethane (5 mL) and washed with 
saturated NaHCO3 (5 mL). The phases were separated and the aqueous phase was extracted with 
dichloromethane (2 x 5 mL). Combined organic phase was dried over anhydrous Na2SO4 and 
concentrated under reduced pressure to yield a white solid composed of both mono- and 
dibrominated aldehydes. A small amount of ethyl acetate was added to the solid. After standing 
at 5 ºC, a white solid (the dibrominated aldehyde) had precipitated. The solid was separated from 
the liquid by vacuum filtration and the filtrate was concentrated to yield the monobrominated 
aldehyde 406 (50 mg, 32% yield) as white solid. 
Aryl bromide 406. FTIR (thin film/NaCl): 3008, 2970, 2941, 1678, 1590, 1450, 1430, 
1391, 1290, 1222, 1199, 1182, 1160, 1075, 1021; 
1
H-NMR (400 MHz; CDCl3): δ 10.42 (s, 1H), 
7.05 (d, J = 2.8 Hz, 1H), 6.72 (d, J = 2.8 Hz, 1H), 3.92 (s, 3H), 3.85 (s, 3H); 
13
C-NMR (101 




Preparation of alkene 407: 
  
Alkene 407. Following the procedure of Merlic et al.
118
 To an oven dried vial fitted with 
a magnetic stir bar was added sodium hydride (60% in mineral oil, 10 mg, 0.24 mmol) and 
tetrahydrofuran (1 mL), followed by the addition of ethyl triphenylphosphonium bromide (92 
mg, 0.25 mmol) at room temperature. Solution was stirred for 15 minutes and aldehyde 406 (47 














was used to monitor reaction progress. TLC plates were developed with 10% EtOAc/Hex and 
visualized by UV lamp and KMnO4 stain. Reaction was complete after 5 hours. Quenched 
reaction with saturated NH4Cl solution (2 mL) and diluted with ethyl acetate (2 mL). Phases 
were separated. Organic phase was washed with H2O (3 mL), brine (3 mL), dried over anhydrous 
Na2SO4 and absorbed directly onto silica gel (150 mg) under reduced pressure. Purified with 
silica gel chromatography (25:1 silica/crude material, gradient elution 25% EtOAc/Hex) to 
afford alkene 407 (34.3 mg, 70% yield, 1:1 Z/E) as colorless oil. 
Alkene 407. 
1
H-NMR (400 MHz; CDCl3): δ 6.79 (dd, J = 15.6, 1.7 Hz, 1H), 6.64 (d, J = 
2.7 Hz, 1H), 6.47 (td, J = 5.7, 2.2 Hz, 2H), 6.41 (d, J = 2.7 Hz, 1H), 6.38 (d, J = 2.7 Hz, 1H), 
6.18 (dq, J = 15.6, 6.7 Hz, 1H), 5.87 (dq, J = 11.5, 7.0 Hz, 1H), 3.88 (s, 3H), 3.86 (s, 3H), 3.82 
(s, 3H), 3.81 (s, 3H), 1.93 (dd, J = 6.7, 1.7 Hz, 3H), 1.78 (dd, J = 7.1, 1.8 Hz, 3H); 
13
C-NMR 
(101 MHz; CDCl3): δ 159.6, 159.2, 156.9, 139.5, 139.3, 130.5, 130.0, 129.2, 128.2, 107.3, 104.5, 
104.1, 103.1, 98.6, 98.3, 56.5, 55.70, 55.66, 18.8, 14.6. 
Preparation of alcohol 409: 
 
Alcohol 409. Following the procedure of Snyder et al.
93
 To an oven dried vial fitted with 
a magnetic stir bar was added aryl bromide 407 (34 mg, 0.13 mmol) and tetrahydrofuran (2 mL), 
solution was cooled to –78 ºC and n-butyllithium (2.1 M in THF, 70 L, 0.14 mmol) was added 
dropwise resulting in a yellow reaction solution; reaction was stirred for 20 minutes at –78 ºC. 
Methacrolein (21 L, 0.26) as a tetrahydrofuran (1 mL) solution was added dropwise at –78 ºC 














   THF, –78 ºC
ii.THF, –78 ºC ® rt
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night. TLC was used to monitor reaction progress. TLC plates were developed with 10% 
EtOAc/Hex and visualized by UV lamp and KMnO4 stain. Quenched with saturated NH4Cl 
solution (3 mL) at room temperature. Phases were separated. Organic phase was washed with 
H2O (3 mL) and brine (3 mL), dried over anhydrous Na2SO4 and absorbed directly silica gel 
(100 mg). Purified with silica gel chromatography (25:1 silica/crude material, gradient elution 
25101520% EtOAc/Hex) to afford alcohol 409 (12.2 mg, 38% yield) as colorless oil. 
Alcohol 409 (1:1 Z/E). 
1
H-NMR (400 MHz; CDCl3): δ 6.68 (dd, J = 15.5, 1.3 Hz, 1H), 
6.52 (d, J = 2.4 Hz, 1H), 6.50 (d, J = 12.0 Hz, 1H), 6.41 (d, J = 2.3 Hz, 1H), 6.39 (d, J = 2.3 Hz, 
1H), 6.32 (d, J = 2.2 Hz, 1H), 6.01 (dq, J = 15.4, 6.6 Hz, 1H), 5.83 (dq, J = 11.4, 6.9 Hz, 1H), 
5.39 (d, J = 10.1 Hz, 1H), 5.24 (d, J = 11.1 Hz, 1H), 4.86 (d, J = 0.3 Hz, 2H), 4.83 (d, J = 0.8 Hz, 
1H), 3.81 (s, 3H), 3.80 (s, 3H), 3.80 (s, 3H), 3.79 (s, 3H), 3.67 (d, J = 11.1 Hz, 1H), 3.54 (d, J = 
10.2 Hz, 1H), 1.86 (dd, J = 6.6, 1.6 Hz, 3H), 1.70 (s, 6H), 1.69-1.67 (m, 3H). 
Preparation of naphthalene 413: 
  
Naphthalene 413. To an oven dried vial fitted with a magnetic stir bar was added alcohol 
409 (12 mg, 0.04 mmol) and dichloromethane (3 mL), solution was cooled to –78 ºC and 
trifluoroacetic acid was added as a single portion. Reaction solution was slowly warmed to room 
temperature. TLC was used to monitor reaction progress. TLC plates were developed with 10% 
EtOAc/Hex and visualized by UV lamp and KMnO4 stain. After 1 hour at room temperature the 
reaction was quenched with potassium carbonate (small scoop), methanol (3 mL) and stirred at 















dissolved in ethyl acetate (5 mL). Organic phase was washed with H2O (2 mL), brine (2 mL), 
dried over anhydrous Na2SO4 and concentrated under reduced pressure. Crude material was 
purified with silica gel chromatography (eluent 15% EtOAc/Hex) to afford naphthalene 413 (1.2 
mg, 13% yield).  
Naphthalene 413. 
1
H-NMR (400 MHz; CDCl3): δ 7.83 (s, 1H), 7.17 (s, 1H), 6.85 (d, J = 
2.0 Hz, 1H), 6.50 (d, J = 2.1 Hz, 1H), 3.96 (s, 3H), 3.92 (s, 3H), 3.00 (q, J = 7.5 Hz, 2H), 2.46 (s, 
3H), 1.37 (t, J = 7.5 Hz, 3H); 
13
C-NMR (101 MHz; CDCl3): δ 157.5, 156.8, 138.6, 132.2, 131.5, 
128.4, 122.2, 119.3, 97.3, 94.6, 55.7, 55.4, 26.5, 21.8, 14.8; HRMS (EI) m/z 231.1377 [calc’d for 
C15H18O2 (M+H)+ 231.138]. 
Preparation of alcohol 420: 
 
Alcohol 420. To an oven-dried round bottom flask was added aryl bromide 294 (500 mg, 
1.34 mmol) and tetrahydrofuran (10 mL), solution was cooled to –78 ºC and n-butyllithium (1.6 
M in hexanes, 0.92 mL, 1.47 mmol) was added over 10 minutes via syringe pump. Stirred 1 hour 
at –78 ºC. Propionaldehyde (0.2 mL, 2.68 mmol) as a solution in tetrahydrofuran (2 mL) was 
added in one portion, stirred at –78 ºC for 1 hour and warmed to room temperature. TLC was 
used to monitor reaction progress. TLC plates were developed with 10% EtOAc/Hex and 
visualized by UV lamp and KMnO4 stain. Quenched reaction with saturated NH4Cl solution (20 
mL). Phases were separated. Organic phase was washed with H2O (20 mL), brine (20 mL), dried 






i. nBuLi, THF, –78 ºC
ii. propionaldehyde








pressure. Purified with silica gel chromatography (gradient elution 1050 EtOAc/Hex) to afford 
alcohol 420 (300 mg, 64% yield) as colorless oil. 
Alcohol 420. 
1
H-NMR (400 MHz; CDCl3): δ 7.07 (d, J = 3.3 Hz, 1H), 7.06 (d, J = 9.5 
Hz, 1H), 6.78 (dd, J = 8.4, 2.7 Hz, 1H), 6.52 (s, 1H), 4.79 (td, J = 6.3, 2.5 Hz, 1H), 4.18 (s, 2H), 
3.83 (s, 3H), 1.76 (s, 1H), 1.69 (dt, J = 14.4, 7.3 Hz, 2H), 1.64 (s, 3H), 0.95 (s, 9H), 0.89 (t, J = 
8.0 Hz, 3H), 0.12 (s, 6H); 
13
C NMR (101 MHz; CDCl3): δ 158.8, 144.7, 138.1, 131.0, 128.1, 
121.2, 112.5, 110.5, 72.5, 68.0, 55.4, 31.2, 27.1, 26.1, 18.6, 15.0, 10.4, -3.1, -5.1; HRMS (EI) 
m/z 373.2171 [calc’d for C20H34O3Si (M+Na)+ 373.2169]. 
Preparation of ketone 421: 
 
Ketone 421. To a round bottom flask fitted with a magnetic stir bar was added alcohol 
420 (280 mg, 0.80 mmol), dichloromethane (16 mL) and manganese dioxide (1.1 g, 12.00 
mmol). Round bottom flask was fitted with a condenser and reaction was refluxed (40 ºC). TLC 
was used to monitor reaction progress. TLC plates were developed with 10% EtOAc/Hex and 
visualized by UV lamp and KMnO4 stain. After 24 hours starting material remained by TLC but 
reaction worked up. Cooled reaction solution to room temperature and filtered through a 
sand/celite pad. Filtrate was absorbed directly on to silica gel (300 mg) under reduced pressure. 
Purified with silica gel chromatography (50:1 silica/crude material, gradient elution 510% 


















H-NMR (400 MHz; CDCl3): δ 7.16 (d, J = 8.5 Hz, 1H), 7.06 (d, J = 2.4 Hz, 
1H), 6.96 (dd, J = 8.4, 2.2 Hz, 1H), 6.62 (s, 1H), 4.17 (s, 2H), 3.83 (s, 3H), 2.81 (q, J = 7.3 Hz, 
2H), 1.63 (s, 3H), 1.12 (t, J = 7.3 Hz, 3H), 0.93 (s, 9H), 0.11 (s, 6H); 
13
C-NMR (101 MHz; 
CDCl3): δ 206.3, 192.1, 158.2, 140.9, 138.2, 131.9, 131.1, 129.0, 122.5, 116.4, 112.7, 68.2, 55.6, 
35.9, 31.1, 27.1, 26.1, 18.5, 15.0, 8.6, -2.4, -5.2; HRMS (EI) m/z 371.2013 [calc’d for 
C20H32O3Si (M+Na)+ 371.2013]. 
Preparation of allylic alcohol 422: 
 
Allylic Alcohol 422. To a vial was added TBS-ether 421 (81 mg, 0.23 mmol), 
tetrahydrofuran (2 mL); solution was cooled to 0 ºC and tetrabutylammonium fluoride was added 
(1 M in THF, 0.35 mL, 0.35 mmol). Stirred at 0 ºC for 10 minutes and warmed to room 
temperature. TLC was used to monitor reaction progress. TLC plates were developed with 50% 
EtOAc/Hex and visualized by UV lamp and KMnO4 stain. After 3 hours reaction was complete. 
Quenched with saturated NH4Cl solution (2 mL) and separated phases. Organic phase was dried 
over anhydrous Na2SO4 and concentrated under reduced pressure. Crude material was purified 
with silica gel chromatography (gradient elution 2550% EtOAc/Hex) to afford alcohol 422 (28 
mg, 52% yield) as yellow oil. 
Allylic Alcohol 422. 
1
H-NMR (400 MHz; CDCl3): δ 7.18 (d, J = 8.5 Hz, 1H), 7.13 (d, J 
= 2.6 Hz, 1H), 6.98 (dd, J = 8.5, 2.6 Hz, 1H), 6.65 (s, 1H), 4.19 (d, J = 5.5 Hz, 2H), 3.84 (s, 3H), 
















C-NMR (101 MHz; CDCl3): δ 205.4, 158.3, 140.0, 137.6, 132.1, 129.0, 124.3, 116.4, 113.6, 
68.7, 55.6, 35.3, 15.2, 8.6. 
Preparation of allylic carbonate 423: 
 
Allylic carbonate 423. To a stirred solution of allylic alcohol 422 (23 mg, 0.10 mmol), 
pyridine (16 L, 0.20 mmol) and 4-(dimethylamino)pyridine (cat., flake) in dichloromethane (2 
mL) at 0 ºC was added methyl chloroformate (12 L, 0.15 mmol). Reaction solution was 
warmed to room temperature. TLC was used to monitor reaction progress. TLC plates were 
developed with 25% EtOAc/Hex and visualized by UV lamp and KMnO4 stain. Quenched with 
saturated NaHCO3 solution (2 mL) and phases were separated. Organic phase was washed with 
H2O (2 mL), brine (2 mL), dried over anhydrous Na2SO4 and concentrated under reduced 
pressure. Crude material was purified with silica gel chromatography (eluent 25% EtOAc/Hex) 
to afford allylic carbonate 423 (23 mg, 17% yield) as colorless oil. 
Allylic carbonate 423. 
1
H-NMR (400 MHz; CDCl3): δ 7.17 (d, J = 8.5 Hz, 1H), 7.13 (d, 
J = 2.7 Hz, 1H), 6.98 (dd, J = 8.5, 2.7 Hz, 1H), 6.70 (s, 1H), 4.70 (d, J = 1.0 Hz, 2H), 3.84 (s, 
3H), 3.81 (s, 3H), 2.83 (q, J = 7.3 Hz, 2H), 1.72 (d, J = 1.4 Hz, 3H), 1.14 (t, J = 7.3 Hz, 3H); 
13
C 
NMR (101 MHz; CDCl3): δ 205.0, 191.2, 158.4, 155.7, 139.9, 132.1, 131.8, 128.0, 116.2, 113.4, 
















Preparation of silyl enol ether 424: 
 
Silyl enol ether 424. To a solution of lithium bis(trimethylsilyl)amide (32 mg, 0.19 
mmol) and trimethylsilyl chloride (27 L, 0.21 mmol) in tetrahydrofuran (1 mL) at –78 ºC was 
added ketone 423 (50 mg, 0.17 mmol) as a solution in tetrahydrofuran (1 mL) and warmed to 
room temperature. TLC was used to monitor reaction progress. TLC plates were developed with 
25% EtOAc/Hex and visualized by UV lamp and KMnO4. Reaction solution was diluted with 
ethyl acetate (2 mL) and the washed with saturated NaHCO3 solution (4 mL). Organic phase was 
dried over anhydrous Na2SO4 and concentrated under reduced pressure to afford silyl enol ether 
424 (61 mg, 98% yield). No further purification necessary but silyl enol ether 424 is stable to 
silica gel chromatography. 
Silyl enol ether 424. 
1
H-NMR (400 MHz; CDCl3): δ 7.16 (d, J = 8.5 Hz, 1H), 6.93 (d, J 
= 2.8 Hz, 1H), 6.78 (dd, J = 8.5, 2.8 Hz, 1H), 6.55 (s, 1H), 4.91 (q, J = 6.8 Hz, 1H), 4.70 (d, J = 
0.9 Hz, 2H), 3.81 (s, 3H), 3.81 (s, 3H), 1.86 (d, J = 1.4 Hz, 3H), 1.70 (d, J = 6.8 Hz, 3H), 0.02 (s, 
9H); 
13
C NMR (101 MHz; CDCl3): δ 190.9, 157.9, 155.5, 148.0, 140.4, 130.6, 129.2, 128.8, 















Preparation of indanone 427: 
 
Indanone 427. Lewis acid mediated cyclization: To an oven dried vial fitted with a 
magnetic stir bar was added silyl enol ether 424 (3.6 mg, 0.01 mmol) and dichloromethane (1 
mL), solution was cooled to –78 ºC. Boron tribromide (10 L, 0.10 mmol) was added at –78 ºC, 
reaction solution turned bright orange. TLC was used to monitor reaction progress. TLC plates 
were developed with 10% EtOAc/Hex and visualized by UV lamp and KMnO4. After 30 minutes 
reaction was quenched with saturated NH4Cl solution (1 mL) at –78 ºC and allowed to warm to 
room temperature. Phases were separated. Organic phase was washed with brine (1 mL), dried 
over anhydrous Na2SO4 and concentrated under reduced pressure. Crude material was purified 
with silica gel chromatograph (gradient elution 1050% EtOAc/Hex) to afford indanone 427 
(1.3 mg 59% yield, >20:1 dr). 
 
Palladium(0)-catalyzed cyclization: To an oven dried vial fitted with a magnetic stir bar 
was added tris(dibenzylideneacetone)dipalladium(0) (3 mg, 0.005 mmol) and 
ethylenebis(diphenylphosphine) (4 mg, 0.009 mmol) and silyl enol ether 424 (32 mg, 0.09 





























After two days reaction was cooled to room temperature and purified with silica gel 
chromatography (gradient elution 1050% EtOAc/Hex) to afford indanone 427 (15 mg 80% 
yield; >20:1 dr). 
Indanone 427. 
1
H-NMR (400 MHz; CDCl3): δ 7.22-7.20 (m, 1H), 7.14 (d, J = 2.5 Hz, 
1H), 7.12 (d, J = 2.7 Hz, 1H), 4.89 (d, J = 0.7 Hz, 1H), 4.87 (quintet, J = 1.6 Hz, 1H), 3.78 (s, 
3H), 3.44 (d, J = 4.3 Hz, 1H), 2.45 (qd, J = 7.3, 4.3 Hz, 1H), 1.50 (t, J = 1.0 Hz, 3H), 1.25 (d, J = 
7.4 Hz, 3H); HRMS (EI) m/z 217.1221 [calc’d for C14H16O2 (M+H)+ 217.1223]. 
Preparation of TIPS-ether 432: 
 
TIPS-ether 432. To a flame dried round bottom flask fitted with a magnetic stir bar was 
added 3-bromo-5-chlorophenol (431) (25 g, 120.5 mmol) and dichloromethane (120 mL) the 
resulting solution was cooled to 0 ºC with an ice bath. To the stirred solution was added 
1,8-diazabicyclo[5.4.0]undec-7-ene (22 mL, 144.6 mmol) and triisopropylsilyl chloride (27 mL, 
126.2 mmol) at 0 ºC. Reaction was stirred at 0 ºC for 20 minutes and then warmed to room 
temperature. TLC was used to monitor reaction progress. TLC plates were developed with 10% 
EtOAc/Hex and visualized by UV lamp and KMnO4. Reaction solution was diluted with 
dichloromethane (120 mL) and hydrolyzed with H2O (250 mL). Phases were separated and the 
organic phase was washed with brine (250 mL), dried over anhydrous MgSO4 and concentrated 
under reduced pressure. Crude oil was purified with silica gel chromatography (20:1 silica/crude 
material, eluent 100% Hexanes) to afford TIPS-ether 432 (39.7 g, 91% yield) as colorless oil. 
TIPS-ether 432. FTIR (thin film/NaCl): 2946, 2868, 1582, 1559, 1463, 1434, 1385, 
1273, 1092, 993, 968, 882, 837, 777, 749, 685, 670; 
1










1.7 Hz, 1H), 6.93 (t, J = 1.9 Hz, 1H), 6.80 (t, J = 2.0 Hz, 1H), 1.29-1.20 (m, 3H), 1.10 (d, J = 7.2 
Hz, 18H); 
13
C-NMR (101 MHz; CDCl3): δ 157.5, 135.3, 124.3, 122.7, 121.9, 119.4, 18.0, 12.7; 
HRMS (EI) m/z 382.0785 [calc’d for C15H24BrClOSi (M+NH4)+ 362.0468]. 
Preparation of aldehyde 433: 
 
Aldehyde 433. Following the procedure of Serwatoski et al.
111,112
 Preparation of lithium 
diisopropylamide (LDA) solution (0.5 M in THF): To a flame dried round bottom flask fitted 
with a magnetic stir bar was added tetrahydrofuran (200 mL) and diisopropylamine (23 mL, 
163.7 mmol) solution was cooled to –78 ºC and n-butyllithium (1.6 M in THF, 102 mL, 163.7 
mmol) was added. Stirred for 30 minutes at –78 ºC prior to use.  
To a stirred solution of TIPS-ether 432 (39.7 g, 109.1 mmol) in tetrahydrofuran (220 mL) 
was added LDA solution (0.5 M in THF, 325 mL), moderate pace via cannula, at –78 ºC. Upon 
complete addition the reaction solution was stirred 45 minutes at –78 ºC. N,N-
Dimethylformamide (17 mL) was added at –78 ºC and stirred for 45 minutes. TLC was used to 
monitor reaction progress. TLC plates were developed with 10% EtOAc/Hex and visualized by 
UV lamp and KMnO4. Quenched with 1 M HCl (550 mL) at –78 ºC followed by warming to 
room temperature. TLC was used to monitor hydrolysis of the TIPS-ether. TLC plates were 
developed with 10% EtOAc/Hex and visualized by UV lamp and KMnO4. Upon warming to 
room temperature the solution was further acidified to pH = 1 with 6 M HCl. Phases were 
separated. Aqueous phase was extracted with diethyl ether (3 x 250 mL). Combined organic 




i. LDA, THF, –78 ºC
ii. DMF, –78 ºC






phase was dried over anhydrous MgSO4 and concentrated under reduced pressure to afford a 
crude solid. Crude material was purified with silica gel chromatography (510152025% 
EtOAc/Hex) to afford aldehyde 433 (24.1 g, 94% yield) as a pink solid. 
Aldehyde 433. FTIR (KBr pellet): 3234, 1667, 1552, 1439, 1410, 1245, 1057, 948, 862, 
809, 759, 641, 504; 
1
H-NMR (400 MHz; DMSO-d6): δ 11.43 (br s, 1H), 10.14 (s, 1H), 7.13 (d, J 
= 2.3 Hz, 1H), 6.97 (d, J = 2.3 Hz, 1H); 13-C NMR (101 MHz; DMSO-d6): δ 188.6, 162.2, 
137.6, 126.5, 121.7, 120.4, 117.6; HRMS (EI) m/z 234.8988 [calc’d for C7H4BrClO2 (M-H)- 
233.9083]. 
Preparation of methyl ether 434: 
 
Methyl ether 434. To a stirred solution of phenol 433 (24.1 g, 102.35 mmol) in N,N-
dimethylformamide (DMF) (100 mL) was added potassium carbonate (28.3 g, 204.7 mmol) and 
iodomethane (7.6 mL, 122.82 mmol) at room temperature. TLC was used to monitor reaction 
progress. TLC plates were developed with 20% EtOAc/Hex and visualized by UV lamp and 
KMnO4. Reaction was complete after 14 hours. Reaction was diluted with diethyl ether (200 mL) 
and H2O (200 mL) followed by separating phases. Aqueous phase was extracted with diethyl 
ether (3 x 200 mL). Combined organic phase was washed with H2O (3 x 200 mL) and brine (200 
mL). During workup ethyl acetate was added sparingly to help product dissolve. Organic phase 
was dried over anhydrous MgSO4 and concentrated under reduced pressure. Crude material was 
triturated with hexanes, solid with hexanes until filtrate was colorless, to afford methyl ether 434 












Methyl ether 434. FTIR (thin film/NaCl): 1769, 1696, 1591, 1539, 1468, 1431, 1395, 
1296, 1254, 1169, 1179, 1055, 1030, 908, 868, 845, 809; 
1
H-NMR (400 MHz; CDCl3): δ 10.31 
(s, 1H), 7.13 (d, J = 2.5 Hz, 1H), 6.95 (d, J = 2.4 Hz, 1H), 3.87 (s, 3H); 
13
C-NMR (101 MHz; 
CDCl3): δ 189.1, 162.9, 139.1, 127.2, 123.9, 119.3, 116.5, 56.3; HRMS (EI) m/z 250.929 [calc’d 
for C8H6BrClO2 (M+H)+ 247.924]. 
Preparation of -unsaturated ester 435: 
 
-Unsaturated ester 435. Following the procedure of Davies et al.
119
 To a flame dried 
round bottom flask equipped with a reflux condenser and a magnetic stir bar was added 
tetrahydrofuran (15 mL), triethyl-2-phosphonopropionate (0.83 mL, 3.85 mmol) and 
methylmagnesium bromide solution (3.0 M in Et2O, 1.3 mL, 3.85 mmol). Addition of 
methylmagnesium bromide is exothermic. Deprotonation was stirred for 15 minutes at room 
temperature. Aldehyde 434 (800 mg, 3.21 mmol) as a solution in tetrahydrofuran (15 mL) was 
added to the ylide solution at room temperature. Reaction was transferred to a preheated oil bath 
(75 ºC) and refluxed for 24 hours. TLC was used to monitor reaction progress. TLC plates were 
developed with 10% EtOAc/Hex and visualized by UV lamp and KMnO4. Reaction solution was 
cooled to room temperature and quenched with saturated NH4Cl solution (50 mL) followed by 
diluting with ethyl acetate (30 mL). Phases were separated. Aqueous phase was extracted with 
ethyl acetate (1 x 50 mL). Combined organic phase was washed with H2O (60 mL) and brine (60 

















Crude material was absorbed directly onto silica gel (1 g) and purified with silica gel 
chromatography (20:1 silica/crude material; gradient elution 510% EtOAc/Hex) to afford 
-unsaturated ester 435 (1.0 g, 93% yield) as yellow oil. 
-Unsaturated ester 435. 
1
H-NMR (400 MHz; CDCl3): δ 7.39 (d, J = 1.4 Hz, 1H), 
7.10 (d, J = 2.5 Hz, 1H), 6.95 (d, J = 2.5 Hz, 1H), 4.29 (q, J = 7.1 Hz, 2H), 3.81 (s, 3H), 1.76 (d, 
J = 1.4 Hz, 3H), 1.36 (t, J = 7.1 Hz, 3H); 
13
C-NMR (101 MHz; CDCl3): δ 167.6, 159.7, 135.6, 
134.5, 133.3, 128.0, 124.2, 117.3, 114.8, 61.1, 55.9, 14.62, 14.43. 
Preparation of allylic alcohol 436: 
 
Allylic alcohol 436. To a flame dried round bottom flask equipped with a magnetic stir 
bar was added -unsaturated ester 435 (1.7 g, 5.10 mmol) and tetrahydrofuran (45 mL). The 
resulting solution was cooled to 0 ºC and diisobutylaluminum hydride (1 M in hexanes, 10.4 mL, 
10.80 mmol) was added. TLC was used to monitor reaction progress. TLC plates were developed 
with 10% EtOAc/Hex and visualized by UV lamp and KMnO4. Quenched with saturated 
Rochelle salt solution (30 mL) at 0 ºC and warmed to room temperature, stirred over night. 
Phases were separated. Organic phase was washed with H2O (25 mL) and brine (25 mL). 
Organic phase was dried over anhydrous MgSO4 and concentrated under reduced pressure. 
Crude material was absorbed onto silica gel (2 g) under reduced pressure and purified with silica 
gel chromatography (50:1 silica/crude material, gradient elution 102030% EtOAc/Hex) to 














Allylic alcohol 436. 
1
H-NMR (400 MHz; CDCl3): δ 7.08 (d, J = 2.5 Hz, 1H), 6.93 (d, J = 
2.5 Hz, 1H), 6.23 (d, J = 1.3 Hz, 1H), 4.23 (d, J = 5.5 Hz, 2H), 3.78 (s, 3H), 1.75 (t, J = 6.2 Hz, 
1H), 1.56 (d, J = 1.0 Hz, 3H); 
13
C-NMR (101 MHz; CDCl3): δ 159.0, 141.7, 135.1, 129.2, 125.2, 
121.5, 117.1, 114.6, 67.6, 55.9, 15.4. 
Preparation of TBS-ether 437: 
 
TBS-ether 437. To a flame dried round bottom flask equipped with a magnetic stir bar 
was added allylic alcohol 436 (1.5 g, 5.20 mmol), dichloromethane (10 mL), 
4-(dimethylamino)pyridine (62 mg, 0.51 mmol) and imidazole (690 mg, 10.20 mmol). The 
resulting solution was cooled to 0 ºC with an ice bath and tert-butyldimethylsilyl chloride (850 
mg, 5.61 mmol) was added. Reaction was stirred for 30 minutes at 0 ºC after which the ice bath 
was removed and the reaction was warmed to room temperature. TLC was used to monitor 
reaction progress. TLC plates were developed with 5% EtOAc/Hex and visualized by UV lamp 
and KMnO4. Quenched with saturated NH4Cl solution (10 mL). Phases were separated. Organic 
phase was washed with H2O (10 mL) and brine (10 mL). Organic phase was dried over 
anhydrous MgSO4 and concentrated under reduced pressure. Crude material was absorbed 
directly onto silica gel (2 g) under reduced pressure and purified with silica gel chromatography 
(25:1 silica/crude material, gradient elution 2510% EtOAc/Hex) to afford TBS-ether 437 
(2.0 g, 95% yield) as colorless oil. 
TBS-ether 437. 
1
H-NMR (400 MHz; CDCl3): δ 7.08 (d, J = 2.6 Hz, 1H), 6.93 (d, J = 2.5 















0.95 (s, 9H), 0.13 (s, 6H); 
13
C-NMR (101 MHz; CDCl3): δ 158.8, 141.3, 135.2, 129.9, 125.4, 
120.2, 117.0, 114.6, 67.2, 55.9, 26.1, 18.6, 15.2, -5.1.  
Preparation of alcohol 438: 
 
Alcohol 438. To a flame dried round bottom flask equipped with a magnetic stir bar was 
added aryl bromide 437 (250 mg, 0.62 mmol, and tetrahydrofuran (12 mL). The resulting 
solution was cooled to –78 ºC. n-Butyllithium (1.6 M in THF, 0.47 mL, 0.74 mmol) was added 
at a moderate rate at –78 ºC. Reaction was stirred for 30 minutes at –78 ºC. Propionaldehyde (90 
L, 1.24 mmol) as a solution in tetrahydrofuran (2 mL) was added in one portion at –78 ºC. 
Reaction was stirred for 1 hour at –78 ºC. TLC was used to monitor reaction progress. TLC 
plates were developed with 10% EtOAc/Hex and visualized by UV lamp and KMnO4. Quenched 
with saturated NH4Cl solution (3 mL) and warmed to room temperature. Phases were separated. 
Organic phase was washed with H2O (6 mL) and brine (6 mL). Organic phase was dried over 
anhydrous MgSO4 and concentrated under reduced pressure. Crude material was absorbed onto 
silica gel (500 mg) and purified with silica gel chromatography (20:1 silica/crude material, 
gradient elution 210% EtOAc/Hex) to afford alcohol 438 (200 mg, 84% yield) as colorless oil. 
Alcohol 438. 
1
H-NMR (400 MHz; CDCl3): δ 7.00 (d, J = 2.6 Hz, 1H), 6.88 (d, J = 2.6 
Hz, 1H), 6.25 (s, 1H), 4.72 (td, J = 6.2, 3.6 Hz, 1H), 4.20 (s, 2H), 3.81 (s, 3H), 1.78 (d, J = 0.6 
Hz, 1H), 1.64 (t, J = 5.7 Hz, 2H), 1.45 (s, 3H), 0.94 (s, 9H), 0.91 (t, J = 7.4 Hz, 3H), 0.12 (s, 
6H); 
13






i. nBuLi, THF, –78 ºC
ii. propionaldehyde









67.3, 55.6, 26.1, 18.6, 15.1, 10.3, -5.1; HRMS (EI) m/z 385.1969 [calc’d for C20H33ClO3Si 
(M+H)+ 385.196]. 
Preparation of ketone 439: 
 
Ketone 439. To a flame dried round bottom flask equipped with a magnetic stir bar was 
added dichloromethane (25 mL) and dimethylsulfoxide (1 mL, 13.6 mmol). The resulting 
solution was cooled to –78 ºC. Oxalyl chloride (0.6 mL, 6.80 mmol) was added at –78 ºC and 
reaction was stirred for 20 minutes. Alcohol 438 (1.3 g, 3.40 mmol) and triethylamine (2.4 mL, 
17.00 mmol) as a solution is dichloromethane (5 mL) were added via cannula at –78 ºC followed 
by stirring for 1 hour. Reaction solution was warmed to room temperature. TLC was used to 
monitor reaction progress. TLC plates were developed with gradient elution 1020% 
EtOAc/Hex and visualized by UV lamp and KMnO4. Reaction solution was diluted with 
dichloromethane (20 mL) and washed with saturated NaHCO3 solution (60 mL), H2O (60 mL) 
and brine (100 mL). Organic phase was dried over anhydrous MgSO4 and concentrated under 
reduced pressure to afford crude ketone 439 (1.4 g, quantitative) as yellow oil. Crude material 
was taken directly into desilylation. 


































Allylic alcohol 440. To a flame dried round bottom flask was added TBS-ether 439 (1.4 
g, 3.40 mmol) and tetrahydrofuran (12 mL). The resulting solution was cooled to 0 ºC. 
Tetrabutylammonium fluoride solution (1 M in THF, 5.1 mL) was added at 0 ºC. Reaction was 
warmed to room temperature. TLC was used to monitor reaction progress. TLC plates were 
developed with 20% EtOAc/Hex and visualized by UV lamp and KMnO4. Quenched with 
saturated NH4Cl solution (50 mL). Phases were separated. Organic phase was washed with H2O 
(50 mL) and brine (50 mL). Organic phase was dried over anhydrous MgSO4 and concentrated 
under reduced pressure to afford allylic alcohol 440 (1.1 g, quantitative) as oil. Crude material 
was carried on directly to acylation. 
Preparation of allylic carbonate 441: 
 
Allylic carbonate 441. To an oven dried round bottom flask equipped with a magnetic 
stir bar was added allylic alcohol 440 (800 mg, 2.98 mmol), dichloromethane (60 mL), 
4-(dimethylamino)pyridine (40 mg, 0.30 mmol) and pyridine (0.50 mL, 5.96 mmol). The 
resulting solution was cooled to 0 ºC. Methyl chloroformate (0.35 mL, 4.48 mmol) was added at 
0 ºC and stirred for 60 minutes. Reaction was warmed to room temperature. TLC was used to 
monitor reaction progress. TLC plates were developed with 30% EtOAc/Hex and visualized by 
UV lamp and KMnO4. Reaction was complete after 8 hours at room temperature. Quenched with 
saturated NH4Cl solution (50 mL). Phases were separated. Organic phase was washed with H2O 
(50 mL) and brine (50 mL). Organic layer was dried over anhydrous MgSO4 and concentrated 


















gel chromatography (20:1 silica/crude material, gradient elution 1020% EtOAc/Hex) to afford 
allylic carbonate 441 (800 mg, 86% yield) as yellow oil.  
Allylic carbonate 441. 
1
H-NMR (400 MHz; CDCl3): δ 7.04 (d, J = 2.6 Hz, 1H), 6.88 (d, 
J = 2.6 Hz, 1H), 6.51 (d, J = 1.3 Hz, 1H), 4.69 (d, J = 1.0 Hz, 2H), 3.81 (s, 3H), 3.81 (s, 3H), 
2.71 (d, J = 6.8 Hz, 2H), 1.47 (d, J = 1.3 Hz, 3H), 1.09 (t, J = 7.3 Hz, 3H); 
13
C-NMR (101 MHz; 
CDCl3): δ 205.9, 159.1, 155.8, 143.5, 136.4, 135.4, 125.4, 124.2, 117.0, 111.6, 72.0, 55.8, 55.0, 
35.8, 15.4, 8.6. 
Preparation of silyl enol ether 442: 
 
Silyl enol ether 442. To a flame dried round bottom flask equipped with a magnetic stir 
bar was added ketone 441 (419 mg, 1.28 mmol), tetrahydrofuran (9 mL) and trimethylsilyl 
chloride (325 L, 2.56 mmol). The resulting solution was cooled to –78 ºC. Lithium 
bis(trimethylsilyl)amide (0.5 M solution in DME, 3.8 mL, 1.92 mmol) was added at –78 ºC. 
Reaction was stirred at –78 ºC for 1 hour followed by warming to room temperature. Reaction 
was stirred overnight at room temperature. TLC was used to monitor reaction progress. TLC 
plates were developed with 15% EtOAc/Hex and visualized by UV lamp and p-anisaldehyde. 
Reaction solution was washed with saturated NaHCO3 solution (10 mL). Organic phase was 
dried over anhydrous Na2SO4. Crude material was purified with silica gel chromatography (20:1 
silica/crude material, gradient elution 1020% EtOAc/Hex) to afford silyl enol ether 442 (500 


















Silyl enol ether 442. 
1
H-NMR (400 MHz; CDCl3): δ 6.88 (d, J = 2.7 Hz, 1H), 6.84 (d, J 
= 2.7 Hz, 1H), 6.33 (d, J = 1.2 Hz, 1H), 4.93 (q, J = 6.8 Hz, 1H), 4.70 (d, J = 0.9 Hz, 2H), 3.81 
(s, 3H), 3.79 (s, 3H), 1.65 (d, J = 6.8 Hz, 3H), 1.55 (d, J = 1.3 Hz, 3H), 0.03 (s, 9H); 
13
C-NMR 
(101 MHz; cdcl3): δ 158.6, 155.9, 148.6, 142.4, 134.7, 134.1, 126.0, 125.6, 114.0, 113.1, 109.8, 
72.7, 55.6, 54.9, 15.8, 11.5, 0.5. 
Preparation of Indanone 443: 
 
Indanone 443. To an oven dried vial equipped with a magnetic stir bar was added 
Pd(dba)2 (4 mg, 0.007 mmol) and Diphos (5 mg, 0.013 mmol); system was purged with a stream 
of nitrogen prior to the addition of 1,4-dioxane (0.5 mL). Catalyst solution was premixed for 30 
minutes at room temperature. -Allyl precursor 442 (50 mg, 0.13 mmol) was added as a solution 
in 1,4-dioxane (1 mL) and reaction solution was transferred to a preheated (80 ºC) oil bath. After 
19 hours reaction solution was cooled to room temperature. TLC was used to monitor reaction 
progress after 19 hours but reaction was not monitored until this point. TLC plates were 
developed with 15% EtOAc/Hex and visualized by UV lamp and p-anisaldehyde. Indanone 443 
and silyl enol ether 442 have very close Rf’s under the TLC conditions; indanone 443 stains 
green and silyl enol ether stains brown with p-anisaldehyde. Reaction solution was concentrated 
and purified with silica gel chromatography (50:1 silica/reaction mixture, gradient elution 

















1,4-dioxane, 80 ºC, 19 h
 245 
Indanone 443. 1H-NMR (300 MHz; CDCl3): δ 7.20 (d, J = 2.3 Hz, 1H), 7.14 (d, J = 2.3 
Hz, 1H), 4.88 (t, J = 1.5 Hz, 1H), 4.79 (d, J = 0.7 Hz, 1H), 3.85 (s, 3H), 3.57 (d, J = 3.1 Hz, 1H), 
2.48 (qd, J = 7.5, 3.1 Hz, 1H), 1.60 (d, J = 0.5 Hz, 3H), 1.32 (d, J = 7.5 Hz, 3H); 7.18 (d, J = 2.4 
Hz, 1H), 7.14 (d, J = 2.3 Hz, 1H), 5.00 (t, J = 1.5 Hz, 1H), 4.69 (s, 1H), 4.15 (d, J = 7.7 Hz, 1H), 
3.85 (s, 3H), 2.89 (quintet, J = 7.4 Hz, 1H), 1.59 (s, 3H), 1.20 (d, J = 7.3 Hz, 3H). 
Preparation of furan 444: 
  
Furan 444. To a flame dried schlenk tube was added lithium chloride (6 mg, 0.15 mmol) 
and flame dried under vacuum. To lithium chloride was added ketone 441 (50 mg, 0.15 mmol) as 
a solution in 1,2-dimethoxyethane (DME) (1 mL); followed by the addition of lithium 
bis(trimethylsilyl)amide (0.5 M solution in DME, 0.3 mL, 0.15 mmol) at room temperature, 
allowed enolization to stir at room temperature for 30 minutes. Pd(dba)2 (4 mg, 0.008 mmol) and 
Diphos (6 mg, 0.015 mmol) were premixed in DME (0.5 mL) and stirred for 30 minutes at room 
temperature. Catalyst solution was transferred to enolate solution and the reaction solution was 
immediately transferred to a preheated oil bath (80 ºC). After 16 hours reaction was cooled to 
room temperature. TLC was used to monitor reaction progress after 16 hours but reaction was 
not monitored until this point. TLC plates were developed with 15% EtOAc/Hex and visualized 
by UV lamp and p-anisaldehyde. Quenched with H2O (1 mL) and phases were separated. 
Aqueous phase was extracted with diethyl ether (3 x 1 mL). Combined organic phase was dried 


















with silica gel chromatography (gradient elution 123451015% EtOAc/Hex) to 
afford furan 444 (29 mg, 76% yield). 
Furan 444. FTIR (thin film/NaCl): 3452, 3088, 2972, 2939, 1771, 1607, 1487, 1436, 
1377, 1333, 1309, 1280, 1230, 1196, 1134, 1069, 1032, 858; 
1
H-NMR (400 MHz; CDCl3): δ 
6.80 (d, J = 2.0 Hz, 1H), 6.78 (d, J = 2.1 Hz, 1H), 5.81 (s, 1H), 5.23 (s, 1H), 5.10 (t, J = 1.5 Hz, 
1H), 4.93 (q, J = 7.1 Hz, 1H), 3.82 (s, 3H), 1.80 (d, J = 7.0 Hz, 3H), 1.49 (d, J = 0.4 Hz, 3H); 
13
C-NMR (101 MHz; CDCl3): δ 161.2, 154.8, 141.9, 138.2, 130.3, 129.6, 116.8, 115.5, 102.7, 
91.2, 88.0, 56.0, 16.2, 10.4.  
Palladium(0)-Catalyzed Cyclization with Cesium Carbonate as Base: 
 
Palladium(0)-Catalyzed Cyclization with Cesium Carbonate as Base: To an oven 
dried vial equipped with a magnetic stir bar was added Pd(dba)2 (4 mg, 0.008 mmol), Diphos (6 
mg, 0.015 mmol) and cesium carbonate (98 mg, 0.30 mmol); the system was purged with a 
stream of nitrogen prior to the addition of 1,4-dioxane (0.5 mL). Catalyst and base solution was 
premixed for 30 minutes at room temperature. Ketone 441 (50 mg, 0.13 mmol) was added as a 
solution in 1,4-dioxane (1 mL) and reaction solution was transferred to a preheated (80 ºC) oil 





































monitor reaction progress after 21 hours but reaction was not monitored until this point. TLC 
plates were developed with 15% EtOAc/Hex and visualized by UV lamp and p-anisaldehyde. 
Quenched with 1 M HCl (2 mL) and phases were separated. Aqueous phase was extracted with 
diethyl ether (3 x 1 mL). Combined organic phase was dried over anhydrous Na2SO4 and 
concentrated under reduced pressure. Reaction solution was concentrated and purified with silica 
gel chromatography (50:1 silica/reaction mixture, gradient elution 12345% 
EtOAc/Hex) to afford indanone 443, ketone 445, enone 446 and tricycle 447. The yield of each 




H-NMR (400 MHz; CDCl3): δ 7.06 (d, J = 2.8 Hz, 1H), 7.03 (d, J = 2.7 Hz, 
1H), 6.51 (t, J = 0.7 Hz, 1H), 3.82 (s, 3H), 3.03 (dqd, J = 9.2, 7.1, 5.1 Hz, 1H), 2.36 (d, J = 9.2 
Hz, 1H), 2.35 (d, J = 5.1 Hz, 1H), 2.02 (d, J = 1.5 Hz, 3H), 1.25 (d, J = 7.1 Hz, 4H); 
13
C-NMR 




H-NMR (400 MHz; CDCl3): δ 7.29 (d, J = 2.2 Hz, 1H), 7.20 (d, J = 2.2 Hz, 
1H), 5.82 (s, 1H), 5.36 (s, 1H), 5.27 (quintet, J = 1.4 Hz, 1H), 3.88 (s, 3H), 1.47 (t, J = 1.2 Hz, 
3H); 
13
C NMR (101 MHz; CDCl3): δ 169.5, 161.9, 138.3, 137.1, 130.2, 122.9, 119.8, 107.2, 
84.6, 56.3, 16.2. 
Tricycle 447. 
1
H-NMR (400 MHz; CDCl3): δ 7.25 (d, J = 2.7 Hz, 1H), 7.14 (d, J = 2.7 
Hz, 1H), 3.80 (s, 3H), 2.59 (qd, J = 6.6, 1.2 Hz, 1H), 2.38 (dd, J = 8.6, 4.6 Hz, 1H), 1.40 (d, J = 
6.6 Hz, 3H), 1.35 (s, 3H), 1.20 (ddd, J = 8.6, 4.8, 1.3 Hz, 1H), 0.05 (t, J = 4.7 Hz, 1H); 
13
C-NMR 
(101 MHz; CDCl3): δ 198.5, 157.5, 135.8, 133.9, 131.4, 121.3, 109.9, 55.9, 44.3, 25.7, 24.4, 
21.5, 20.6, 12.5; HRMS (EI) m/z 251.0833 [calc’d for C14H15ClO2 (M+H)+ 250.0761]. 
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Preparation of amine of amine 455:  
 
Amine 455.  To an oven dried vial equipped with a magnetic stir bar was added aryl 
chloride (16 mg, 0.06 mmol), BrettPhos (286) (2 mg, 0.003 mmol), BrettPhos precatalyst (287) 
(2 mg, 0.003 mmol); the system was evacuated and backfilled with nitrogen (3 x). To the vial 
was added 1,4-Dioxane (0.7 mL), allylamine (6 L, 0.07 mmol) and lithium 
bis(trimethylsilyl)amide (0.5 M in 1,4-dioxane, 0.3 mL, 0.15 mmol). Vial was immediately 
placed in a preheated oil bath (80 ºC). After 24 hours the reaction solution was cooled to room 
temperature. TLC was used to monitor reaction progress after 24 hours but reaction was not 
monitored until this point. TLC plates were developed with 10% EtOAc/Hex and visualized by 
UV lamp and p-anisaldehyde. Reaction solution was quenched with saturated NH4Cl solution (1 
mL) and diluted with dichloromethane (2 mL). Phases were separated and the organic layer was 
dried over anhydrous MgSO4 and concentrated. Crude residue was purified with silica gel 
chromatography (gradient elution 151020% EtOAc/Hex) to afford amine 455 (2 mg, 12% 
yield) the mass balance of the material appears correspond to loss of the chloride and the 
1
H 
NMR spectra matches that of indanone 427. 
Amine 455. 
1
H-NMR (300 MHz; CDCl3): δ 6.59 (d, J = 2.2 Hz, 1H), 6.33 (d, J = 2.3 Hz, 
1H), 5.97-5.84 (m, 1H), 5.24 (dd, J = 17.3, 1.4 Hz, 1H), 5.18 (dd, J = 10.3, 1.5 Hz, 1H), 5.11 (dt, 
J = 1.2, 0.6 Hz, 1H), 4.99-4.98 (m, 1H), 3.81 (s, 3H), 3.43 (d, J = 3.4 Hz, 1H), 2.48-2.39 (m, 
1H), 1.57 (t, J = 0.7 Hz, 3H), 1.31 (d, J = 7.4 Hz, 3H). 
H2N
BrettPhos (286) (5 mol%)
BrettPhos Precat. (287)(5 mol%)
(1.2 eq)
LiHMDS















References Relevant to Chapter 5 
(91) Abell, A. D. C., James Morriss; Jones, Matthew Alan; McNabb, Stephen Brian; Neffe, 
Axel Thomas; Aitken, Steven Geoffrey; Stuart, Blair Gibb; Nikkel, Janna Marie; Duncan, 
Joanna Kimberley; Klanchantra, Mutita; Morton, James David; Bickerstaffe, Roy; 
Robertson, Lucinda Jane Goodricke; Lee, Hannah Yun Young; Muir, Matthew Stewart; 
Lincoln University, N. Z.; Canterprise Limited: 2008; Vol. Apr 24, 2008 
WO 2008048121 A2. 
(92) Boumendjel, A.; Miller, S. P. F. Tetrahedron Lett. 1994, 35, 819. 
(93) Snyder, S. A.; Breazzano, S. P.; Ross, A. G.; Lin, Y. Q.; Zografos, A. L. J. Am. Chem. 
Soc. 2009, 131, 1753. 
(94) Kobayashi, S. M., K.; Ishitani, H.; Matsuo, J.-I. Science of Synthesis 2002, 4, 317. 
(95) Reetz, M. T.; Huttenhain, S.; Hubner, F. Synthetic Commun. 1981, 11, 217. 
(96) Paterson, I. Tetrahedron Lett. 1979, 1519. 
(97) Shono, T.; Nishiguchi, I.; Komamura, T.; Sasaki, M. J. Am. Chem. Soc. 1979, 101, 984. 
(98) Greene, T. W., Wuts, P.G.M Protective Groups in Organic Synthesis, Third Edition; John 
Wiley & Sons, Inc., 1999. 
(99) Lu, Z.; Ma, S. M. Angew. Chem. Int. Ed. 2008, 47, 258. 
(100) Trost, B. M. J. Org. Chem. 2004, 69, 5813. 
(101) Graening, T.; Schmalz, H. G. Angew. Chem. Int. Ed. 2003, 42, 2580. 
(102) Trost, B. M. Chem. Pharm. Bull. 2002, 50, 1. 
(103) Helmchen, G. J Organomet. Chem. 1999, 576, 203. 
(104) Trost, B. M.; VanVranken, D. L. Chem. Rev. 1996, 96, 395. 
(105) Trost, B. M. Accounts Chem. Res. 1996, 29, 355. 
 250 
(106) Trost, B. M.; Crawley, M. L. Chem. Rev. 2003, 103, 2921. 
(107) Consiglio, G.; Waymouth, R. M. Chem. Rev. 1989, 89, 257. 
(108) Braun, M.; Meier, T. Angew. Chem. Int. Ed. 2006, 45, 6952. 
(109) Tsuji, J.; Minami, I.; Shimizu, I. Chem. Lett. 1983, 1325. 
(110) Tsuji, J. Tetrahedron 1986, 42, 4361. 
(111) Dabrowski, M.; Kubicka, J.; Lulinski, S.; Serwatowski, J. Tetrahedron Lett. 2005, 46, 
4175. 
(112) von Hirschheydt, T.; Voss, E. Synthesis-Stuttgart 2004, 2062. 
(113) Sarpong, R.; Marcus, A. P. Org. Lett. 2010, 12, 4560. 
(114) Zheng, W. H.; Zheng, B. H.; Zhang, Y.; Hou, X. L. J. Am. Chem. Soc. 2007, 129, 7718. 
(115) Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. 
Organometallics 1996, 15, 1518. 
(116) Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923. 
(117) Mattson, A. E.; Scheidt, K. A. J. Am. Chem. Soc. 2007, 129, 4508. 
(118) Merlic, C. A.; Aldrich, C. C.; Albaneze-Walker, J.; Saghatelian, A.; Mammen, J. J. Org. 
Chem. 2001, 66, 1297. 
(119) Claridge, T. D. W.; Davies, S. G.; Lee, J. A.; Nicholson, R. L.; Roberts, P. M.; Russell, 










































































H-NMR (400 MHz, CDCl3) of Compound 132 
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H-NMR (400 MHz, CDCl3) of Compound 133 
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H-NMR (400 MHz, CDCl3) of Compound 134
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H-NMR (300 MHz, CDCl3) of Compound 135 
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H-NMR (400 MHz; CDCl3) of Compound 143 
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H-NMR (400 MHz; CDCl3) of Compound 145 
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H-NMR (400 MHz; CDCl3) of Compound 146 
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H-NMR (400 MHz; CDCl3) of Compound 147 
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H-NMR (400 MHz; CDCl3) of Compound 148 
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H-NMR (400 MHz; CDCl3) of Compound 149 
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H-NMR (400 MHz; CDCl3) of Compound 150 
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H-NMR (400 MHz; DMSO-d6) of Compound 142
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H-NMR (300 MHz; CDCl3) of Compound 157 
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H-NMR (400 MHz; CDCl3) of Compound 158
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H-NMR (300 MHz; CDCl3) of Compound 159
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H-NMR (400 MHz; CDCl3) of Compound 160 
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H-NMR (300 MHz; CDCl3) of Compound 161
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H-NMR (400 MHz; CDCl3) of Compound 162
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H-NMR (500 MHz; CDCl3) of Compound 176 
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C-NMR (126 MHz, CDCl3) of Compound 176 
MH-IV-147SM
 Sample Name:
   MH-IV-147SM
 Data Collected on:
   nano-inova500
 Archive directory:
   /home/_data/walkup/mwhaley
 Sample directory:
   MH-IV-147SM_20110817_01
 FidFile: CARBON_01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Aug 17 2011
 Temp. 25.0 C / 298.1 K
Sample #1, Operator: mwhaley
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.042 sec
 Width 31446.5 Hz
 128 repetitions
OBSERVE  C13, 125.7686754 MHz
DECOUPLE  H1, 500.1757973 MHz




 Line broadening 0.5 Hz
FT size 65536







H-NMR (500 MHz; CDCl3) of Compound 177 
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C-NMR (126 MHz, CDCl3) of Compound 177 
MH-IV-147
 Sample Name:
   MH-IV-147
 Data Collected on:
   nano-inova500
 Archive directory:
   /home/_data/walkup/mwhaley
 Sample directory:
   MH-IV-147_20110817_01
 FidFile: CARBON_01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Aug 17 2011
 Temp. 25.0 C / 298.1 K
Sample #2, Operator: mwhaley
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.042 sec
 Width 31446.5 Hz
 256 repetitions
OBSERVE  C13, 125.7686754 MHz
DECOUPLE  H1, 500.1757973 MHz




 Line broadening 0.5 Hz
FT size 65536







H-NMR (500 MHz; CDCl3) of Compound 179 
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C-NMR (126 MHz, CDCl3) of Compound 179 
MH-IV-153
 Sample Name:
   MH-IV-153
 Data Collected on:
   nano-inova500
 Archive directory:
   /home/_data/walkup/mwhaley
 Sample directory:
   MH-IV-153_20110817_01
 FidFile: CARBON_01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Aug 17 2011
 Temp. 25.0 C / 298.1 K
Sample #3, Operator: mwhaley
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.042 sec
 Width 31446.5 Hz
 1000 repetitions
OBSERVE  C13, 125.7686754 MHz
DECOUPLE  H1, 500.1757973 MHz




 Line broadening 0.5 Hz
FT size 65536







H-NMR (500 MHz; CDCl3) of Compound 180 
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C-NMR (126 MHz, CDCl3) of Compound 180 
MH-IV-154
 Sample Name:
   MH-IV-154
 Data Collected on:
   nano-inova500
 Archive directory:
   /home/_data/walkup/mwhaley
 Sample directory:
   MH-IV-154_20110817_01
 FidFile: CARBON_01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Aug 17 2011
 Temp. 25.0 C / 298.1 K
Sample #4, Operator: mwhaley
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.042 sec
 Width 31446.5 Hz
 2880 repetitions
OBSERVE  C13, 125.7686754 MHz
DECOUPLE  H1, 500.1757973 MHz




 Line broadening 0.5 Hz
FT size 65536







H-NMR (500 MHz; CDCl3) of Compound 183 
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C-NMR (126 MHz, CDCl3) of Compound 183 
MH-IV-155
 Sample Name:
   MH-IV-155
 Data Collected on:
   nano-inova500
 Archive directory:
   /home/_data/walkup/mwhaley
 Sample directory:
   MH-IV-155_20110818_01
 FidFile: CARBON_01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Aug 18 2011
 Temp. 25.0 C / 298.1 K
Sample #9, Operator: mwhaley
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.042 sec
 Width 31446.5 Hz
 8064 repetitions
OBSERVE  C13, 125.7686754 MHz
DECOUPLE  H1, 500.1757973 MHz




 Line broadening 0.5 Hz
FT size 65536

















H-NMR (300 MHz; CDCl3) of Compound 188 
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H NMR (300 MHz, CDCl3) of Compound 253
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H NMR (400 MHz, CDCl3) of Compound 254
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H NMR (300 MHz, CDCl3) of Compound 256
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H NMR (400 MHz, CDCl3) of Compound 261
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H NMR (400 MHz, CDCl3) of Compound 294 
 353 
 







































H NMR (400 MHz, CDCl3) of Compound 308
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C NMR (101 MHz, CDCl3) of Compound 308
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H NMR (300 MHz, CDCl3) of Compound 366
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H NMR (400 MHz, CDCl3) of Compound 365
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H NMR (400 MHz, CDCl3) of Compound 380
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H NMR (400 MHz, CDCl3) of Compound 378
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H NMR (300 MHz, CDCl3) of Compound 382 
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H NMR (400 MHz, CDCl3) of Compound 406
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H NMR (400 MHz, CDCl3) of Compound 432 
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H NMR (400 MHz, DMSO-d6) of Compound 433 
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H NMR (400 MHz, CDCl3) of Compound 444  
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H NMR (300 MHz, CDCl3) of Compound 448
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LIST OF ABBREVIATIONS  
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Å   angstrom 
Ac    acetate 
AcOH    acetic acid 
app    apparent 
Ar    aryl 
Bn    benzyl 
br    broad 
Bz    benzoyl 
C    carbon 
C6H6    benzene 
cat.    catalytic 
CH2Cl2   dichloromethane 
CH3CN   acetonitrile 
CuI    copper(I) iodide 
d    doublet 
DCC    dicyclohexylcarbodiimide 
DCE    1,2-dichloroethane 
dd    doublet of doublets 
ddd    doublet of doublet of doublets 
dddd    doublet of doublet of doublet of doublets 
DDQ    2,3-dichloro-5,6-dicyanobenzoquinone 
DIBAL-H   diisobutylaluminum hydride 
DMAP   4-(dimethylamino)pyridine 
DME    dimethoxyethane 
DMF    dimethylformamide 
DMP    Dess-Martin periodinane 
DMS    dimethylsulfide 
DMSO   dimethylsulfoxide 
dt    doublet of triplet 
ent    enantiomer 
ESI–APCI   electrospray ionization – atmospheric pressure chemical ionization 
Et    ethyl 
Et3N    triethylamine 
EtOAc   ethyl acetate 
EtOH    ethanol 
g    gram 
h    hour(s) 
H    hydrogen 
H2O    water 
H2SO4    sulfuric acid 
Hg(OAc)2   mercury(II) acetate 
HMPA   hexamethylphosphoramide 
HRMS   high resolution mass spectrometry 
HWE    Horner-Wadsworth-Emmons 
Hz    hertz 
449 
h    light 
Im    imidazole 
i-Pr2NEt   N,N-Diisopropylethylamine, H nig’s Base 
IR    infrared 
J    coupling constant 
K2CO3    potassium carbonate 
kg    kilogram 
KHMDS   potassium bis(trimethylsilyl)amide 
KOt-Bu   potassium tert-butoxide 
LAH    lithium aluminum hydride 
LDA    lithium diisopropylamide 
LiHMDS   lithium bis(trimethylsilyl)amide 
m     multiplet (NMR), mid (IR) 
Me    methyl 
Me2SO4   dimethylsulfate 
MeOH   methanol 
mg    milligram 
min    minute(s) 
mL    milliliter 
mmol    millimole 
mol sieves   molecular sieves 
mol    mole(s) 
NaBH4   sodium borohydride 
NaH    sodium hydride 
NaHCO3   sodium bicarbonate 
NaHMDS   sodium bis(trimethylsilyl)amide 
NaI    sodium iodide 
n-BuLi   n-butyllithium 
NH4Cl   ammonium chloride 
nm    nanometer 
NMR    nuclear magnetic resonance 
O3    ozone 
ºC    degrees Celsius 
Pd(OAc)2   palladium(II) acetate 
Pd2(dba)3   tris(dibenzylideneacetone)dipalladium(0) 
PG    protecting group 
Ph    phenyl 
PMB    paramethoxybenzyl 
ppm    parts per million 
p-TSA   p-toluenesulfonic acid 
Py    pyridine 
q    quartet 
quint.    quintuplet 
RCM    ring closing metathesis 
Rf    retention factor 
rt    room temperature 
450 
s    singlet (NMR), strong (IR) 
SOCl2    thionyl chloride 
t    triplet 
TBAF    tetrabutylammonium fluoride 
TBDPS   tert-butyldiphenylsilyl 
TBS    tert-butyldimethylsilyl 
t-Bu    tert-butyl 
t-BuLi   tert-butyllithium 
tert    tertiary 
Tf2O    triflic anhydride 
TFA    trifluoroacetate, trifluoroacetic acid 
TFAA    trifluoroacetic anhydride 
THF    tetrahydrofuran 
TIPS    triisopropylsilyl 
TLC    thin layer chromatography 
TMSCHN2  trimethylsilyldiazomethane 
TOF LCMS   time of flight liquid chromatography mass spectrometry 
w    weak 
    chemical shift 
∆    heat 
 
